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Abstract 
The present dissertation entitled, “Design of Luminescent Magnetic 
Nanostructures for Sensor, Drug delivery and Bioimaging Applications” is an 
embodiment of the investigations intended at developing simple inexpensive synthetic 
methods for producing luminescent carbon quantum dot and multifunctional magnetic 
luminescent nanostructures applicable for sensor and biomedical application. The in vitro 
applications of synthesized materials have also been investigated. The thesis is divided 
into two parts.   
The first part of the thesis includes the low cost synthetic route for fabrication of 
carbon quantum dots (CD) and their composites for sensing and bioimaging applications. 
Highly photoluminescent CDs with a quantum yield of 26% have been synthesized in one 
step by hydrothermal treatment of orange juice (Citrus nobilis deliciosa). Due to high 
photostability and low toxicity these CDs have been demonstrated as excellent probes in 
cellular imaging. These synthesized CD has been also used for the development of 
reusable novel magnetic silica/CD based hybrid nanostructure for monitoring and 
separation of fluoride ion through fluorescence sensing and external magnetic field 
respectively. The assay is based on the binding of fluoride ion into magnetic receptor 
substituting already bound CD. This method is highly sensitive, fast and selective for 
fluoride ion in aqueous solution having a linear response range of 1 to 20 μM (R2=0.992). 
The practical utility of the method is well tested with tap water and also extended for 
fluoride detection in cellular environment. Furthermore an easily separable sensitive CD 
based fluorescence glucose sensor comprising of CD deposited mesoporous silica 
nocomposite (m-SiO2-CD) and 3-aminophenylboronic acid (APBA) has been prepared. 
The observed fluorescence recovery of quenched APBA adsorbed m-SiO2-CD on 
addition of glucose is due to the formation of glucoboronate ester which could lift out the 
APBA from close vicinity of fluorophore. The boronic acid modified (m-SiO2-CD-
APBA) fluorescent probe is also explored for targeted imaging of colon cancer cell 
overexpressed with sialyl Lewis A (sLe
a
) receptors. To improve the luminescence 
properties of the CD, nitrogen, sulphur co-doped carbon quantum dot (NSCD) with an 
improved fluorescent quantum yield of 69% have been synthesized from single molecular 
v 
 
precursor. The synthesized NSCD exhibits high selectivity and sensitivity towards 
mercury ion in aqueous environment. Due to high photostability, low toxicity and low 
detection limit as 0.05 nM, these NSCDs are demonstrated as excellent probes for the 
detection of Hg
2+
 in living cells 
The second part of this thesis demonstrates the design and fabrication of 
multifunctional fluorescent magnetic nanostructures which are of special interest in 
cancer diagnostic and therapy. Multifunctional luminescent magnetic 
Fe3O4@mesoporous silica-YPO4:Tb core-shell nanoparticle has been prepared for the 
storage as well as controlled targeted release of 5-fluorouracil (5-FU). The hydrophobic 
anticancer drug 5-FU has been successfully loaded on the fluorescent magnetic 
nanoparticles via formation of 5-FU/β-cyclodextrin inclusion complex which favors more 
sustained release at lower pH owing to stability of inclusion complex. These findings 
show that the developed multifunctional nanocomposite can be potentially used in 
magnetically guided delivery of 5-FU. Furthermore, hierarchical theranostic hollow 
magnetic mesoporous spherical particles with fluorescent carbon encapsulated within 
mesoporous framework have been prepared by hydrothermal carbonization approach. 
These fluorescent magnetic nanoparticles have been conjugated with hydrophobic drug 
camptothecin and a molecular marker folic acid using appropriate surface chemistry to 
ensure the targeted specific delivery of the camptothecin. The drug conjugated hybrid 
nanoparticles inhibit cell growth through induction of apoptosis as demonstrated in HeLa 
cells. In addition to this, the particles show MR contrast behaviour by affecting the proton 
relaxation with transverse relaxivity (r2) 150.03 mM
-1
S
-1
.  
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1.1. Preface 
Since last decades remarkable effort has been devoted for the development of 
luminescent materials due to their promising and diverse applications ranging from 
optoelectronics to biomedical fields, such as cellular imaging, biosensing, and drug 
delivery.
1-3
 Among fluorescent nanomaterials organic dyes, quantum dots, metal 
nanoparticles and lanthanide nanomaterials are widely used.
4-7
 Usually, dye molecules 
suﬀer from photobleaching and quenching due to interactions with solvent molecules 
when they are exposed to a variety of harsh environments.
8,9
 More over poor aqueous 
solubility, broad absorption and emission bands, chemical instability, blinking properties 
and moderate quantum yields associated with these materials restrict their use. In the 
development of fluorescent nanomaterials, the discovery of semiconductor quantum dots 
(QDs) is considered as a major milestone. Semiconductor QDs usually have tunable and 
narrow emission spectral features, bright fluorescence, high photo-stability, and  
resistance to metabolic degradation in bioapplications.
10,11 
However issues of toxicity due 
to use of heavy metal ions, photo-oxidation, and diﬃcult surface conjugation chemistry 
associated with QDs limit their application.
12 
 
Recently, ﬂuorescent carbon dots (CDs) have been proposed as a new generation 
of luminescent materials and as a viable alternative to these conventional fluorescent 
materials due to their excellent luminescence properties, including large two-photon 
excitation cross-sections, lack of blinking, high water solubility, low cytotoxicity, and 
excellent biocompatibility.
13-16 
CDs are new class of recently discovered quasi-spherical 
nanocarbons with sizes below 10 nm comprising amorphous to nanocrystalline cores with 
predominantly graphitic or turbostratic carbon (sp
2
 carbon) or graphene and graphene 
oxide sheets fused by diamond-like sp
3
 hybridized  carbon  insertions.
13,17 
CDs were first 
obtained accidentally by Xu et al. during the separation and purification of single-walled 
carbon nanotubes (SWCNTs), which triggered subsequent studies to exploit the 
fluorescence properties of CDs.
18 
Since their discovery, these fluorescent carbon 
nanoparticles have come to be known as carbon dots and fabricated by numerous 
research groups to achieve better synthetic routes with improved properties, assemble a 
better understanding into the origins of their photophysical behavior and develop novel 
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applications of these nanomaterials. Similar to CD, another carbon based nanomaterials 
named as graphene quantum dots (GQDs) have generated exciting features and wide 
application, which has been extensively reviewed.
15,19 
Basically GQDs are kind of CD 
with a large conjugated domain and regular structure, exhibiting excellent performance of 
graphene. Though the GQDs are even considered as a kind of CDs, still there are some 
differences exist between them. As GQDs are generally produced from graphene based 
starting materials, they clearly have graphitic lattices inside the dots,
20 
whereas CDs can 
be either amorphous or crystalline.
21 
Moreover, luminescent CDs comprise discrete, 
quasi-spherical carbon nanoparticles with sizes below 10 nm,
13,22 
whereas GQDs consist 
of graphene sheets with lateral dimensions less than 100 nm in single-, double- and few- 
(3 to <10) layers.
23 
 
These CDs also possess several additional distinctive features, such as size- and 
wavelength-dependent luminescence emission, ease of production and bioconjugation, 
use of cheap and abundant raw materials. The various surface functional groups such as 
hydroxyl, carboxylic acid moieties present on CD surface imparts excellent water 
solubility and the suitability for subsequent functionalization with various organic, 
inorganic polymeric or biological species. Upon surface passivation, the fluorescence 
properties of CDs are enhanced.
24 
Moreover these CDs exhibit excellent up- and down-
conversion photoluminescence properties of CDs similar to semiconductor quantum 
dots.
25 
With their bright one- and multi-photon fluorescence emissions and other linear 
and nonlinear optical properties, CDs have been pursued for a wide variety of 
applications including bioimaging, photodynamic therapy, fluorescent probing and 
analysis, and photocatalysis.
26-29 
Particularly near-infrared excited photoluminescence 
emission of CD is significant and useful for in vivo bioimaging because of the 
transparency of body tissues in the NIR ‘‘water window’’.30 Moreover the fluorescence 
properties of CDs can be quenched efﬁciently by either electron acceptor or electron 
donor molecules in solution, which offer exciting opportunities for light energy 
conversion, photovoltaic devices and related applications.
31,32 
These interesting 
photoinduced electron transfer properties of CD can also be utilized for sensitive ion 
detection.
33,34 
Owing to superior luminescence properties and potential applicability of 
CD, much eﬀort has been made in the development of facile synthetic methodologies for 
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the synthesis of highly fluorescent CD suitable for above mentioned applications. 
Although there have been numerous efforts for synthesis of high quality CDs, there 
remain substantial challenges like to control particle aggregation, size and surface 
properties for particular application.  
In this prospective our current exploration involves the development of facile 
synthetic method for quantitative production of high quality fluorescent CDs for sensing 
and imaging application. The detailed efforts in this field have been discussed in 
subsequent chapters.  Relevant to our work, here we present the updated literature review 
on different synthetic approaches for CD and their sensing applications. We also discuss 
the ﬂuorescence mechanism of CD in detail.  
 
1.2.Synthesis of carbon dots 
CDs are generally synthesized by two routes, namely the top-down route and the 
bottom-up route, and they can be modified during preparation or post-treatment. Top-
down approaches consist of arc discharge,
18 
electrochemical oxidation
35,36 
and laser 
ablation technique,
31,37 
where CDs are formed from break down of larger carbon 
structures, such as nanodiamonds,
38 
graphite,
39 
carbon nanotubes,
1 
carbon soot,
2 
activated 
carbon
40
 and graphite oxide.
41 
On the other hand bottom-up methods involve synthesis of 
CDs from molecular precursor such as citrate,
3 
carbohydrates,
30,42 
and  polymeric 
molecule
43
 through supported synthetic route,
44 
combustion/thermal/hydrothermal 
treatment,
45-47 
microwave/ultrasonic 
48,49 
and solution chemistry route.
50
 
Top-down approach 
Arc-discharge Method: CDs were first obtained ironically by Xu et al. while purifying 
single-walled carbon nanotubes (SWCNTs) from arc-discharged soot.
18 
The arc-
discharged soot was first oxidized with nitric acid to introduce carboxyl functional group, 
then extracted using sodium hydroxide solution, from which CDs were separated through 
gel electrophoresis. They also isolate different fractions of carbonaceous materials, which 
show size dependent fluorescent properties similar to semiconductor quantum dots.  
Part-I                                                                                                             Chapter-1 
 
4 
 
Laser-Ablation Method: Sun and coworkers pioneered the synthesis of CDs by laser 
ablation of a carbon target in the presence of water vapour with argon as a carrier gas at 
900 °C and 75 kPa.
39 
The obtained non-fluorescent nanosized carbon particles on acid 
oxidative treatment followed by surface passivation using different polymeric agents such 
as diamine-terminated poly(ethylene glycol), poly(propionyl-ethylenimine-co-
ethylenimine) showed bright fluorescence. A slightly modified technique using 
13
C 
powder and more rigorous control was introduced to produce CDs with high quantum 
yield of 20%.
51 
Hu et al. introduced a single-step procedure that integrated synthesis and 
passivation.
52 
They used a pulsed Nd:YAG laser to irradiate graphite or carbon black 
dispersed in diamine hydrate, diethanolamine, or PEG200N for 2h, which serve as 
surface passivating agent. After laser irradiation centrifugation was carried out to obtain 
bright luminescent CD suspension. Subsequently a simple laser ablation technique was 
introduced by Li et al. to prepare CDs using nanocarbon and a simple solvent such as 
ethanol, acetone or water as liquid media.
53 
  
Electrochemical Oxidation: Electrochemical oxidation is a prevailing method to prepare 
CDs using various bulk carbon materials as precursors.
1,35 For the first time, Zhou’s 
group demonstrated an electrochemical method to prepare CDs.
1 
They grew multi-walled 
carbon nanotubes (MWCNTs) obtained from scrolled graphene layers on a carbon paper, 
which was then inserted into an electrochemical cell containing degassed acetonitrile 
with 0.1 M tetrabutylammonium perchlorate as the supporting electrolyte. They found 
that CDs were not formed from carbon paper devoid of MWCNTs. CDs were also 
synthesized by Chi and co-worker through electrochemical oxidation of graphite rod with 
a Pt mesh counter electrode, and Ag/AgCl reference electrode assembly in phosphate 
buffer solution (pH 7.0).
36
 Ionic liquid (IL) assisted electro-oxidation of graphite produce 
a variety of carbon-based nanoparticles including CDs. Later an alkali-assisted 
electrochemical method was introduced by Kang et al. to prepare CDs with controlled 
sizes.
54 
They used the graphite rods as both anode and cathode, and NaOH/EtOH as 
electrolyte, where alkaline environment is the key factor, and OH groups are essential for 
the formation of CDs. Subsequently large-scale synthesis of highly photocatalytic active 
CDs was synthesized by the same group using only pure water as an electrolyte without 
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any other chemical additives.
55 
Interestingly the prepared CDs show both down- and up-
conversion fluorescence emissions. 
Bottom-up Approach 
Microwave/Ultrasonic Synthesis: One of the rapid and low cost methods to synthesize 
CD is microwave irradiation of organic compounds. A microwave pyrolysis was 
introduced to synthesize CDs by combining PEG200 and a saccharide (for example, 
glucose, fructose) in water to form a transparent solution, followed by heating in a 500 W 
microwave oven for 2 to 10 min.
48 
The duration of microwave heating controlled the size 
and fluorescence properties of these CDs. Qu et al. proposed a facile one-step microwave 
synthetic method to synthesize CDs without any surface passivating agent.
56 
Microwave 
treatment of the mixture of carbohydrate (glycerol, glycol, glucose, sucrose, etc.) and a 
tiny amount of an inorganic ion in water produced CDs in few minutes. Zheng et al. 
explore the microwave-hydrothermal synthesis of ﬂuorescent CDs using graphite oxide.41 
Green luminescent diethylene glycol stabilized CDs were obtained on microwave 
irradiation of sucrose.
57 
There was no noticeable emission peak shift for synthesized CD 
over an excitation range from 320-380 nm. Moreover, these CDs could be used as a 
potential bioimaging agent, which were eﬃciently ingested by C6 glioma cells. Liu et al. 
promoted microwave-mediated pyrolysis of citric acid with various amine molecules to 
synthesize highly luminescent CDs.
58 
In this technique the amine molecules serve  dual 
roles as N-doping precursors and surface passivation agents, both of which considerably 
enhanced the ﬂuorescence of the CDs. These highly fluorescent CDs are highly 
biocompatible and have great potential for biomedical application. Very recently Wang et 
al. prepared CDs through microwave technique using benzenediol isomer (catechol, 
resorcinol and hydroquinone) as carbon precursor and sulphuric acid as catalyst.
59 
These 
CDs could easily penetrate into cells in a short time (30 min) and possess low 
cytotoxicity and good biocompatibility. 
Supported Synthetic Methods: It is important to synthesize monodisperse size controlled 
CDs for particular applications and mechanistic study. In this regard supported synthetic 
method has been widely used for the synthesis of monodisperse CDs using molecular 
sieve, porous carbon, mesoporous silica nanoparticles and so on. In this method, the used 
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support serves to localize the growth of CDs by blocking nanoparticle agglomeration 
during high temperature treatment. For instance, Li et al. reported a synthetic method for 
synthesis of monodisperse CDs using silica spheres as carriers and resols as carbon 
precursors.
44 
Porous silicas are the most widely used support for synthesis of CDs due to 
their various, tunable and easily obtained textures, thermal stability and easy removal. 
Hydrophilic CDs were synthesized by Zhu et al. using mesoporous silica nanospheres as 
nanoreactors by impregnation of a citric acid precursor.
60 
The synthesized CDs showed 
good photostability, low toxicity, excellent luminescence, and up-conversion properties. 
Following different approach, CDs were synthesized using NaY zeolites as supports.
61
 
The ion exchanged zeolite on thermal oxidation produced CD decorated zeolite. The CDs 
were mainly decorated on the surface of zeolite as ion exchange took place mostly on the 
surface opposed to the interior. The zeolitic material was then etched away by 
hydrophilic acid to produce fluorescent CDs.  
Combustion/Hydrothermal/Solvothermal Method: A simple source of CDs is the soot 
derived from the combustion of unscented candles or natural gas burners.
2,44 
Mao and co-
workers for the first time, produced water soluble multicolor fluorescent CDs (< 2 nm) 
from the candle soot through oxidative acid treatment, which introduced OH and COOH 
groups to the CD surfaces.
2
 The particles were purified by using polyacrylamide gel 
electrophoresis (PAGE) fraction. Ray et al. synthesized CDs by refluxing the candle soot 
with 5M HNO3 for 12 h adopting similar approach.
44 
The CDs were collected by high 
speed centrifugation and the size separation was achieved using water/ethanol/chloroform 
solvent mixture through stepwise high-speed centrifugation. In a further study, Chen and 
co-workers purified CDs from the combustion soot of natural gas. Hydrophilic 
fluorescent CD was synthesized from pollutant soot of diesel engine by treatment of 
nitric acid.
62 
The purified CDs displayed multicolored emissions covering the green to red 
and extended to the near-infrared region, which was used for bioimaging and sensing 
cholesterol. 
   The above-described various synthetic approaches generally need costly 
precursors, complex instrumental set-ups or post-treatments to synthesize fluorescent 
CDs. In this context recently introduced hydrothermal carbonization or solvothermal 
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carbonization is a low cost, environmentally friendly, and nontoxic route to produce 
fluorescent CDs from various precursors.
63,64 
In this technique a solution of carbon 
precursor is sealed and reacted in a high pressure reactor at high temperature. Giannelis et 
al. employed one-step thermal decomposition of low-temperature melting molecular 
precursor to obtain CDs.
46 
Careful selection of the carbon source and surface modifier 
resulted better control over the geometry and physical properties of the CDs.  
Hydrothermal treatment of carbohydrates (glucose, sucrose, fructose, glucosamine etc.) 
was an important approach to obtain CDs.
65-67 
Wu et al. exploited a high-yield synthesis 
of hydrophilic CDs by controlled carbonization of sucrose.
66 
The green luminescent CDs 
and non-luminous CDs, which on functionalization with PEG emitted blue ﬂuorescence, 
were effectively separated. Chitosan carbonization leads to the production of amino 
functionalized CDs.
68 
Thereafter, the uses of other inexpensive starting materials, like 
ethanol, citrate, ascorbic acid, saccharides, and gelatin were developed to produce CDs 
with high quantum yields.
3,69-72 
Recently Liu et al. demonstrated a hydrothermal method 
to simultaneously enhance the up-conversion ﬂuorescence and tune the down-conversion 
luminescence of CDs from blue to green light by simply adding H2O2 in during 
hydrothermal treatment.
73 
 
Fabrication of CDs from renewable bioprecursors is an exciting achievement in 
the area of bottom-up synthesis. Fluorescent CDs was synthesized from fresh tender 
ginger juice which provide high suppression of the growth of human hepatocellular 
carcinoma cells (HepG2), with low toxicity to normal mammary epithelial cells (MCF-
10A) and normal liver cells (FL83B).
74 
The hydrothermal treatment of pommel peel,
75 
 
egg,
76 
water-melon peel
77 
and potato
78
  produced CDs. However the quantum yield (QY) 
of obtained CDs was lower than 8% and not suitable for bioimaging. Subsequently high 
quality fluorescent CDs were produced using various natural precursor such as plant 
leaf,
79 
banana juice,
80
 soya milk,
81 
bombyx mori silk,
82 
citrus pectin,
83 
honey
84
 and so on. 
The produced CDs have high fluorescence QY suitable for various applications including 
bioimaging, fluorescence sensing, multicolor printing etc. Fluorescent CDs isolated from 
sweet pepper shows up-conversion fluorescent properties suitable for hypochlorite 
detection.
85 
These approaches are less costly and easier to manage, and the CDs produced 
were found to possess desirable fluorescence properties along with high aqueous 
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solubility and photostability. The various chemical constituents such as carbohydrate, 
proteins, vitamins, ascorbic, citric acids, crude fibers, lipid, fatty acids, and amino acids 
present in natural sources serve as the molecular precursor during carbonization for the 
synthesis of CDs.  
 
1.3. Light emission properties of carbon dots 
One of the most fascinating features of CD is its light emitting properties. Till 
date numerous CDs with different fluorescence properties ranging from visible to near-
infrared region have been reported. Although several theories have been proposed for the 
fluorescence phenomenon including excitons of carbon, emissive traps, quantum 
confinement eﬀect, aromatic structures, oxygen-containing groups, free zigzag sites and 
edge defects,
1,14,30,86 
the exact mechanism of fluorescence is still enigma.
 
The quantum confinement and edge effects associated with CD play important 
role in the luminescence.  The band gap transitions in CD (π-π*) arise from conjugated π 
domains and the energy gap depends on the size of the graphene fragments. Such size 
effect can produce different fluorescence emission with variable sized CDs. Moreover the 
different types of edges (armchair and zigzag edges) produced during CD synthesis plays 
an important role in tuning the electronic, magnetic, and optical properties. The quantum 
confinement effect is responsible for size dependence of the band gap in CDs which gives 
rise to unique, size-dependent optical and spectroscopic properties.
87 
The quantum 
confinement effect and size-dependent optical properties of CD was reported by Li and 
co-worker.
54 
They prepared fluorescent CDs by alkali-assisted electrochemical method 
and separated through column chromatography to obtain different sized CDs. They found 
that the fluorescence properties strongly depend on CDs size: small CDs (1.2 nm) give 
UV light emission, medium-sized CDs (1.5-3 nm) give visible light emission and large 
CDs (3.8 nm) give near-infrared emission. 
The surface defect (any sites that have non-perfect sp
2
 domains) associated with 
CD will result in surface energy trap. Most of the CDs have various oxygen-containing 
functional groups, such as hydroxyl, epoxy/ether, carbonyl and carboxylic acid groups. 
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Along with these functionalized surface defect (carbonyl-related localized electronic 
state), both sp
2
 and sp
3
 hybridized carbons present in CDs contribute to their multicolor 
emissions that are concentrated in the blue and green regions of the visible light 
spectrum. These surface defects are responsible for multicolor emissions in CD due to the 
existence of multiple surface defects with different excitation and emission properties.
88 
Moreover the surface passivation plays an important role in certain CDs leading to 
luminescent properties. The presence of surface energy traps became emissive (through 
radiative recombination of excitons) upon stabilization as a result of surface 
passivation.
44
 
Most of the fluorescent CDs exhibit excitation-dependent fluorescence properties 
with bathochromic shift of emission peaks.
3,69-71 
They exhibit multicolor fluorescence 
properties under different excitation wavelength, which is important for certain practical 
applications. These interesting excitation dependent luminescence properties are not only 
due to the eﬀects from particles of diﬀerent sizes in the sample, but also a distribution of 
diﬀerent emissive sites on each   CD surface.13,14 Thus the excitation dependent properties 
may result from optical selection of diﬀerently sized CDs and/or diﬀerent emissive sites 
on CDs. There were also some exceptions, where CDs showed excitation independent 
fluorescence properties. For example in case of CDs derived from alkoxy silane, the 
emission wavelength remained at 547 nm for the excitation wavelength changed from 
340-450 nm.
89 
This phenomenon was attributed to both the uniform size and the surface 
state of those sp
2
 clusters contained in CDs.  
Up-conversion Fluorescence: In addition to the strong down-conversion fluorescence, 
some CD shows up-conversion fluorescence.
60,90 
Up-conversion luminescence is an 
attractive feature of CD, which devise many promising applications. The sequential 
absorption of two or more photons leading to shorter wavelength fluorescence emission is 
attributed as up-conversion photoluminescence. The emission is an anti-stokes type 
where the photon energy of emission is higher than the excitation energy.  For the first 
time Sun et al. synthesized CDs which were strongly emissive in the visible region under 
irradiation by an argon-ion laser (458 nm) or a femtosecond pulsed laser for two-photon 
excitation in the near-infrared range (800 nm) indicating the up-conversion 
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photoluminescence properties.
91 
Subsequently several other groups synthesized CDs 
exhibiting up-conversion luminescence properties using different synthetic route and they 
attributed the properties to multiphoton active process.
54,92 
However the Shen group 
argued considering the constant energy difference (1.1 eV) between the up-converted 
emission (Em) and excitation light (Ex) that multi-photon excitation is inadequate to 
account for the up-conversion fluorescence emission properties of CDs.
93 
According to 
their view, the up-conversion fluorescence emission originates from the relaxation of 
electrons from a higher energy state of the p orbital (LUMO) to the s orbital since some 
electrons would inevitably transit to the LUMO when a large number of low-energy 
photons excite the electrons in the p orbital. Along with p orbital electrons, electrons in 
the s orbital can also be excited, but their relaxation process leads to only conventional 
down-conversion fluorescence. On the other hand Gan et al. summarized several reports 
on up-converted fluorescent CD, where the up-conversion fluorescence emissions are 
artefacts originating from the conventional down-conversion emissions.
94 
These 
emissions have been usually excited by the leaking component from the second order 
diﬀraction in the monochromator of the spectrofluorometer.95 By removing the leaking 
component through simply inserting a long pass filter into the excitation pathway, real 
up-conversion properties can be monitored.   
 
1.4. Fluorescence sensor application of carbon dot 
Fluorescent sensing is found to be a convenient and inexpensive approach for the 
sensitive and selective detection with rapid and easy manipulation. Advances in synthesis 
and surface modification technologies  made CDs  appealing  platforms  for fluorescent 
detection of  DNA,
96 
phosphate,
97 
thrombin,
98 
nitrite,
99 
glucose,
100 
biothiol,
39
  pH,
101
 
proteins,
102 
metal ions,
103,104
 anions
105,106 
and so on. CDs have been used as excellent 
fluorescent probe owing to their intrinsic sensitivity, selectivity and capacity for rapid, 
real-time monitoring. By monitoring the changes in their fluorescence intensity under 
external physical or chemical stimuli, CDs were used to detect the various substances and 
quantities. The recent progresses in the development of CD-based sensors have been 
discussed in the followings. 
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Metal ion sensing 
Heavy metal ion detection is important due to their toxic effects on the environment and 
human health. Mercury (II) ion (Hg
2+
) is one of the most hazardous and ubiquitous 
pollutants causing serious environmental and health threat. CDs were first explored for 
the detection of mercury in aqueous solution
107-111 
and live cell 
112
.
  
Hg
2+
 detection using 
CD solution and sol-gel immobilized CD was achieved by Gonclaves et al..
113,114
 They 
demonstrated that the fluorescence quenching was probably due to static quenching 
arising from the formation of stable non-fluorescent complex between CD and Hg
2+
 as 
evidenced by large Stern-Volmer constant. The improvement in the sensitivity of 
mercury detection was later achieved using nitrogen doped CD (N-CD).
115 
The presence 
of nitrogen element in the N-CD is probably responsible for improved performance of 
Hg
2+
 sensing. Very recently N, S co-doped CD was utilized by Wang group for sensitive 
and selective detection of Hg
2+
 with a lower detection limit of 0.05 nM.
116 
The high 
selectivity of the system was due to specific thiol-Hg
2+
 interaction. It was observed that 
the fluorescence intensity increased linearly with mercury from 1 nM to 50 µM. The 
significant reduced life time of CD on Hg
2+
 binding suggested dynamic quenching 
through electron transfer process occurred in Hg-S bands. 
Apart from Hg
2+
 sensing, fluorescent CDs have been used for the sensing of other 
metal ions such as Cu
2+
,
117,118 
Co
2+
,
119 
Fe 
3+
,
120 
Pb
2+
,
121 
Sn
2+
,
122 
Cr( VI )
123 
and Ag
+
.
124 
Most of these sensing method involves the fluorescence quenching by metal ions similar 
to the Hg
2+
 sensing. Branched poly(ethylenimine) (BPEI)-functionalized CD was utilized 
by Chi et al. for selective detection of Cu
2+
 with a detection limit of 6 nM over a dynamic 
range from 10 to 1100 nM.
117 
They argued that Cu
2+
 ions could be captured by the amino 
groups of the BPEI-CDs to form an absorbent complex at the surface of CDs, resulting in 
a strong quenching of the CDs through an inner filter effect. Similar mechanistic pathway 
for Cu
2+
 quenching through the interaction of -COOH and -NH2 groups of CD was also 
demonstrated by Liu group.
125 
They modified the surface of CD with lysine and bovine 
serum albumin. Later the sensitivity of the fluorescent probe toward Cu detection was 
improved using metal-organic frameworks (ZIF-8–zinc imidazolate frameworks)126 and 
silica coating
127 
on CD apart from polymeric coating. A sensitive and reliable approach 
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was established for ratiometric fluorescent detection of intracellular Cu ion in living 
cells.
128 
For this purpose a dual-emission hybrid fluorophore composed of CD and 
CdSe/ZnS quantum dot with integrated amino-TPEA (N-(2-aminoethyl)-N,N’,N’-
tris(pyridine-2-yl-methyl)ethane-1,2-diamine) was synthesized. The inorganic-organic 
fluorescent probe showed good cell permeability and low cytotoxicity demonstrating the 
imaging and biosensing of Cu
2+
 ions in living cells. More interestingly the fluorescence 
properties of CDs were explored for label-free detection of Fe
3+
 and dopamine with high 
sensitivity and selectivity.
120 
Fe
3+
 induced oxidized hydroquinone species on CD surface 
quench the fluorescence of CD, which can be restored by the addition of dopamine due to 
their competition with CDs to react with Fe
3+
. The developed method was simple and 
cost-effective as no further chemical modification of CD was required. 
Most of the reported metal ion sensing by CD based fluorophore involve 
fluorescence quenching of CD due to interaction of metal ions. The fluorescence 
quenching may be due to either dynamic quenching through electron transfer process or 
static quenching through the formation of stable metal ion-CD complex. 
Anion sensing 
A number of fluorescent assay for anion detection have been developed owing to 
their critical roles in biological and chemical processes, as well as in environmental 
pollution. In this line CD based fluorophore have been explored  for the detection of 
various anions such as C2O4
2-
,
118 
PO4
3-
,
97
 NO2
-
,
99
 CN
-
,
129
 F
-
,
105 
I
-
,
106 
S
2-130 
and ClO
-
.
85 
However many of the anion detection methods involve fluorescence recovery of the 
already quenched CD-metal complexes. For example, the quenched fluorescence of CD 
due to mercury metal ion was recovered by the addition of I
-
.
106 
The iodide ion formed 
more stable complexes with the metal ions displacing CD from CD-metal complexes. An 
oﬀ-on ﬂuorescence probe of europium-adjusted CD was applied to the phosphate 
detection in very complicated matrixes such as artiﬁcial wetlands system.86 Eu3+ induced 
the aggregation of the CD by coordinating with the carboxylate group of CD, which 
resulted in fluorescence quenching through the charge- or energy- transfer process. 
However the presence of phosphate induced disassociation of the CDs aggregation 
species due to higher affinity of Eu
3+
 towards oxygen donor atoms from phosphate than 
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that of carboxylate groups on CD surface, which resulted turn-on fluorescence. 
Interestingly both down- and up-conversion ﬂuorescence of the CD was utilized for the 
detection of ClO
-
 with a low detection limit of 0.05 µmol L
-1
 and 0.06 µmol L
-1 
respectively.
85 Liu group reported a ﬂuorescent probe (Zr(CDs–COO)2EDTA) for F
- 
detection whose working principle based on F
- 
induced fluorescence quenching.
105
 The 
quenching of fluorescence signal was due to the formation of non-fluorescent complex 
Zr(F)2EDTA based on the stronger affinity of F than the -COOH in the CDs to Zr(IV). 
The method was also explored for F
-
 detection in toothpaste. 
Biosensing 
Apart from metal ion and anion detection CDs have also been used for the 
detection of biologically important molecules. The wide scope of CD surface 
functionalization facilitates the formation of tailored biologically compatible probes with 
high QY, good stability and low-toxicity against living species. Cost effective, stable 
sensitive CDs are mainly applied as fluorescent labels in immunoassays.
131,132 
Based on 
fluorescence resonance energy transfer (FRET) principle, an immunosensor comprising 
of CD and gold nanoparticle was developed by Zhuang group for the determination of 
small size persistent organic pollutant 4,4’-dibrominated biphenyl (PBB15).132 The gold 
nanoparticle (AuNP)-modified-anti-PBB15 antibodies acts as fluorescence energy 
acceptor and CD-labelled PBB15 antigens that donors for FRET process. They showed 
that in the absence of PBB15, FRET between CD and gold nanoparticles resulted in 
fluorescence quenching. On the other hand, presence of PBB15 induced fluorescence 
recovery due to release of CD-labelled antigen from gold nanoparticle surface through 
competitive immunoreaction. The sensor found a good liner range of 0.05-4 µg/mL, with 
a low detection limit of 0.039 µg/mL. Based on the same FRET principle a 
multifunctional CD probe was demonstrated for detecting and imaging mitochondrial 
H2O2.
133 
Recently, naphthalimide-azide coupled CDs were reported as a highly selective 
and sensitive H2S detector base on the FRET between CDs and the H2S induced 
reduction product of naphthalimide-azide.
134 
 
CDs have been used as an effective fluorescent sensor for nucleic acid detection, 
where the level of selectivity was so high that even a single-base mismatch could be 
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identified.
135 
The working principle was based on the fluorescence quenching of 
fluorescent dye due to the adsorption of the fluorescently labeled single-stranded DNA 
(ssDNA) probe on CD surface followed by specific hybridization with its target to form 
double-stranded DNA (dsDNA). The formation of dsDNA resulted in desorption of the 
hybridized dsDNA from CD surface leading to fluorescence recovery. This strategy was 
also employed for determination of metal ions such as Hg
2+
 and Ag
+
 through T-Hg
2+
-T 
and C-Ag
+
-C base pairs, respectively.
124,136 
Highly specific assay of thrombin using 
aptamer biosensor with a detection limit of 1 nM was demonstrated by Xu’s group.137 
The generalized working principle involves the detectable change in radiometric response 
due to conformational change of coupled aptamers induced by the target. Based on FRET 
from up-converting phosphors to CDs, another aptamer biosensor was recently 
constructed for thrombin detection.
138 
Fluorescent CDs were also employed for the 
protein detection by staining it and the sensitivity were found to be comparable with 
conventional staining agents such as Coomassie Brilliant Blue and Ag
+
.
139 
  
Along with the microbiomolecule sensing CDs have also been utilized for the 
detection of small bioanalytes such as dopamine,
140 
ascorbic acid,
123 
anti-bacterial 
drugs
141 
and glucose.
142,143 
The anti-bacterial drug amoxicillin was successfully detected 
using N-CD. The increase in fluorescence intensity of the N-CD via interaction with 
amoxicillin was the basis for fluorescent detection of anti-bacterial drug.
141 
Recently 
Shen and Xia reported CD based fluorescence sensor for non-enzymatic blood glucose 
sensing.
143 
The fluorescence of boronic acid modified CD was found to be quenched on 
addition of glucose due to assembling of CDs. These CDs showed excellent sensitivity 
and selectivity with minimal interference from various biomolecule.  
 
1.5. Objective of the present work 
Though several simple and efficient routes have been proposed for the synthesis 
of CDs, still there remain sufficient scope to improve the fabrication methods to achieve 
precise control over the particle size, structure and surface chemistry. Furthermore issues 
like the low product yield and quantum yield, the confusing PL mechanism, the narrow 
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spectral coverage, the lack of tenability in optical properties need to be addressed. In the 
direction of luminescence sensing, although a wide variety of CD based fluorescent 
sensors have been reported in last couple of years, many of them suffer from complicated 
sensing mechanism, less selectivity and high detection limit. In this context, our present 
investigation involves:  
 Development of facile, cost-effective and green synthetic method for quantitative 
production of CD from naturally available molecular precursors.  
 Enhancement of optical and surface properties of the CD through heteroatom 
doping or size controlled growth in a mesoporous host material. 
 Design of CD-based fluorescence sensors for high sensitive, selective and 
accurate detection of metal ions, anions and bioanalytes. 
 Evaulation of diagnostic and sensing applicability of the synthesized materials in 
vitro.  
Our work involves synthesis of highly luminescent CD using cheap and readily 
available natural precursor through bottom-up strategy. The luminescent character of the 
synthesized CD has been explored for bioimaging application. Subsequently the optical 
and surface properties of the CD have been improved through heteroatom doping or 
controlled growth in mesoporous host material. The synthesized luminescent CD based 
nanoprobes have been characterized through standard techniques and their sensing 
properties for metal ion, anion and glucose have been evaluated in both water and living 
cells. The complete efforts of the research work have been described in subsequent 
chapters. 
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Simple one-step synthesis of highly luminescent carbon dots from 
orange juice: Application as an excellent bio-imaging agent 
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2.1. Introduction 
Recently, fluorescent carbon-based materials which include carbon dots (CDs),
1-3
 
nanodiamonds,
4
 carbon nanotubes,
5
 fullerene,
6
 and fluorescent graphene
7
 have attracted 
tremendous attention because of their exceptional advantages such as high optical 
absorptivity, chemical stability, biocompatibility, and low toxicity.
8-10 
Among them
 
CDs 
are found a promising alternative to more toxic metal-based semiconductor quantum dots 
(QDs) for applications such as bioimaging. Subsequent to the pioneering work towards 
the synthesis of CDs by laser ablation,
11
 several top down approaches and more reliable 
bottom up approaches have been proposed to produce fluorescent carbon dots.
12-17 
 
However most of these synthesis methods need several steps and strong acids and post 
treatment with surface passivating agents are essential in order to improve their water 
solubility and luminescence property. Alternatively, several one-step strategies to 
fabricate surface-passivated CDs such as syntheses of amino-functionalized fluorescent 
carbon dots by hydrothermal carbonization of chitosan at high temperature,
18
 microwave 
assisted hydrothermal carbonization of sucrose,
19 
and carbonization of glucose in reverse 
micelle
20
 offer facile methods for the fabrication of fluorescent CDs without any surface 
passivation. However, all these above-mentioned methods suffer some degree of 
drawbacks like requirement of complex and time-consuming processes, high temperature, 
severe synthetic conditions, and high cost, which limit their wide applications. On the 
other hand, fabrication of nanomaterials from renewable bioprecursors is a challenging 
concept in the area of bottom-up nanotechnology. Recently some successes to produce 
fluorescent CD have also been demonstrated by employing renewable bio-sources as 
starting materials such as sweet potato,
21
 egg,
22
 water-melon peel,
23 
plant leaf,
24 
strawberry juice,
25
 banana juice,
26
 soya milk,
27
 bombyx mori silk,
28 
sugar cane juice,
29
 
honey
30
 and so on. These natural materials are found as excellent precursor to produce 
biocompatible luminescent CD beneficiated with low cost and bulk production. In spite 
of  recent  remarkable advances  in  the  fabrication  of  CDs,  there  still remains broad 
research space for developing new synthetic strategy to produce high quality CD. 
 In the pursuit of exploring natural precursors for the synthesis of CDs, this chapter 
demonstrates a very simple one step hydrothermal synthesis of highly luminescent 
biocompatible CD from orange juice (Citrus nobilis deliciosa). Owing to the existence of 
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sugar, citric acid and ascorbic acid as main constituents of orange juice, it could provide 
an alternative precursor to synthesize advantageous CD nanomaterials. The developed 
method has following notable advantages: 1) one step generation at comparatively low 
temperature 120 ºC) and less time (150 min), 2) easy isolation of highly luminescent CDs 
by simple optimization of the centrifugation speed, 3) high yield production 400 mg of 
CD from 40 mL pulp free juice, 4) synthesis of highly luminescent CD with fluorescence 
quantum yield of 26% 4) varstile application as fluorescent dye for in vitro optical 
imaging. The synthesized material has been characterized by X-ray diffraction, Raman 
spectrophotometry, TEM, SEM, FTIR, DLS and fluorescence spectrophotometry. The 
cytotoxicity of the fluorescent CD as well as in vitro optical imaging has also been 
investigated. 
  
2.2. Experimental 
Synthesis of fluorescent carbon dot (CD) 
CDs were synthesized by hydrothermal treatment of orange juice in ethanol. In a 
typical procedure, 40 mL of pulp free orange juice was mixed with 30 mL ethanol, and 
then the mixture was transferred into an 80 mL Teflon-lined stainless-steel autoclave and 
was heated to 120 ºC (1 ºC/min) and held there for 150 minutes. After the reaction, the 
autoclave was cooled down naturally. The resulted dark brown solution was washed with 
dichloromethane (30 mL×3) to remove the unreacted organic moieties. The aqueous 
solution was centrifuged at 3000 rpm for 15 min to separate the less-fluorescent deposit 
(CP). Excess acetone (100 mL) was added to upper brown solution and centrifuged at 
speed of 10,000 rpm to obtain highly fluorescent carbon dots (CD, 400 mg) of average 
size 2.5-4.5 nm. The deposit coarse nanoparticles (CP, 250 mg) have larger diameters in 
the range of 30-50 nm and exhibits weak fluorescence in compared to CD. 
In vitro cytotoxicity and intracellular uptake 
In vitro cytotoxicity: L929 cells were harvested and the cell concentration was adjusted 
to 1×10
4
 cells/mL, cells were placed in a 96 well flat bottom culture plates (180 µL/well) 
and incubated with various concentrations (0.78, 3.185, 12.5, 25.0, 50.0, 100.0, and 200.0 
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µg/mL) of CD (in 20 µL). All cultures were incubated for 72 h at 37 ºC and 5% CO2 in a 
humidified incubator. Viable cell concentration was checked by MTT (3-(4,5-Dimethyl-
2-2thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay. The assay experiment was 
performed in triplicate. 
Intracellular uptake: Human osteosarcoma cell line MG63 (maintained in Dulbecco’s 
Modified Eagle’s Medium or DMEM supplemented with 10% Fetal Bovine Serum or 
FBS) was trypsinized and seeded in tissue culture plates at 3×10
4
 cells/well. After 
overnight incubation inside humidified 5% CO2 incubator for cell attachment, cells are 
treated with the CD at a final concentration of 200 µg/mL in 300 µL of media and 
incubated for 12 h. prior to fixation of the cells on the slide for imaging experiment the 
cells were washed three times with fresh media. Live-cell-imaging was done under 
confocal microscope with laser excitation of 405 and 488 nm and fluorescence was 
collected in blue and green region. 
Quantum Yield Calculations 
The quantum yield (Φ) of the carbon dot was calculated using quinine sulfate as 
reference.
31,32
 For calculation of quantum yield, five concentrations of each CD and CP 
were made, all of which had absorbance less than 0.1 at 340 nm. Quinine sulfate 
(literature Φ = 0.54) was dissolved in 0.1 M H2SO4 (refractive index (η) of 1.33) while 
the carbon sample was dissolved in water (η = 1.33). Their fluorescence spectra were 
recorded at same excitation of 340 nm. Then by comparing the integrated fluorescence 
intensities (excited at 340 nm) and the absorbance values (at 340 nm) of the carbon 
sample with the references quinine sulfate, quantum yield of the carbon sample was 
determined. The data was plotted (Figure 2.1) and the slopes of absorbance versus 
integrated fluorescence intensity curve for standards and samples were determined. The 
data showed good linearity with intercepts of approximately zero. 
The quantum yield was calculated using the equation    
Φx = ΦST  (mx / mST) (η
2
x /η
2
ST )   
Where Φ is the quantum yield, m is slope, η is the refractive index of the solvent, ST is 
the standard and X is the sample. The quantum yield for CD and CP is found to be 25.6% 
and 19.7% respectively. 
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Figure 2.1 Fluorescence and absorbance of the CD, CP and quinine sulfate. 
 
2.3. Characterization 
The morphology and microstructure of CD and CP were analyzed by scanning 
electron microscope (HITACHI COM-S-4200) and high resolution transmission electron 
microscopy (JEOL 3010, Japan) operated at 300 kV respectively. Particle size and zeta 
potential were measured after suitable dilution of the CD solution at 25.0 ± 0.5 ºC, by 
laser light scattering using a particle size analyzer (Nano ZS 90, Malvern). The 
crystalline phase was investigated by an X’Pert Pro Phillips X-ray diffractometer. The 
Raman spectrum of as-prepared samples was recorded at ambient temperature on 
Renishaw in Via Raman (UK make). Fluorescence microscopy images were captured 
using Axiovert 40 carlzeiss india fluorescence microscope at excitation wavelength of 
405 and 488 nm. The Fourier transform infrared spectroscopy (FTIR) spectra were 
measured by a Thermo Nicolet Nexus FTIR model 870 spectrometer with the KBr pellet 
technique ranging from 400 to 4000 cm
-1
. The presence of different functional groups on 
the surface of CD was investigated by X-ray photoelectron spectroscopy using AlKα 
excitation source in an ESCA-2000 Multilab apparatus (VG microtech). Fluorescence 
spectroscopy was performed with a Horiba Fluoromax 4 spectrophotometer at different 
excitation energies ranging from 320 to 450 nm. UV-vis absorption spectra were obtained 
using a Shimadzu 220V (E) UV-vis spectrophotometer. Live-cell imaging was done 
under Olympus FV-1000 confocal microscope with laser excitations of 405 and 488 nm. 
2.4. Results and Discussion 
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Synthesis 
A simple one-step hydrothermal synthetic route was employed for the fabrication 
of highly green luminescent CDs. As illustrated in scheme 2.1, the CD sample has been 
synthesized from orange juice (Citrus nobilis deliciosa) at comparatively low temperature 
(120 ºC) and less time (150 min) without using either any strong acid or post-synthetic 
surface passivation. The starting material can be obtained from a single natural source 
and the synthesis method is cost-effective and green. More importantly, 400 mg of CDs 
can be produced from 40 mL of pulp free juice. 
 
Scheme 2.1 Illustration of formation of CDs from hydrothermal treatment of orange 
juice. 
 
Plausible mechanism for the formation of carbon dots 
Hydrothermal carbonization of bioprecursor is an emerging technique for the 
production of novel carbon based materials for various potential applications.
33
 The 
major constituents of orange juice are sucrose, glucose, fructose, ascorbic acid and citric 
acid
34
 which are already been reported to act as excellent precursors for the synthesis of 
carbonaceous materials.
16,35,36
 Thus we deemed to synthesize CDs from orange juice 
where constituents can act as efficient precursors.   
The mechanism for synthesis of carbon dots from orange juice involves 
carbonization of its constituents. In fact, in the hydrothermal carbonization of sucrose for 
the formation of final material structure is complicated and a clear scheme has not yet 
been reported. The plausible mechanism for the formation of carbons dots may be 
illustrated as follows.  
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Figure 2.2 Schematic presentation of formation mechanism of carbon dots.                
Sucrose when hydrothermally treated undergoes hydrolysis to form glucose which 
subsequently isomerises to form fructose.
37
 The dehydration and decomposition of 
fructose/glucose gives rise to different soluble products such as furfural compounds (for 
ex: 5-hydroxymethyl furfural, furfural, 5-methyl furfural etc), several organic acids such 
as acetic, lactic, propionic, levulinic and formic acids, aldehydes and phenols. It is worth 
mentioning that the hydronium ion formed from these acids act as a catalyst in 
subsequent decomposition reaction stages. Here it is important to note that due to 
presence of weak acids like citric acid and ascorbic acid in orange juice the dehydration 
and decomposition reaction proceeds in a controlled manner. The polymerization and 
condensation of these products gives rise to soluble polymers. Aromatization and 
formation of aromatic clusters take place via aldol condensation, cycloaddition and a 
hydroxymethyl mediated furan resin condensation. When concentration of aromatic 
clusters reaches a critical supersaturation point a burst nucleation takes place and carbon 
dots are formed.  
XRD and Raman study 
The X-ray diffraction pattern of CDs and coarse particles (CP) are shown in 
Figure 2.3a. The XRD pattern of the CD shows a broad peak centered at 2θ = 19.1degree 
which is assigned to [002] diﬀraction pattern of graphitic carbon. The broadening of the 
peak is due to small size and amorphous nature of the synthesized CD. The [002] peak 
centered at 19.1degree in CDs has been shifted to 21 degree in case of coarse particles 
(CP). The corresponding interlayer spacing in graphite (0.34 nm) becomes larger in CP 
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(0.46 nm) which shifts to further larger end in CD (0.46 nm). The increase in d value 
indicates increase in amorphous nature attributed to the introduction of more oxygen 
containing groups.
14 
 
Figure 2.3 (a) XRD patterns of CD and CP, (b) Raman spectrum of CP. 
In the Raman spectrum (Figure 2.3b) of coarse particles (CP), the peak at 1360 
cm
-1
 is assigned to D-band arising from vibrations of carbon atoms with dangling bonds 
of the disorder carbon structure.  The peak at 1578 cm
-1
 due to vibration of sp
2
-bonded 
carbon atoms in a 2D hexagonal lattice of graphite cluster matches well with the 1st order 
G band of graphitic carbon. The overlapping of the D-line and G-line indicates 
amorphous nature of the sample. The intensity ratio of the D and G band (ID /IG) is a 
measurement of the disorder extent, as well as the ratio of sp
3
/sp
2
 carbons. The relative 
intensity of disorder D band to crystalline G band is ID/IG is 0.75, which is supportive to 
the partial amorphous nature of the coarse particles and consistent with reported studies.
13 
Microstructure, Hydrodynamic size and Stability 
HRTEM images (Figure 2.4a) clearly reveal that the CDs are spherical, 
monodisperse and have a narrow size distribution between 1.5-4.5 nm with maximum 
population at 2.5 nm. The inset in Figure 2.4a shows the lattice spacing of 0.18 nm which 
corresponds to [102] facet of graphitic carbon. The SEM images of coarse particles 
appear like 2D exfoliated GO sheets consisting of layered structures (Figure 2.4c), while 
the TEM image taken after ultrasonication shows particles with uniform size in the range 
of 50-60 nm (Figure 2.4d).  
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Figure 2.4 (a) TEM image with lattice imaging (inset), (b) particle size distribution of CDs, 
(c) SEM image and (d-f) TEM images of CP. 
 
Figure 2.5 Variations of hydrodynamic size with (a) time and (b) pH, (c) zeta potential 
variation with pH. 
The as-synthesized CDs without any further surface modiﬁcation could be easily 
dispersed in deionized water with an average size of 16 nm at pH 9.1 being measured by 
DLS. The dispersion of the particles is highly stable without any precipitation for months. 
It is observed that HD size increases with decrease in pH (Figure 2.5b) indicating the 
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presence of –COOH groups on the surface. The presence of surface –COOH group is also 
evidenced of zeta potential measurement. Variation of zeta potential from positive to 
negative with increase in pH (Figure 2.5c) demonstrates the presence of –COOH groups 
on the surface. The existence of certain hydrophilic functional groups on the surface of 
the CDs makes the hydrodynamic diameter larger than observed from TEM. The 
hydrophilic functional groups in aqueous dispersion extended in water and were counted 
by the DLS. 
Surface Properties 
FTIR spectrum (Figure 2.6a) was recorded to investigate the bonding composition 
of the carbon dot and its functional groups. Sharp peak centered at 1650 cm
-1
 for CD and 
1627 cm
-1
 for CP  were attributed to aromatic C=C stretching, which is the elementary 
unit of the CDs. The appearance of broad peak centering at 3300-3500 cm
-1
 (O–H 
vibrational stretch), a sharp peak at 1708 cm
-1
 (C=O vibrational stretch) and peaks at 
1081 and 1043 cm
-1
 (C–O–C/C-O vibrational stretch) suggest the existence of 
carboxylate and hydroxyl groups on the surfaces. The presence of these functional groups 
imparts excellent solubility in water without further chemical modification. Furthermore 
these functional groups can be modified for potential applications in drug delivery, 
biosensing and biomedical imaging.  
To further conﬁrm the surface functional groups and composition of the CD, XPS 
measurements have been done. The atomic ratio of C/O is 6.2. In a typical survey 
spectrum (Figure 2.6b) of the CD, the peaks at binding energies 275-290 and 525-539 eV 
are ascribed to C1s and O1s regions respectively. The high resolution scan of C1s region 
shows carbons present in five different chemical environments (Figure 2.6c), 
corresponding to sp
2
 (C=C) at 284.1 eV, sp
3
 (C-C and C-H) at 285.5 eV, C-OH/C-O-C at 
285.7 eV, C=O at 288 and –COOH at 289.3 eV. The high resolution scans of the O1s 
regions can be fitted into three peaks (Figure 2.6d). The peak appeared at 532.7 is 
attributed to carbonyl (C=O) group, whereas the C-O group and adsorbed CO appears at 
slightly lower binding energies at 531.7 and 530 eV respectively. These functional groups 
confirm the highly oxidized surface of carbon dot.  
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Figure 2.6 (a) FTIR spectra of CD and CP, (b) XPS survey and high resolution scan of the 
(c) C1s, (d) O1s region of CD. 
Optical Properties 
 The UV-visible absorption and emission spectra have been presented in Figure 
2.7a. CDs show broad UV absorption at 288 nm which is consistent with carbon 
nanoparticles synthesized by carbonization of chitosan.
18
 The aqueous solution is yellow 
and transparent in daylight but changes to intense green under UV excitation (insets 
Figure 2.7a). In case of coarse particles the absorption in the visible region intensifies and 
the shoulder in UV region becomes more prominent. This change in optical property with 
increase in particle size is consistent with that of graphene quantum dots (GQDs) 
prepared by Kwon et al. by reverse micellar method.
20 
The absorption is typically 
ascribed to the presence of aromatic π orbitals of which CPs have plenty more. The size 
dependent absorption is associated with a red shift in the emission spectrum. At a fixed 
λex=390 nm, CDs show emission peak at 455 nm while the corresponding peak for CP 
appears at 474 nm. This difference in position of emission peak is attributed to the 
variation in size, as recently reported by Peng et al.
14 
The optical properties of CDs vary 
with size which could also result in the variation in density and the nature of sp
2
 sites 
Part-I                                                                                                            Chapter-2 
 
34 
 
available in CDs. The energy gap decreases with increase in size parallel to the trend 
observed in other semiconductor quantum dots due to quantum confinement effect.
38
 In 
case of CD a broad emission spectrum was observed (390-580 nm centered at 441 nm) at 
λex = 360, which indicates size distribution of CDs is broad as supported by TEM image 
and is consistent with reported observations.
18,39,40 
Furthermore, the unique phenomemon 
of excitation dependent photoluminescence was observed in case of both synthesized 
CDs and CPs in consistency with the PL property of CDs reported by other groups 
(Figure 2.7c,d).  
 
Figure 2.7 (a) UV absorption and PL emission spectra (λex = 390 nm) of CD and CP, inset: 
optical images under daylight (left) and UV light (right), (b) Fluorescence microscopy 
images of CD (1) and CP (2) with excitation wavelength at 488 nm, emission spectra of 
CD (c) and CP (d) recorded for progressively longer excitation wavelength of 10 nm 
increments. 
Another interesting phenomenon here is the pH dependent PL behavior. PL 
intensity decreased at very high pH and slightly decreased at low pH, but remained 
almost unchanged at pH 4.8-8.7 (Figure 2.8a). This pH dependent behavior is in 
accordance with that of GQDs synthesized by one-step solvochemical route from 
graphene oxide.
40 
There were no changes in fluorescence intensity or peak characteristics 
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at different ionic strengths (Figure 2.8b), which is important during CDs use in the 
presence of physical salt concentrations in practical applications. The measurement of 
fluorescence intensity with time indicates that the CDs do not show photobleaching 
behavior for 3 h upon excitation at 360 nm (Figure 2.8c). Due to consistent PL within 
biological pH range this CD may be suitable for biological imaging. The fluorescence 
quantum yield of CD is 26% (taking quinine sulphate as standard, Figure 2.1) while that 
of CP is 20%. These values are appreciably higher than QY of carbon nanoparticles 
synthesized by other methods. As photoluminescence originates from surface emissive 
traps, smaller the carbon particles with a larger surface-to-volume ratio, the ratio of the 
number of trap sites-to-the number of photo excitable electrons increases and hence QY 
of CDs is more than that of CPs.  
 
Figure 2.8 (a) Effect of pH on the fluorescence intensity of CD (b) Effect of ionic 
strengths on the fluorescence intensity of CD (ionic strengths were controlled by various 
concentrations of NaCl), (c) Effect of time on fluorescence intensity of CD in DI water. 
To demonstrate orange juice as an efficient precursor for synthesis of highly 
luminescent CD, we have also synthesized a series of CDs using glucose, fructose, 
sucrose, ascorbic acid and citric acid which are main constituents of orange juice. These 
CDs were synthesized using similar hydrothermal condition as that of orange juice 
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decomposition. We found that all the synthesized CDs are highly water soluble due to 
presence of various functional group and show excitation dependent fluorescence 
properties similar to CD. The various optical properties of these CDs are summarized in 
Table-2.1. However the PL quantum yields of the synthesized CDs are much less than 
that of CD synthesized from orange juice. Furthermore isolation of these CDs are a 
tedious process, their separation requires dialysis followed by lyophilization instead of 
easy centrifugation followed in case of orange juice derived CD. In addition to this, these 
synthesized CDs do not show stable fluorescence in biological pH range demonstrating 
their incongruity towards biological applications. These findings clearly demonstrate that 
orange juice is a better reliable precursor for synthesis of CD.  
Table 2.1 Comparative data of HD size, emission wavelength at λex = 330 nm and PL 
quantum yield (φ) of carbon dots synthesized from different precursors. 
SI No. precursor HD size 
(nm) 
λemission (nm) at 
λex=330 nm  
PL QY 
(%) 
1 Glucose  18.9 414 13.98 
2 Fructose  38.3 433 8.8 
3 Sucrose  25.3 421 13.5 
4 Ascorbic acid 36.0 432 9.2 
5 Citric acid  39.4 438 6.9 
6 Glucose+Ascorbic acid 16.3 413 14.6 
7 Glucose+Citric acid  29.4 419 3.2 
8 Fructose+Ascorbic acid 19 412 12.7 
9 Fructose+Citric acid 35.2 424 5.9 
10 Sucrose+Ascorbic acid 16.3 416 9.7 
11 Sucrose+Citric acid 34.03 427 7.3 
12 Orange juice 16 420 26 
 
Cellular uptake and fluorescence imaging 
The excellent optical properties of the CD can be used for noninvasive monitoring 
of disease, therapy and other biological metabolic process. In this regard, the possible 
application of synthesized CD as cell-imaging agent was explored. The inherent 
cytotoxicity of CD was evaluated using L929 cell lines through MTT assay (Figure 2.9a). 
Here it is noteworthy that CdSe QDs cause 76% reduction in cell viability with a 
concentration of 6.25 µg mL
-1
 and 24 h exposure time.
43 
In contrast, these synthesized 
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CD do not impose any significant toxicity to cells and tolerable even at high dose 
(200μg/mL) and long incubation time (72 h). Hence it is safe for in vitro and in vivo 
applications. We have performed in vitro cellular uptake experiments in human 
osteosarcoma (MG-63). Figure 2.9 shows confocal images of MG-63 cells treated with 
CDs at bright field, excitation wavelengths 488 nm and 405 nm. The phase contrast 
images of MG-63 cells at λex= 488 nm clearly shows the agglomeration of green 
fluorescent carbon nanoparticles inside the cells leaving clear zones of nuclei (Figure 
2.9c). Furthermore, the excitation dependent luminescence of synthesize CDs gives rise 
to several visible consequences in imaging. When the laser excitation was changed to 405 
nm fluorescent blue color was observed. In addition to this there is no reduction in 
luminescence intensity even after excitation for a prolonged time. All these preludes 
demonstrate that the CDs obtained from orange juice can serve as a potential substitute 
for organic dyes or semiconductor QDs in bioimaging. 
 
Figure 2.9 (a) Cell viability by MTT assay, (b) MG-63 cells under bright field, at excitation 
(c) 488 nm and (d) 405 nm. 
 
2.5. Conclusion 
 In this chapter highly luminescent carbon dots with fluorescence quantum yield of 
26% have been synthesized in one-step hydrothermal treatment of orange juice. 
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 These partially crystalline carbon nanoparticles show strong and stable 
photoluminescence which is dependent on excitation wave length and pH. 
 The CDs do not show any cytotoxicity and efficiently taken up by the cells.  
 Due to the combined advantages of green synthesis, high aqueous stability, good 
and tunable luminescence and high biocompatibility these CDs can promise 
potential applications in biolabelling as well as solution state optoelectronics. 
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Chapter-3 
Design of Fe3O4@SiO2/CD based nanostructure for simultaneous 
fluorescence sensing, magnetic separation and live cell imaging of 
fluoride ion 
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3.1. Introduction 
In past few years, generous effort has been devoted to the design of sensors for the 
detection of ﬂuoride anion due to its high analytical signiﬁcance in environmental and 
biological processes.
1-6
 Fluoride anion is an essential element of human body and plays a 
beneficial role in treating osteoporosis and protecting dental health.
7,8
 However, 
excessive ﬂuoride ingestion may cause kidney disorders, ﬂuorosis and urolithiasis in 
humans, and exposure to very high levels of fluoride can cause death.
9-11
 The maximum 
permissible limit of F
-
 in drinking water is set at 1.5 mg/L by the World Health 
Organization.
12
 Currently, many people still regularly drink the water containing ﬂuoride 
above this level all over the world. In order to decrease the possibility of excessive 
fluoride intake, a simple, economical, and selective assay is highly desirable for practical 
purpose.  
The fluorescence sensing method has been used as an useful technique for  
detecting  anions  and  metal  ions  due  to    high sensitivity and  selectivity,  simplicity,  
and  real-time  detection.
13-15
 Considerable eﬀorts have been devoted to design F- 
selective ﬂuorescent probes by exploiting different strategies including supramolecular 
recognition,
16-18
 hydrogen bonding,
19,20
 Lewis acid base interactions,
21-24 
and F
-
 ion-
induced chemical reactions.
25-29 
In most cases, the measurements need to be conducted in 
purely organic solvents or less eﬃciently in organic solvent/water mixtures due to 
competitive interactions with water molecules. Moreover, interference from the presence 
of H2PO4
-
, AcO
-
, and CN
-
 ions is unavoidable and the detection selectivity is a severe 
issue.
30
 To solve the selectivity problem, fluoride-induced chemical reactions have been 
utilized to design fluoride ﬂuorescence sensors. The chemical reaction-based ﬂuorometric 
F
-
 probes are exclusively based on small molecule dyes which operate in organic 
medium. Water-insolubility and concentration quenching effect of conventional 
fluorophores result in organic solvent dependence and slow sensing response limiting 
their practical utility. In addition to this, fluorophores which operate in UV excitation are 
not preferable for sensing fluoride in biological system. Therefore the prime challenges in 
designing fluoride sensors are 1) must be based on turn-on principle rather than turn-off 
as it enable small amounts of light to be measured relative to a dark back ground, 2) high 
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selectivity and sensitivity of the system in the back ground of competing anions, 3) low 
detection limit and fast usability in totally aqueous medium, 4) good luminescence under 
visible light excitation 5) cost effectiveness.  
In recent times, carbon dots (CDs) have drawn great attention of interdisciplinary 
scientists owing to their small sizes, excellent water solubility, strong fluorescence, high 
photostability and non-toxicity and excellent biocompatibility.
31-33
 These superior 
properties make these materials promising alternatives to common toxic metal-based 
quantum dots in sensing applications. Although carbons dots have been exploited for 
fluorescence sensing of a wide range of cations and anions, organic/biological molecules, 
and target gases,
34
 the literature on the design of CD based sensor for potential sensing on 
fluoride ion in aqueous medium is inadequate. The scanty example includes zirconium 
complexed CD ﬂuorescent probe for ﬂuoride ion detection which is based on the 
competitive ligand reactions between the carboxylate groups (–COOH) on the surface of 
the luminescent carbon dots (CDs) and F
-
 coordinated to Zr(H2O)2EDTA.
35
 In spite of 
conscious effort to develop a fluoride sensor to be operated in aqueous medium, the 
number of fluoride probes suitable for cell-imaging applications is still very sparse. For 
effective sensitivity in biological medium the probe has to meet stringent requirements 
such as a high selectivity for F
-
 in presence of other competitive anions, a high cell 
permeability, and low/no toxicity.  
On the other hand, heterogeneous fluoride sensors, based upon the immobilization 
of molecular anion receptors to solid supports, are technologically attractive due to their 
potential ease of use and reusability. However, only limited examples of such 
heterogeneous sensors have been reported. The use of complex architectures employing 
surfactant micelles, silica nanoparticles, or other functionalized substrates has allowed 
one to overcome several innate limitations.
36-38
 More specifically among solid supports, 
silica based nanomaterials provide an excellent choice for designing sensors because of 
their chemical stability, large surface area, biocompatibility and ease of surface 
modification.
39,40
 Nonetheless, the use of silica nanoparticles and other solid supports in 
water treatment is limited due to their tedious separation process. In order to simplify the 
separation, incorporation of magnetic nanoparticles would be a good choice. Magnetic 
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nanoparticles would facilitate the magnetic separation and recuperation of the anion from 
the detection system using external magnetic field.    
Following this line of thought, we demonstrate a robust reusable fluorescent 
sensor for fluoride ion detection and removal from aqueous solution. The design of a 
ﬂuorescent probe includes two fundamental moieties, a receptor in charge of the 
recognition and a ﬂuorophore responsible to signal the recognition event. We have used 
highly fluorescent CD as fluorophore and magnetically separable EDTA-Ni complex 
functionalized silica coated magnetite as fluoride ion receptor. The sensing principle 
involves the binding of CD onto the magnetic receptor inducing reduction of fluorescence 
intensity of the CD solution. On addition of fluoride ion to the system, the fluorescence 
intensity was gradually recovered due to substitution of bound CD by F
-
 ion. It is 
important to note that the fluoride deposited magnetic silica particles can be recovered 
and reused without significant loss of its activity. This technique is found to be extremely 
sensitive to achieve selective recognition of F
-
 in competitive aqueous environments. The 
technique has been further extended to monitor F
-
 in living cells as experimented in HT29 
cells. 
 
3.2. Experimental 
Chemicals 
Anhydrous ferric chloride (FeCl3), ferrous sulphate (FeSO4·7H2O), nickel 
chloride (NiCl2), ammonia, ethanol and anionic  compounds  such  as  NaF, NaCl, NaBr, 
CH3COONa, Na2CO3, NaHCO3, Na3PO4, Na2HPO4, NaH2PO4, NaNO2, NaNO3, Na2S, 
NaHSO3, NaHSO4, Na2SO3 were procured from Merck, Germany. Tetraethylorthosilicate 
(TEOS) and 3-aminopropyltriethoxysilane (APTES) were purchased from Sigma 
Aldrich, USA. Thionyl chloride (SOCl2) and ethylenediaminetetraacetic acid (EDTA) 
were purchased from Spectrochem Private Limited. Comercially available 
dichloromethane and toluene were purified by distillation over phosphorous pentoxide 
and sodium metal with benzophenol, respectively. All other reagents and solvents were 
used without further purification. 
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Synthesis of Fe3O4 nanoparticles 
Fe3O4 nanoparticles were prepared by chemical co-precipitation method. FeCl3 
(0.324 g, 2 mmol)  and  FeSO4.7H2O  (0.278 g, 1 mmol) were dissolved in 40 mL of 
deionized water under vigorous  stirring  at  70-80
 
°C  for  10  min  under  a nitrogen 
atmosphere. Subsequently, 5 mL ammonia solution (25%) was added drop wise into the 
solution and stirring continued for another 30 min. The solution was then cooled to room 
temperature and the resulting particles were subjected to magnetic decantation followed 
by repeated washing with millipore water and finally dried in a vacuum oven at 70 °C. 
Synthesis of amine modified silica coated magnetite nanoparticle (Fe3O4@SiO2-NH2) 
Prior to amine modification, silica coated Fe3O4 nanoparticles were prepared. For 
the synthesis, 50 mg of the iron oxide nanoparticles were well dispersed in a mixture of 
50 mL ethanol, 10 mL millipore water and 1 mL 28% ammonia solution. Then, 0.5 mL 
TEOS was added drop wise under vigorous stirring conditions to the above nanoparticle 
suspension. After continuous stirring for 12 h at room temperture, the silica coated 
magnetic nanoparticles were recovered and washed with ethanol and dried. For amine 
modification, about 0.3 g of Fe3O4@SiO2 particles were added to 30 mL of dry toluene 
with 0.7 mL (3 mmol) of 3- aminopropyltriethoxysilane (APTES) under reﬂuxing in N2 
atmosphere for 24 h. The functionalized particles were magnetically separated, washed 
extensively with acetone, and dried. 
Synthesis of EDTA bound silica coated Fe3O4 nanoparticle (Fe3O4@SiO2-EDTA) 
The EDTA modification of Fe3O4-SiO2-NH2 was carried out in an anhydrous 
condition using dichloromethane as solvent.
41
 To the mixture of  EDTA (3.72 g, 0.01 
mol) and 40 mL dichloromethane, SOCl2 ( 0.72 ml, 0.01 mol) was slowly added with 
continuous stirring under argon atmosphere. Immediately after SOCl2 was completely 
dropped, 0.5 g of Fe3O4@SiO2-NH2 was rapidly added to the mixture and allowed to stir 
for 2 h under room temperature. Then EDTA modified silica coated magnetite sample 
was separated magnetically and washed in a row with DCM, acetone, milipore water, 
NaHCO3 (0.1 M), milipore water and acetone. Finally it was dried overnight at 50 °C.  
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Synthesis of EDTA-Ni complex modified Fe3O4@SiO2 nanoparticle (Fe3O4@SiO2-
EDTA-Ni) 
The complexation of Fe3O4@SiO2-EDTA was carried out with Ni
2+
 ion by 
equilibration method. The functionalized magnetic support Fe3O4@SiO2-EDTA (200 mg) 
was stirred with excess NiCl2 salt for 30 min. Then the pH of the solution was set at 8 and 
allowed to stir overnight. The Fe3O4@SiO2-EDTA-Ni complex was collected by 
magnetic separation, washed with aqueous solution to remove non-complexed metal ion 
and oven dried at 50 °C.  
Fluorescence sensing and removal of Fluoride anion 
The detection of F
-
 ion was performed in milipore water, tap water and phosphate 
buffer solution. In a typical assay, 5 mg Fe3O4@SiO2-EDTA-Ni was added into CD (10 
mL, 2 ppm) dispersion and the fluorescence (FL) spectra was recorded after and before 
the addition of Ni complex bound magnetic support. To the above mixture different 
concentrations of F
-
 ion was added and the change in FL intensity was monitored. The 
selectivity for F
-
 was confirmed by adding other anion stock solutions instead of F
-
 in a 
similar way at a concentration of 500 µM. All experiments were performed at room 
temperature. The fluoride bound magnetic support was recovered through external 
magnet. 
In vitro cytotoxicity and fluorescence imaging  
In vitro cytotoxicity: Human colon adenocarcinoma cell line HT29 cells (3×10
3
 cells) 
were seeded into 96-well plates and incubated in 200 μL DMEM containing 10% FBS for 
24 h (37 °C, 5% CO2). Then the cells were incubated with different concentration of 
Fe3O4@SiO2-EDTA-Ni@CD (12.5, 25, 50, 100, 200, 300, 400, 500 μg/mL) in fresh 
DMEM without serum for another 24 h and after incubation viable cell concentration was 
checked by MTT (3-(4,5-Dimethyl-2-2thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) 
assay. All the experiments were performed in triplicate. 
Fluorescence Imaging: For live cell imaging, the HT29 cells were incubated with 
Fe3O4@SiO2-EDTA-Ni@CD (100 μg/mL) for 12 h at 37 °C inside humidified 5% CO2 
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incubator.  After being washed with fresh PBS three times the cells were imaged through 
confocal microscope at 488 nm excitation. Then F
-
 (500 mM) was added and incubated 
for 2 h and the cells were imaged again after washing three times with PBS at same 
excitation wavelength of 488 nm. 
 
3.3. Characterization 
The prepared materials were characterized by standard analytical techniques as 
described in characterization section of chapter-2. In addition, the morphology and 
microstructure of the samples were analyzed by Field Emission Scanning electron 
microscope (Nova NanoSEM/ FEI-450).  The magnetic property of Fe3O4@m-SiO2-
EDTA-Ni nanoparticle was determined using a SQUID-VSM instrument (Evercool 
SQUID VSM DC Magnetometer) at 25.0 ± 0.5 °C.  
 
3.4. Results and discussion 
Synthesis 
The magnetically separable fluorescent sensor comprising of two components one 
fluorophore (CD) for FL signal recognition and other EDTA-Ni complex bound silica 
coated magnetite nanoparticle, which serve as recipient of fluoride ion. The fluorescent 
CD was synthesized by hydrothermal treatment of orange juice, whereas the fluoride ion 
receptor magnetic particle was synthesized by a multistep process (Scheme-3.1). The 
silica-coated magnetite nanoparticles were synthesized using modified Stöber’s method, 
which were further amine functionalized by APTES. The superparamagnetic nature of the 
F3O4 would facilitate their easy and quantitative separation using external magnetic field, 
whereas silica coating stabilize the magnetic nanocore and eliminate the interaction of 
magnetic core with fluorophore CD. Moreover silica coating provides enough sites for 
further surface modification. In the second step, the surface of the nanoparticles was 
modiﬁed with EDTA in order to prepare Ni-EDTA complex bound silica coated 
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magnetite nanoparticle which would serve as fluoride ion receptor. The metal 
complexation was done using excess NiCl2 salt at pH 8.  
 
Scheme 3.1 Illustration of synthesis of EDTA-Ni complex conjugated Fe3O4@m-SiO2. 
Characterization of fluoride ion receptor 
Structure and morphology 
The crystal structures and the phase purity of the Fe3O4@SiO2 were determined 
by XRD. The diffraction peak of Fe3O4 and Fe3O4@SiO2 (Figure 3.1a) can be easily 
indexed to a crystalline cubic spinel structure of Fe3O4 (JCPDS No. 82-1533). No other 
impurity peaks were detected. The broad band at 2θ=22° can be assigned to the 
amorphous silica shell (JCPDS No. 29-0085).  
Figure 3.1 (a) XRD patterns of Fe3O4 and Fe3O4@SiO2, (b) FESEM image, (c) TEM image 
of Fe3O4@SiO2, the inset is at high magnification showing the core-shell structure and 
(d) hydrodynamic size of Fe3O4@SiO2. 
The morphology and size distribution of the silica coated magnetite nanoparticles 
were obtained from FESEM and HRTEM analysis. The FESEM image (Figure 3.1b) 
clearly showed the formation of monodisperse spherical particles with a smooth surface. 
The average particle size of Fe3O4@SiO2 was found to be 120 nm. The TEM image 
(Figure 3.1c) of Fe3O4@SiO2 particles shows the formation of core-shell structure of size 
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100-120 nm. The dark core of the Fe3O4 and the grey silica shell of thickness 35-40 nm 
were clearly observed. Each silica sphere contains one or more magnetite nanocrystals 
embedded within its structure. However, aggregation/coalescence of individual 
Fe3O4@SiO2 was found, and the aggregation might occur during TEM sample 
preparation and drying effect as observed in other cases.
42
 The average size of the particle 
in dispersion was found to 117 nm as measured by dynamic light scattering. 
 Surface properties  
The various stages of synthesis of Fe3O4@SiO2-EDTA-Ni were verified through 
FTIR spectroscopy (Figure 3.2a). Fe3O4@SiO2 particles show strong absorptions at 555 
cm
-1
, characteristic vibration of Fe-O in the magnetite lattice. The bands at 1000-1200 
and 942 cm
-1 
were attributed to the Si-O-Si asymmetric stretching vibration and bending 
vibration of Si-OH. Furthermore appearance of bands for OH (3300 cm
-1
), H2O (1627 
cm
-1
), Si-O-Si (ʋsym, 802 cm
-1
) and Si-O (δ, 458 cm-1) bonds confirms the successful 
silica coating on Fe3O4 nanoparticle. The presence of broad band centered at 3300 cm
-1
 
and intense band at 1635 cm
-1
 suggest the presence of large number of H2O and –OH 
groups on the surface which play the major role not only in high aqueous stability but 
also provides enough scope for further surface modification with APTES. The 
appearance of methylene peak at 2882 cm
-1
 confirms the successful amine modification 
by APTES. However, the asymmetric and symmetric stretching vibrations of the N-H 
bond, located at wavenumbers 3366 and 3296 cm
-1
 on the spectrum of APTES, are not 
seen, possibly owing to the overlapping with the stretching vibration of the hydroxyl 
group. The band at about 1698 cm
-1
 in Fe3O4@SiO2-EDTA spectrum was assigned to the 
–C=O stretching vibration of the acylamide group, which was the principal band of the 
acytamide ligand (EDTA). The bands corresponding to the C-N stretching and/or C-O 
stretching vibration overlap in the silica vibrational region 1300–1000 cm-1. The shift of –
C=O stretching vibration of carboxylic group to 1661 cm
-1
 in case of Fe3O4@SiO2-
EDTA-Ni can be attributed to EDTA co-ordination to Ni through carboxylic group. In a 
typical survey spectrum (Figure 3.2b) of the fluoride bound nanoparticles, the peaks at 
binding energies 100, 285-290, 402.3, 530-538, 683-692, 705-730, 855-880 eV are 
ascribed to binding energy in Si2p, C1s, N1s, O1s, F1s, Fe2p and Ni2p regions 
respectively. High resolution scan for C1s (Figure 3.2c) shows that the curve is well fitted 
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into five peaks centered at 283.7, 285.2, 286.2, 288.5 eV corresponding to the C-Si, C-
C/C-H, C-N, -NHCO/-COOH carbon respectively. The broad peaks for O1s binding 
530.4 and 532.5 eV correspond to M-O and -COOH/NHCO respectively (Figure 3.2d). 
The high resolution scans of the N1s (Figure 3.2e) can be fitted into three peaks. The 
peak at 400.1 eV corresponds to unreacted-NH2 group of the magnetic receptor. The 
peaks appearing at 401 and 402.4 eV are attributed to nitrogen in amide (CONH) and C-
N respectively.  Fe2p3/2 and Fe2p1/2 electrons show binding energy at 711.7 and 725.4 eV 
which is consistent with the Fe2p binding energy of magnetite nanoparticles (Figure 
3.2f). Presence of Ni2p3/2 and Ni2p1/2 at 859 and 876.9 eV confirms the formation of Ni 
complex on Fe3O4@SiO2-EDTA (Figure 3.2g). The high resolution spectrum of F1s at 
689.8 eV corresponds to semi ionic bonded fluoride (Figure 3.2h). 
 
Figure 3.2 (a) FTIR spectra of (i) Fe3O4@SiO2, (ii) Fe3O4@SiO2-NH2, (iii) Fe3O4@SiO2-EDTA 
(iv) Fe3O4@SiO2-EDTA-Ni, and (b) Survey spectrum, high resolution scan corresponding 
to (c) C1s, (d) O1s, (e) N1s, (f) Fe2p, (g) Ni2p, (h) F1s, (i) Si2p of fluorine bound  
Fe3O4@SiO2-EDTA-Ni sample. 
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Magnetic Properties 
The magnetic properties of the Fe3O4@SiO2-EDTA-Ni receptor were investigated 
by using a vibrating sample magnetometer (VSM) with the magnetic field cycle between 
-15000 and +15000 Oe at room temperature. Field dependent magnetization curve 
(Figure3.3a) of Fe3O4@SiO2-EDTA-Ni receptor at room temperature shows that the 
magnetization value increased rapidly as the applied field increased up to 8000 Oe and 
reached at a saturation point at 12000 Oe. The saturation magnetization (Ms) was found 
to be 94 emu g
-1
 which is much higher than the as prepared Fe3O4@SiO2 (40 emu g
-1
). 
The higher saturation magnetization can be interpreted as the synergistic magnetization 
effect of Ni
2+
 in bound nickel complex on silica coated magnetite and Fe3O4 core. The 
room temperature magnetic curve for both the sample exhibit no hysteresis and 
completely reversible at room temperature indicating the superparamagnetic nature. The 
above observation indicates that although complexation of Ni to Fe3O4@SiO2 has led to a 
signiﬁcant increase in saturation magnetization (Ms), but the superparamagnetic behavior 
remain unaffected on complexation. The complete magnetic separation by external 
magnetic field near the fluoride bound Fe3O4@SiO2-Ni nanocomposite (Figure 3.3b) 
demonstrates the strong magnetic sensitivity of the fluoride receptor. The high saturation 
magnetization and superparamagnetic behavior enable the magnetic receptor to be used 
as an efficient recoverable fluoride receptor which can be easily removed by applying 
external magnetic field after binding with fluoride ion. 
 
Figure 3.3 Field dependent magnetization curves of Fe3O4@SiO2 and Fe3O4@SiO2-EDTA-
Ni, (b) Magnetic separation of Fe3O4@SiO2-EDTA-Ni through Dynamag2.  
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Fluorescence detection of Fluoride ion 
We explored the combined features of CD (FL behavior) and magnetic 
Fe3O4@SiO2-EDTA-Ni nanoparticles (fluoride ion receptor) for selective fluoride ion 
detection and removal in aqueous solution. The fluorescence property of CD is utilized 
for fluorescence monitoring of fluoride ion, whereas the magnetic nature of the receptor 
is used for recovery and reusability of the nanosystem. The CD exhibits strong and stable 
fluorescence signal at 420 nm on excitation to 340 nm. As expected the addition of 
Fe3O4@SiO2-EDTA-Ni to the aqueous CD solution shows sharp decline in the 
fluorescence intensity (Figure 3.4a). The observed sensations can be attributed to the 
binding of the CD to the magnetic receptor resulting in reduction of CD level available in 
the analytic sample which ultimately leads to fluorescence quenching. However addition 
of the fluoride ion results in gradual restore of the fluorescence. As shown in Figure 3.4a, 
the PL intensity of the CD at around 420 nm increases gradually with increasing 
concentration of F
-
, indicating that addition of F
-
 ions can effectively recover the 
ﬂuorescence of the CD. This fluorescence regain can be ascribed to the replacement of 
the bound CD into the solution by F
-
. To evaluate the sensitivity of the system, different 
concentrations of F
-
 ranging from 1µM-1mM were studied and found that the 
fluorescence intensity of the CD is recovered to 95% with addition of 1mM F
-
. By 
plotting relative intensity (F/F0) against ﬂuoride concentration, we established good 
linearity for ﬂuoride in the range 1-20 µM with R2=0.992 (Figure 3.4c). These results 
suggest that the PL of CD solution can be recovered due to the strong binding of F
-
 to Ni 
bound receptor. On applying external magnetic field, the magnetic support along with F
-
 
can be simply removed from the medium as illustrated in the Figure 3.3b. Although the 
mechanism of fluorescence sensing is not clear, we suggest a possible approach for the 
interaction between the sensor and fluoride. We anticipate that the surface –COOH group 
of CD interacts with postively charged Ni centre and free amine group present on 
magnetic receptor through electrostatic interaction which results in binding of the CD on 
to the magnetic receptor leds to diminished fluorescence signal. The diminished 
fluorescence intensity is recovered on addition of F
-
 due to its high binding affinity to the 
receptor. After adding F
-
, it occupies the binding sites and thus replaces CD into the 
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analytical solution. The binding of the fluoride is clearly evidenced by the semi-ionic 
fluoride in high resolution F1s XPS spectrum (Figure 3.2h).   
To investigate the response time of the receptor towards the fluoride anion, we 
measured the fluorescence intensity variation as a function of time upon addition of 
fluoride anion. Figure 3.4d clearly indicates that the fluorescence intensity of the system 
reached its maximum value within fifteen minutes upon addition of fluoride anion. This 
demonstrates that the coordination of fluoride ion with receptor (Fe3O4@SiO2-EDTA-Ni) 
is 15 minute. 
 
Figure 3.4 (a) Fluorescence spectra of CD-Fe3O4@SiO2-EDTA-Ni with gradual addition of 
F- in millipore water, (b) Relative fluorescence (F/F0) vs F
- concentration, (c) the linear 
response, (d) Fluorescence recovery in response to times after addition of F-. 
Selectivity of the receptor for F
-
 detection 
To evaluate the selectivity of the developed system towards F
-
, fluorescence 
screening experiment was carried out. Figure 3.5a shows the histogram of fluorescence 
response with different anions and very little FL enhancement was observed after the 
addition of H2PO4
-
, S
2-
 and NO3
-
 ions. The fluorescence of CD solution was recovered 
almost completely in the presence of F
-
, whereas negligible recovery was observed in 
presence of other anions like Cl
-
, Br
-
, CO3
2-
, HPO4
2-
, PO4
3-
, HCO
3-
, NO
2- 
and CH3COO
- 
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indicating that synthesized sensor is highly specific and selective for F
-
. Fluorine is the 
strongest electronegative element and that can recognize a positively charged center 
which assists the release CD from the magnetic receptor into the analytic solution 
ensuing fluorescence enhancement.  
 
Figure 3.5 Fluorescence recoveries (a) in the presence of different anion (500 μM), and 
(b) mixture of anions (500 μM). 
Figure 3.5b presents the fluorescence response of CD towards F
-
 in the presence 
of above mentioned anions. Evidently, the co-existence of these anions does not interfere 
with the coordination of fluoride anion with the receptor as well as the subsequent 
fluorescence enhancement. These results suggest that the probe can function as a highly 
selective sensor for F
-
. 
Application of Fluoride ion sensing  
Efficient F
- 
detection in water samples and PBS 
To evaluate the efficacy of this sensing system in some real samples, the sensor 
was applied for sensing fluoride ions in tap water and PBS. Prior to use all the samples 
were filtered through a 0.22 µm membrane to remove any suspended particles. As shown 
in Figure 3.6a, this sensing system worked quite well in tap water with the recovery of 
96%. It was observed that the fluorescence intensity increased with increasing 
concentration of F
-
. The present approach provides a linear response to F
-
 ions at 
concentrations over the range from 0 to 10 µM having R
2 
= 0.9978 (Figure 3.6c). 
Although numerous organic/inorganic impurities and minerals exist in the tap water, this 
sensing system can still selectively respond to F
-
, satisfying the practical detection of F
-
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in real samples. Although the flourescence recovery rate on F
- 
addition in PBS was found 
to be slow in the lower concentration range (1-20 µM) compared to milipore water and 
tap water, it worked quite well in higher concentration range (50-1000 µM) with recovery 
of 92% (Figure 3.6d). This discrepancy may be due to the trivial interference of H2PO4
-
 
ion present in PBS.  
 
Figure 3.6 Fluorescence spectra of CD-Fe3O4@SiO2-EDTA-Ni with gradual addition of F
- in 
(a) tap water and (d) PBS, Relative fluorescence (F/F0) vs F
-concentration in (b) tap water 
and (e) PBS, the linear response in (c) tap water and (f) PBS.  
Imaging of fluoride ion in live cells 
To investigate the biocompatibility of the sensor, the cytotoxicity of the 
Fe3O4@SiO2-EDTA-Ni@CD sensor was evaluated in HT29 cells. The viability of the 
cells was declined by 10% upon addition of the sensor at up to 100 μg/mL for an 
incubation period of 72 h (Figure 3.7a). Thus the sensor is nontoxic and biocompatible, 
thus can be explored for bioimaging of F
-
 inside the living cell. We performed in vitro 
cellular uptake experiment with HT29 cells. The cells were first incubated with the probe 
(Fe3O4@SiO2-EDTA-Ni@CD) for 12 h at 37 ºC. After the uptake, the particles were 
monitored by confocal microscopy and found to reside mainly in the cell membrane. It 
was observed that in absence of F
-
 hardly any green fluorescence was observed under 
excitation of 488 nm. However when the cells were supplemented with F
-
 a clear green 
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signal was observed surrounding the nuclear region indicating the ability of our 
nanoprobe to show turn-on behavior in presence of F
-
 inside the cell (Figure 3.7). 
 
Figure 3.7 (a) Cell viability by MTT assay and (b) Reusability of the receptor for detection 
of F-, The confocal image of HT29 cells stained with Fe3O4@SiO2-EDTA-Ni@CD (c), (e) 
Bright-ﬁeld transmission image of HT29 cells (d) confocal image of cells visualized at 
excitation wavelength of 488 nm, (f) confocal image of cells post-incubated in 100 mM 
F- solution. 
 
Table 3.1 Fluoride binding capacity of the receptor for conjugative cycle. 
No. of Cycle Fluoride binding capacity 
1st 16.4 mg/g 
2nd 16.0 mg/g 
3rd 15.6 mg/g 
4th 14.8 mg/g 
 
Fluoride removal, separation and reusability of the system 
The reusability of the system was further investigated by separating the fluoride 
bound Fe3O4@SiO2-EDTA-Ni using an external magnet. The recovered nanoreceptor 
was recycled three times for F
-
 detection with negligible loss of its activity (Figure 3.7b). 
At the end of each cycle the recovered nanoreceptor was first treated with excess of 
calcium solution to form the insoluble CaF2 precipitate followed by repeated washing 
with milipore water and, finally magnetically separated and dried for further use. The 
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bound fluoride ion in each cycle is quantified by analyzing the residual aqueous fluoride 
solution through fluoride electrode analysis (Table 3.1).  
3.5. Conclusion 
 In summary, we have presented here a novel strategy for the selective detection 
and removal of fluoride ion from aqueous solution using a nontoxic fluorescent 
probe and a magnetic receptor.  
 The assay is based on the exchange reaction between the CD and F-, which 
induces the binding of fluoride to magnetic receptor resulting in recovery of 
fluorescence.  
 This proposed sensing method has been successfully applied in the detection of 
fluorine in tap water which can have promising applicability in drinking water 
quality monitoring.  
 The excellent magnetic properties of the nanoreceptor offers an advantage for 
easy, rapid and assessable separation of the fluoride bound receptor from analytic 
solution which allows quantification of fluoride ion.  
 The probe can also be used for monitoring fluoride anion inside cells.  
 In comparison with existing fluorescence fluoride assay, our method possess 
several remarkable advantages including (1) easy removal of F
-
 through magnetic 
separation (2) reusability of the system for successive study (3) quantification of 
fluoride ion (4) wide linear response range 1-20 µM.  
 The present strategy may offer a new approach for developing reusable low-cost, 
high sensitive and selective F
-
 sensors in environmental applications. 
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4.1. Introduction 
As one of the primary biological materials, saccharides play important roles in many 
biological processes
1,2
 and can also act as important markers for different diseases, the 
most common of them being glucose for diabetes.
3
 Furthermore owing to broad utility of 
saccharides in food, cosmetic and medicinal applications, saccharide sensing has attracted 
continuous concern. Much research has been carried out for monitoring glucose 
concentrations through various methods such as colorimetric,
4
 electrochemical,
5
 and 
fluorescence detection.
6
 Among these methods, fluorescence sensing have attracted rising 
attention due to their intrinsic advantages, considerable research space and applicability 
to living cells.
7
 The conventional glucose sensors mostly rely on the use of an enzyme 
such as glucose oxidase or glucose dehydrogenase.
8
 However these methods are 
expensive, complex, time-consuming and inherently sensitive to factors influencing 
enzyme activity such as heat, solvent, pH which limit their practical application. In this 
respect synthetic chemosensors are more desired in terms of the stability, low cost and 
oxygen independence. Boronic acid-based synthetic sensors therefore represent 
promising alternatives for saccharide sensing owing to their tight yet reversible covalent 
complex formation ability with 1,2- and 1,3-cis diols to form five- or six-membered 
cyclic esters respectively.
9
 Furthermore boronic acid can differentiate structurally similar 
saccharide molecule depending on its binding strength ability influenced by the 
orientation and relative position of hydroxyl groups. These features can boost the 
saccharide sensing with high selectivity and signify the real world saccharide sensing 
application.  
On the other hand, recently discovered luminescent carbon quantum dots (CDs) 
have gained considerable attention as luminophore due to their sizes below 10 nm, high 
biocompatibility and excellent luminescent properties.
10-12
 These features provide 
promising prospects for their application in biodetection and sensing, particularly in 
glucose sensors. For instance, Zheng et al. utilized the peroxidase-like catalytic activity 
of CDs to achieve colorimetric detection of H2O2 and glucose.
13
 Subsequently a similar 
glucose sensor was developed by Liu and coworker using N-doped CDs.
14 
They 
quantified the glucose by monitoring the coloration of 3,3,5,5-tetramethylbenzidine 
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(TMB) induced by the oxidation of hydrogen peroxide. Although CDs can act as a signal 
transduction substrate, they have no intrinsic recognition ability to bind or sense 
saccharide selectively. Thus a specific recognition unit is needed to prepare a highly 
selective probe for glucose detection. In this respect CD functionalized with boronic acid 
having the specific recognition ability to 1,2 and 1,3-cis diol are important for the 
development of glucose sensor. Qui et al. developed a label-free fluorescence assay for 
glucose detection using CDs and a boronic acid substituted bipyridinium salt, which was 
realized via fluorescence quenching with the salt and subsequent recovery by glucose.
15
 
Subsequently Shi et al. reported a boronic acid functionalized CDs for selective and 
sensitive glucose determination in microdialysate.
16
 The added glucose induced the 
assembly of CDs based on the covalent binding between the cis-diols of glucose and 
boronic acid of the CD surface resulting in fluorescence quenching. This boronate-
affinity sensing principle was further explored for blood sugar sensing
17
 where the 
fluorescent probe was synthesized through one step hydrothermal carbonization of phenyl 
boronic acid. Although these reported sensing methods present efficient detection 
techniques for monitoring glucose, however the separation of water soluble CDs from the 
inspective medium are questionable. The isolation of carbon dot can be easily achieved 
by encapsulating CDs in a suitable matrix, which can preserve the luminescence 
properties of CDs and avoid the leaching of CDs abolishing any possible interference. In 
this respect, ordered mesoporous silica can serve as an efficient matrix for uniform 
growth of CDs in the mesoporous channels, due to their advantageous structural 
properties, such as high internal surface area and pore volume, tunable pore sizes, 
colloidal stability, and the low cytotoxicity.
18,19
   
In the present chapter, we present a simple effective fluorescent platform for 
glucose sensing using easily recoverable CD deposited silica nanoparticles (m-SiO2-CD) 
as fluorophore in association with 3-aminophenylboronic acid (APBA).  The synthesized 
fluorophore was well characterized by standard spectrometric techniques such as XRD, 
FESEM, TEM, BET, FTIR, XPS etc. The quenched fluorescence signal due to π-π 
interaction of APBA and m-SiO2-CD has effectively recovered in response to the binding 
of glucose which lift-off the APBA from the CD surface. Exploiting the excellent 
luminescent properties of synthesized m-SiO2-CD and high affinity of APBA towards 
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cis-diol, we extend our work for targeted imaging of cancer cell overexpressed with sialyl 
Lewis A (sLe
a
) receptor. The sLe
a
 is a tetrasaccharide having free cis diols, which can be 
detected by APBA through the formation of boronate ester. For this purpose, 3-
aminophenylboronic acid modified m-SiO2-CD (m-SiO2-CD-APBA) has been prepared 
separately through amide linkage using the surface carboxyl group of CD. The 
cytocompatibilty and targeted imaging of the particle was evaluated on human colon 
adenocarcinoma cell HT29.  
 
4.2. Experimental 
Chemicals 
Cetyltrimethylamminium bromide (CTAB), Tetraethyl orthosilicate (TEOS), 3-
aminophenylboronic acid (APBA) were obtained from Sigma Aldrich, India. Glucose, 
methanol, ethanol, NaOH and HCl were procured from Merck, India. N-hydroxy-
succinamide (NHS) and ethyl-(N',N'-dimethylaminopropyl) carbodimide hydrochloride 
were purchased from Spectrochem, India. All the chemicals were used as such without 
any further purification. Milipore water was utilized throughout the experiment. 
Synthesis of mesoporous silica nanoparticle (m-SiO2) 
Mesoporous silica nanoparticles were synthesized by following the general 
procedure. In a typical procedure, 500 mg of CTAB was dissolved in 250 mL milipore 
water, followed by the addition of NaOH aqueous solution (1.75 mL, 2M). The mixture 
was heated up to 80 °C under vigorous stirring.  When the temperature was stabilized, 2.5 
mL of TEOS was slowly added into the mixture solution and allowed to stir at 80 °C for 
another 2 h. Then nanoparticles were collected by centrifugation at 10000 rpm for 10 
minutes and the product was washed with methanol and water thoroughly. To remove the 
surfactant (CTAB) the nanoparticles were suspended in 50 mL methanol containing 3 mL 
of concentrated HCl and subjected to reflux for 12 h. The product m-SiO2 was collected 
by centrifugation at 1000 rpm for 15 minutes and repeatedly washed by methanol and 
water. The collected nanoparticles were vacuum dried. 
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Synthesis of luminescent carbon dot deposited mesoporous silica nanoparticle (m-SiO2-
CD) 
Luminescent carbon dot integrated mesoporous silica nanoparticle was prepared 
by hydrothermal carbonization of orange juice in the template free channels of the 
mesoporous silica. Typically, dispersed m-SiO2 nanoparticles (300 mg in 30 mL ethanol) 
were mixed with 20 mL of absolutely pulp free orange juice and then the mixture was 
transferred into an 80 mL Teflon-lined stainless-steel autoclave which was heated at 
constant temperature of 130 °C for 150 min (1 °C/min). After the reaction, the autoclave 
was cooled down naturally and the resulted luminescent nanocomposite (m-SiO2-CD) 
was separated through centrifugation. The product was first washed thoroughly with 
dichloromethane followed by water to remove the unreacted organic moiety and water 
soluble adsorbed luminescent CDs respectively. 
Detection procedure 
For the sensing of sugar, to a 5 mL volumetric flask was sequentially added 1 mL 
of m-SiO2-CD dispersion (1 mg/mL), 1 mL of 100 mM solution of 3-
aminophenylboronic acid, different amount of glucose solution, and then diluted with 
milipore water to a final volume of 5 mL. After the solution was shaken for 2 minutes, 
the PL spectra of the resulting solution were recorded at the excitation wavelengths of 
360 nm. 
Synthesis of 3-aminophenylboronic acid conjugated m-SiO2-CD 
For targeted imaging experiment APBA modified m-SiO2-CD nanoparticles were 
synthesized separately.  In a typical procedure 5 mL of aqueous solution containing  NHS  
(41  mg, 0.358 mmol) and EDC (18 mg, 0.0938 mmol) was taken in a 50 mL of round 
bottom ﬂask and was kept in the dark for 2 h. After that the aqueous solution of APBA 
(74 mg in 12 mL water) was added to the above solution followed by addition of m-SiO2-
CD (100 mg) nanoparticles. The resulting suspension was stirred at room temperature for 
overnight and the particles (m-SiO2-CD-APBA) were isolated through centrifugation. 
The particles were washed repeatedly with millipore water.   
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In vitro cytotoxicity and fluorescence imaging  
In vitro cytotoxicity: Human colon adenocarcinoma cell line HT29 cells (3×10
3
 cells) 
were seeded into 96-well plates and incubated in 200 μL DMEM containing 10% FBS for 
24 h (37 °C, 5% CO2). Then the cells were treated with different concentration of m-
SiO2-CD-APBA (12.5, 25, 50, 100, 200, 300, 400, 500 μg/mL) in fresh DMEM without 
serum and incubated for another 24 h. Viable cell concentration was checked by MTT (3-
(4,5-Dimethyl-2-2thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay. The assay 
experiment was performed in triplicate. 
Fluorescence Imaging: HT29 cells were seeded into 24 well plates and incubated in 
DMEM supplemented with 10% FBS and 1% antibiotic (penicillin, streptomycin) at 37 
°C inside humidified 5% CO2 incubator.  After 24 h of incubation, media were replaced 
with fresh DMEM containing m-SiO2-CD and m-SiO2-CD-APBA separately at 
concentration 200 μg/mL and incubated for 4 h. Prior to fixation of the cells on the slide 
for imaging experiment the cells were washed three times with PBS. The cells were fixed 
with 2% Paraformaldehyde for 10 min at -20 °C and again washed with PBS. Live-cell 
imaging was carried out under confocal microscope (Olympus, Japan) with excitation at 
488 nm. 
 
4.3. Characterization 
The synthesized materials were well characterized by using standard techniques 
as described in chapter-2. Additionally the speciﬁc surface areas and total pore volume 
were calculated by the Brunauer–Emmett–Teller (BET) and BJH methods respectively. 
 
4.4. Results and Discussion 
For selective detection of saccharide and glycan, the luminescent properties of m-
SiO2-CD in response to 3-aminophenylphenylboronic acid have been utilized. Addition 
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of boronic acid resulted in quenching of the fluorescence signals arising from m-SiO2-
CD, the fluorescence recovery was achieved by the addition of glucose.  
Characterization of the carbon dot deposited mesoporous silica nanoparticle  
Structural analysis 
Structural characterization of the m-SiO2-CD hybrids was carried out by means of 
XRD and Raman spectroscopy. In wide angle XRD pattern of m-SiO2 (Figure 4.1a), a 
broad stronger diﬀraction peak centered at 2θ of 21.5º was observed, which can be 
assigned to amorphous silica (JCPDS No. 29-0085).  XRD pattern of m-SiO2-CD (Figure 
4.1a) also exhibited a stronger diﬀraction peak in the wide 2θ region, suggesting the high 
structural stability after hydrothermal treatment. The peak corresponding to (002) plane 
of deposited CD overlaps with the silica region. However the peak is slightly shifted to 
higher angle at 2θ = 22.4º (lesser d value), which suggested the introduction of partial 
crystalline nature resulting from deposition of partially crystalline CDs in the mesopores 
of the m-SiO2. Furthermore, hydrothermal decomposition of orange juice on m-SiO2 also 
introduced a weak peak at 2θ=44.5° corresponding to (101) diﬀraction patterns of 
graphitic carbon suggesting successful deposition of CD. Low-angle XRD pattern of m-
SiO2-CD (Figure 4.1b) showed three characteristic diffraction peaks between 1 to 4.0° 
which could be indexed to (100), (110), and (200) diffractions associated with typical 
two-dimensional hexagonal symmetry (P6mm). The appearance of these peaks indicated 
that the long range hexagonal symmetry of m-SiO2 was preserved even after the 
hydrothermal carbonization of orange juice.  
The Raman spectra of the m-SiO2-CD (Figure 4.1c) showed intense bands at 
about 1358 cm
-1 
and 1597 cm
-1
 corresponding to the characteristic D and G peaks of 
graphitic materials respectively. The G band arises due to the vibration of sp
2
-bonded 
carbon atoms in a two-dimensional (2D) hexagonal lattice, whereas the D band is 
associated with the vibrations of carbon atoms with dangling bonds in the termination 
plane of disordered graphite or glassy carbon. The intensity ratio (ID/IG), which signifies 
the extent of disorderliness as well as the ratio of sp
3
/sp
2
 carbons was found to be 0.94 
indicating partial crystalline nature with large disordered amorphous carbon in the hybrid 
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sample. This ID/IG ratio was slightly higher than the bare CD synthesized from orange 
juice reported in chapter-2. The relatively high value may be due to small size growth of 
CD in mesopores of mesoporous silica and the presence of abundant oxygen containing 
groups on the surface.  
 
Figure 4.1 (a) Wide-angle X-ray diffraction pattern of m-SiO2 and m-SiO2-CD, (b) low-
angle XRD, and (c) Raman spectrum of m-SiO2-CD. 
Microstructure and stability 
The SEM image of m-SiO2 (Figure 4.2a) indicates that prepared nanoparticles 
consist of monodisperse sphere with a mean particle size of 110 nm. These particles are 
non-aggregated with narrow size distribution. The morphological features such as the 
spherical shape, non-aggregation and narrow size distribution are observed to be retained 
in case of m-SiO2-CD (Figure 4.2b). These results indicate that deposition of the CD in 
the mesopore of silica through hydrothermal treatment does not alter the structure and 
morphology. TEM was employed to further investigate the detailed structure and 
morphology of m-SiO2-CD. The low-magnification TEM image (Figure 4.2c) shows that 
m-SiO2-CD silica consists of spherical particles with a diameter of 110-130 nm. The 
corresponding high-magnification TEM image (Figure 4.2d,e) clearly shows the typical 
ordered mesostructure arrays consist of hexagonal porous channels with tunable pore 
diameters ranging from 3 to 4 nm. This uniform ordered mesoporous pore would 
facilitate the size controlled growth of CD which tunes its optical properties. Appearance 
of well-ordered mesostructure indicates that hydrothermal treatment has little influence 
on the structure of the CD deposited mesoporous silica. Numerous dark spots are noticed 
in the porous network of mesoporous silica, (Figure 4.2f) which confirms the successful 
deposition of CD in the mesopores of silica. 
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The hydrodynamic (HD) size of m-SiO2 and m-SiO2-CD (Figure 4.2g) 
demonstrates the formation of stable non-aggregated particles. The CD deposited 
particles showed a mean HD size of 112 nm, which is slightly smaller than m-SiO2 (123 
nm). The observed decrease in HD size in case of CD deposited sample may be due to the 
introduction of -COOH group in the particle surface associated with CD. These 
functionalized particles show a more stable dispersible colloidal suspension resulting 
from repulsion of carboxylic group. Measurement of zeta potential against pH (Figure 
4.2h) shows that at low pH zeta potential is 30.4 mV which shifts to -33.2 mV at higher 
pH which specifies the presence of –COOH groups on the surface. 
 
Figure 4.2 SEM images of (a) m-SiO2 and (b) m-SiO2-CD, (c) TEM image of m-SiO2-CD, 
TEM images at higher magnification (d, e) at different tilting angles, (f) higher magnified 
TEM image representing deposition of CDs in the mesopores, inset is the TEM image of 
single m-SiO2-CD showing hexagonal ordered mesopores, (g) Hydrodynamic size of m-
SiO2 and m-SiO2-CD measured from DLS, (h) Zeta potentials of m-SiO2-CD. 
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BET surface area 
The synthesized samples exhibit high surface area, large pore volume, and narrow 
pore size distribution. The nitrogen adsorption-desorption isotherm (Figure 4.3a) of both 
m-SiO2 and m-SiO2-CD samples show the typical type IV isotherms with a hysteresis, 
which is a characteristic of mesoporous material. However, in case of m-SiO2, the 
desorption curve of the isotherm is close to the closure point; around 0.06 P/P
0
 which is 
extremely low than m-SiO2-CD at 0.5 P/P
0
. These results indicate the disordered pore 
structure in synthesized m-SiO2 which is also evident from the pore size distribution 
curve. This discrepancy can be explained on the basis of synthetic process. It seems that 
during the synthesis of m-SiO2 at 80 °C the loose crosslinking between the micelles takes 
place forming spherical structure, whereas hydrothermal treatment is responsible for the 
further ordering and ripening of the porous system. The hydrothermal treatment during 
the CD deposition in mesoporous silica induces the tightening of silica cross-linkage 
resulting ordered structure. Therefore the first step of m-SiO2 formation is the setting 
phase where the forces controlling particle morphology can take precedence while the 
second hydrothermal treatment in m-SiO2-CD is responsible for hardening and ordering 
of the structure. The BET surface area of the m-SiO2 was found to be 1342 m
2
g
-1
 which 
was slightly decreased to 834 m
2
g
-1
 after deposition of CD. The pore diameter of m-SiO2-
CD (Figure 4.3b) as determined from BJH method was found to be 5 nm which is in 
close proximity to that determined from TEM. 
 
Figure 4.3 (a) Nitrogen adsorption-desorption isotherm and (b) pore-size distribution of 
m-SiO2 and m-SiO2-CD 
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Photoluminescence 
The solution of m-SiO2-CD shows two UV/Vis absorption bands at 228 and 288 
nm (Figure 4.4a). The origin of these peaks is related to π electron transition in oxygen-
containing CD. The absorption is typically ascribed to π→π* transition of aromatic 
cluster (288 nm) and n→π* transition of the C=O bond of oxygen containing functional 
groups. These particles exhibit strong emission in blue region under excitation at 380 nm 
(Figure 4.4a). Similar to CD synthesized in chapter-2, these hybrid particles show 
excitation-dependent emission (Figure 4.4b). By following the similar procedure 
described in chapter-2 (quinine sulfate as the standard and 340 nm as the excitation 
wavelength), the photoluminescent quantum yield of m-SiO2-CD was calculated to be 
14.9% (Figure 4.c). 
 
Figure 4.4 (a) UV absorption and PL emission spectra (λex=380 nm), (b) excitation 
wavelength-dependent emission of m-SiO2-CD, (c) PL and Absorbance of the m-SiO2-CD 
and quinine sulfate 
Surface properties 
Figure 4.5a shows FTIR spectra of m-SiO2, m-SiO2-CD and m-SiO2-CD-APBA. 
The appearance of typical bands due to OH (3455 cm
-1
), H2O (1635 cm
-1
), Si-O-Si (1200-
1000cm
-1
), Si-OH (955 cm
-1
) and Si-O (469 cm
-1
) of silica confirms the successful 
synthesis of m-SiO2. These results show that there is a large amount of OH groups and 
H2O on the surface of m-SiO2 which imparts excellent water dispersibility to the silica 
nanoparticle. After deposition of the CD, the peak at 1635 cm
-1
 gets broader and a small 
hump appears at 1704 cm
-1
 indicating the introduction of aromatic C=C cluster and -
COOH functional group. Furthermore intensification of the 1200-1000 cm
-1
 region due to 
C–O–C/C-O vibrational stretching and appearance of new peaks at 2924, 2850 cm-1 for 
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C-H stretching indicates the successful deposition of CD. The appearance of these 
functional groups indicates that deposited CD has highly oxidized surface with hydroxyl, 
epoxy, carbonyl and carboxylic acid functional groups. These functional groups impart 
excellent solubility in water without further chemical modification. The successful 
conjugation of APBA on the surface of m-SiO2-CD through amide linkage is evidenced 
by the appearance of characteristic peaks at   3638, 3272, 1650 cm
-1
 corresponding to N-
H, C=O stretching of amide linkage. 
Figure 4.5 (a) FTIR spectra of m-SiO2, m-SiO2-CD and m-SiO2-CD-APBA, (b) survey 
spectrum and (c) high resolution scan corresponding to C1s of m-SiO2-CD-APBA. 
In a typical survey spectrum of m-SiO2-CD-APBA (Figure 4.5b), the peaks at 
binding energies 104, 156, 189, 280-290, 402 and 528-540 eV are ascribed to Si2p, Si2s, 
B1s, C1s, N1s and O1s electrons. High resolution scan for C1s (Figure 4.5c) can be well 
fitted into three peaks centered at 283.9, 284.6 and 287.1 eV. The lower binding energy at 
283.9 corresponds to the C-B bond and peak at 284.6 eV accounts for reference and the 
aromatic carbons present in CD and APBA. The fitted peak at higher binding energy site 
287.1 eV corresponds to the carbon present in C=O/-COOH/-CONH environment. The 
peaks at binding energies 189 and 402 eV matching to B1s and N1s regions respectively 
confirms the successful conjugation of APBA on m-SiO2-CD, which was used for 
targeted cell imaging.  
Fluorescence sensing of sugar 
We explored the photoluminescence behavior of m-SiO2-CD in association with 
APBA for designing highly sensitive OFF-ON fluorescent glucose sensor in aqueous 
solution. The bright luminescence of m-SiO2-CD gets quenched on treatment with 3-
aminophenyl boronic acid (APBA). The boronic acid absorbs on the m-SiO2-CD through 
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π-π stacking interactions between the aromatic cluster of CD and pendent aromatic 
moiety of APBA, causing a fluorescence quenching. It is suggested that the π-π stacking 
interaction facilitates the non-radiative excited state electron transfer from CD to the 
boronic acids, leading to a decrease in PL intensity of the m-SiO2-CD. As our expectation 
subsequent addition of glucose to the APBA adsorbed m-SiO2-CD solution caused 
gradual fluorescence recovery (Figure 4.6a) and about 85% fluorescence recovery was 
achieved with 8 mM of glucose. As the glucose concentration increases, the absorbed 
APBA gets converted to tetrahedral glucoboronate esters resulting enhancement of PL 
intensity. Figure 4.6b shows the relative intensity of recovered PL signals (F/F0) plotted 
against the concentration of glucose. In the range of 0 mM to 0.6 mM, the recovered PL 
intensity shows a good linear response with glucose concentration having linearly 
dependent coeﬃcient of 0.998. These results suggest that the quenched PL of APBA 
adsorbed m-SiO2-CD solution can be recovered in response to glucose demonstrating a 
low cost sensing platform for glucose. The influence of pH on fluorescence recovery was 
also investigated. As shown in Figure 4.6c, the fluorescence recovery efficiencies of 
glucose are low in the pH range of 4-6. As pH reaches to 8, the fluorescence recovery 
enhanced appreciable, this is the maximum in the pH range of 4-10. The observed pH 
effect is obvious as a basic condition is favorable for the interaction of boronic acid and 
glucose to form glucoboronate ester through the release of proton.  
 
Figure 4.6 (a) Effect of different concentrations of glucose on the PL recovery of APBA 
adsorbed m-SiO2-CD, (b) Plot of the relative PL intensity (F/F0) vs glucose concentration, 
(c) Effects of pH on the detection of glucose. F0 and F are PL intensities of the APBA 
adsorbed m-SiO2-CD in the absence and presence of glucose respectively. 
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Proposed working principle for fluorescence sensing 
Figure 4.7 depicts the proposed fluorescence sensing principle for the developed 
system. The boronic acid absorbs on the surface of m-SiO2-CD through π-π stacking 
interactions with the aromatic cluster of CD in m-SiO2-CD. We anticipate that π-π 
interaction facilitates the non-radiative photoinduced excited state electron transfer from 
m-SiO2-CD to APBA, as reported by Strano in case of single walled carbon nanotube.
20
 
This non radiative electron transfer process resulted in diminution of PL intensity of m-
SiO2-CD with the addition APBA. The fluorescence energy transfer from m-SiO2-CD to 
APBA can be ruled out as the absorption of APBA does not overlap with the emission 
spectrum of m-SiO2-CD. The quenched fluorescence is gradually recovered on 
subsequent addition of glucose which can disrupt the non-radiative electron transfer 
process by lifting out the APBA from CD surface. APBA effectively bind with glucose 
forming tetrahedral glucoboronate ester, which effectively remove the quencher from the 
immediate vicinity of the m-SiO2-CD fluorophore.   
 
Figure 4.7 Schematic illustration of proposed working principle in glucose sensing. 
Cellular uptake and targeted fluorescence imaging 
The inherent cytotoxicity of synthesized m-SiO2-CD-APBA was evaluated using 
human colon adenocarcinoma cell HT29 through MTT assay (Figure 4.8a). The m-SiO2-
CD-APBA do not impose any signiﬁcant toxicity to cells and are tolerable even at high 
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dose (500 µg/mL) and long incubation time (24 h), hence it is safe for in vitro and in  
vivo  applications. 
 As demonstrated above, the advantages of high binding affinity of APBA for cis-
diol, together with remarkable stability, good biocompatibility of m-SiO2-CD-APBA 
nanoparticles substantially provide a reliable platform for sLe
a
 receptor-mediated targeted 
imaging of cancer cell. Herein, to demonstrate its competence in targeting colon cancer 
cell, m-SiO2-CD and m-SiO2-CD-APBA samples were incubated with HT29 cell line for 
4 h. Strong green fluorescence images (Figure 4.8c) were observed from m-SiO2-CD-
APBA treated cells upon 488 nm excitation. The perinuclear region localized visible 
green luminescence signal comes from carbon dots as already demonstrated in chapter-2. 
This suggests that m-SiO2-CD-APBA nanoparticles are selectively targeted to the cells 
through the sLe
a
 receptor-mediated endocytosis and localize into the cytoplasm leaving 
clear zones of nuclei. As expected the m-SiO2-CD treated cell lines shows negligible 
uptake of the particles indicated by very weak fluorescence signal (Figure 4.8e). The m-
SiO2-CD sample has devoid of marker (APBA) to induce sLe
a
 receptor mediated uptake. 
The observed low fluorescence is due to uptake of the particles through simple diffusion. 
These results suggested that the m-SiO2-CD-APBA could allow efﬁcient binding of sLe
a
 
on the cell surface. 
 
Figure 4.8 (a) In vitro cell viability of HT29 cells with m-SiO2-CD-APBA, The fluorescence 
image of HT29 cells incubated with m-SiO2-CD-APBA under (b) bright-field, (c) by 
excitation at 488 nm, and with m-SiO2-CD under (d) bright field, (e) by excitation at 
488nm. 
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4.5. Conclusion 
 In summary, an easily separable sensitive CD based fluorescence glucose sensor 
comprising of m-SiO2-CD and 3-aminophenylboronic acid has been reported. 
 The working principle involves fluorescence recovery of quenched APBA 
adsorbed m-SiO2-CD on addition of glucose due to the formation of 
glucoboronate ester which could lift out the APBA from close vicinity of 
fluorophore.  
 The fluorescence modulation with glucose concentration in a physiological range 
and separation of fluorophore are two important aspects of the developed system. 
 APBA conjugated m-SiO2-CD nanoparticle have been sucessfully synthesized 
and applied for targeted imaging of human colon adenocarcinoma cell HT29 
overexpressed with sialyl Lewis A (sLe
a
) receptors.  
 The sensitivity of the method provides a new approach for optical sensing and 
targeting.  
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Chapter-5 
High quantum yield N,S co-doped carbon dots as fluorescent probe for 
selective and sensitive detection of Hg
2+
 in water and living cells 
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5.1. Introduction 
Luminescent carbon dots (CDs) as alternatives to common toxic metal-based quantum 
dots have drawn great attention for bioimaging,
1
 biosensing,
2
 catalysis
3
 and drug 
delivery
4 
applications because of their fascinating physical properties.
5
 Much progress 
has been achieved for the preparation of fluorescent CDs by electrochemical oxidation,
6
 
chemical oxidation methods,
7
 hydrothermal cutting process,
8
 and carbonization of a wide 
variety of carbon precursor starting from small molecule to natural precursor.
9-12
 There 
are still some drawbacks for CDs obtained at present, for example relatively low 
fluorescence quantum yield (usually less than 50%) compared to conventional inorganic 
quantum dots. Although surface passivation is an effective approach to improve the 
fluorescence of CDs, recent research work indicated that hetero element doping has 
greater advantage in increasing CD fluorescence quantum yields. Doping carbon 
nanomaterials with heteroatoms can effectively change their electron density and tune 
their optical and electrical properties.
13,14
 The N atom, having a comparable atomic size 
and five valence electrons for bonding with carbon atoms, has been widely used for 
chemical modification of carbon nanomaterials.
15
 In last few years tremendous work has 
been done for the development of one-step bottom-up approach to synthesize N-doped 
CD (NCD) and it has been revealed that NCD exhibit emission intensity dependent on the 
nitrogen content.
16-18
 The enhanced fluorescence quantum yield and life time of NCD are 
owing to the introduction of new kind of surface states which trap electron and thus able 
to facilitate a high yield of radiative recombination. More importantly, if CDs are co-
doped with N and S the effect of N is more enhanced through a cooperative effect as 
compared to NCD.
19
 As a result, in last couple of years conscious effort has been made to 
develop simple synthetic methods to produce of N,S co-doped carbon dots (NSCDs). 
Dong et al. prepared NSCD through one-step hydrothermal treatment of L-cysteine and 
citric acid, which provide deep insights to their photoluminescence (PL) enhancement 
mechanism.
20
 These prepared NSCD showed excitation independent emission different 
from the mostly reported un-doped and doped CD. Subsequent efforts involve 
carbonization of hair fiber in presence of sulphuric acid,
21
 hydrothermal treatment of α-
lipoic acid and ethylenediamine,
22
 microwave assisted pyrolysis of rice and N-acetyl-L-
cysteine,
23
 and hydrothermal treatment of citric acid and thiourea.
24
 These advances 
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provided a viable route to extend their applications in photocatalysis, bioimaging, 
biosensor. Very recently Feng and co-worker developed a solvent free method to prepare 
N,S co-doped CD from glutathione for mercury sensing.
25
 Although these developed 
methods are quite promising, in most of these processes a mixture of chemicals as 
precursors and harsh reaction conditions complicate the synthesis methods. So there 
remains ample opportunity in developing a simple synthetic method N, S co-doped CD 
(NSCD) for sensing and bioimaging applications.  
Mercury is a highly toxic and bioaccumulative heavy metal ion that causes serious 
health problems even at very low concentration.
26,27
 Continuous exposure to mercury 
may cause severe damage to the central nervous system, kidney failure and various 
cognitive and motion disorders.
28
 The maximum allowable Hg
2+
 level in drinking water 
as established by the Environmental Protection Agency (USA) is 2 ppb (10 nM). Various 
luminescent,
29,30
 chemical,
31
 electrochemical,
32
 and bio-sensor-based
33
 analytical 
methods have been developed for detecting mercury. Among these methods, fluorescence 
sensing is one of the reliable methods due to its high sensitivity, fast analysis, non-
destructing and simple operation method which translates molecular recognition 
information into tangible ﬂuorescence signals.34 Although fluorescent sensors for Hg(II) 
detection such as organic  molecule,  metal nanoclusters, semiconductor quantum dots 
(QDs) have been reported, many of these are associated with certain limitations like poor 
aqueous solubility, cross-sensitivity towards other metal ions, short emission 
wavelengths, and/or weak fluorescence intensities.
35-37
 Therefore the prime challenges in 
creating Hg
2+
 sensor are (1) high sensitivity and selectivity in detection, (2) selectivity 
against background of competing analytes, (3) consist of stable rceptors that associate 
with analytes selectively, (4) retain high aqueous solubility, and (5) cost-effectiveness of 
the sensor. 
Newly the improved luminescence properties of NCD has been exploited  for 
detection of Ag(I),
38
 Fe(III),
39
 Iodide,
40
 mercury,
41-43
 cupper
44
 etc. have been developed. 
Although N-doped CD based Hg
2+
 sensor is found to be superior to undoped CD in terms 
of high fluorescence quantum yield, most of them suffer from high detection limit. Thus 
development of CD based fluorescent probe for highly sensitive and selective detection 
Part-I                                                                                                             Chapter-5 
 
77 
 
of mercury is desirable. On the other hand, optical  imaging  with fluorescent  metal  ion  
probes is currently attracting much attention as a method to reveal the molecular  
functions  of  the  metal  ions and detection of level of metals  in  living  cells. However, 
less attention is paid to explore the optical properties of carbon dot towards intracellular 
metal ion detection. Effective fluorescent probes for imaging metal ions in living cellular 
systems must meet several strict requirements. Most importantly, a sensor should be 
selective for a specific metal ion over other biologically abundant cations, including those 
that exist at much higher cellular concentrations. Principles like hard-soft acid-base 
interactions are crucial for designing and obtaining metal-selective responses. Thus 
efficient fluorescent sensors for Hg
2+
 may be designed based on the presence of soft 
donor such as sulphur on flurophore for effective binding of the metal. In this regard, 
nitrogen and sulphur co-doped carbon dot (NSCD) can serve as an efficient fluorophore 
towards selective mercury detection due to soft-soft interaction between NSCD and Hg
2+
.  
 In this chapter, we have described a one-step synthesis of N,S co-doped carbon 
dots (NSCDs) with high PL quantum yield 69%. The synthesized NSCDs have been well 
characterized through standard technique such as XRD, Raman, TEM, Fluorescence 
spectrophotometry etc. These prepared NSCDs were employed for the selective and 
sensitive detection of Hg
2+
 in water and living cells. This sensor contains thiol and 
thioacid moiety in the metal binding site, which is expected to preferably bind to soft 
metal ion Hg
2+
 over other metal ions showing high selectivity.  
 
5.2. Experimental 
Reagents and Chemicals 
3-Mercaptopropionic acid, ethylenediamine, diethylenetriamine and 
triethylenetetramine were purchased from Sigma Aldrich, USA. FeCl2, CuCl2.2H2O, 
HgCl2, CaCl2.2H2O, CoCl2.6H2O, NiCl2.6H2O, MnCl2.4H2O, ZnCl2, Pb(OAc)2 and 
SnCl2 were  purchased  from Merck, India. Oxalyl chloride and DMF were obtained from 
Spectrochem, India. Dichloromethane and DMF were purified by distillation over 
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phosphorous pentoxide and anhydrous CaH2 respectively. All other chemicals were used 
as received without further purification.  
Synthesis of N,S Containing Carbon Precursor 
The synthesis of N, S containing carbon precursors has been presented in scheme 
5.1. A solution of 3-mercaptopropionic acid (0.87 mL, 10 mmol) in dichloromethane (5 
mL) was cooled to 0 °C under nitrogen. Oxalyl chloride (2 mL, 20 mmol) was added 
followed by the addition of catalytic amount of DMF. The mixture was allowed to react 
for 4 h at room temperature. The solvent and unreacted oxalyl chloride was completely 
removed under vacuum. Then to it ethylenediamine (0.33 mL, 5 mmol) in 
dichloromethane was added and allowed to react for another 6 h under nitrogen 
atmosphere. The solid product was recovered through filtration and repeatedly washed 
with petroleum ether to remove the DMF. Other carbon precursors C-2 and C-3 with 
increased N atom were synthesized in similar process by reacting diethylenetriamine 
(0.53 mL, 5mmol) and triethylenetetramine (0.75 mL, 5mmol) respectively instead of 
ethylenediamine. The compounds are named as C-1, C-2 and C-3. 
C-1: Elemental Analysis: (C 40.2, H 6.92, N 11.9, O 13.51, S 27.13), IR (KBr): 3369, 
2973, 2926, 2893, 2742, 2540, 2410, 2139, 1923, 1656, 1451, 1415, 1380, 1328, 1274, 
1088, 1048 cm
-1
.
1
H NMR (400 MHz, D2O): δ 1.5 (bs, 2H), 2.42 (t, 4H), 2.94 (m, 4H,), 
3.09 (m, 4H), 8.13 (bs, 2H). MS (ESI): m/z (relative intensity) 275 ([M+K], 90). 
C-2: Elemental Analysis: (C 42.81, H 7.62, N 14.91, O 11.53, S 23.23)  IR (KBr) 3379, 
3018, 2966, 2914, 2847, 2706, 2572, 2450,1727, 1662, 1427, 1368, 1333, 1226, 1215, 
1110 cm
-1
.
1
H NMR (400 MHz, D2O): δ 1.5 (bs, 2H,), 2.02 (bs, 1H), 2.3 (t, 4H), 2.92 (m, 
8H,), 3.08 (m, 4H), 8.05 (bs, 2H). MS (ESI): m/z (relative intensity) 314 ([M+N2H7], 
100). 
C-3: Elemental Analysis: (C 44.52, H 8.34, N 17.4, O 9.81, S 19.8) IR (KBr) 3414, 3018, 
2967, 2918, 2840, 2557, 1740, 1640, 1440, 1366, 1323, 1228, 1048 cm
-1
. 
1
H NMR (400 
MHz, D2O): δ 1.5 (bs, 2H,), 2.0 (bs, 2H), 2.34-2.7 (m, 12H), 2.8-3.32 (m, 8H), 8.0 (bs, 
2H). MS (ESI): m/z (relative intensity) 321 ([M-H], 84). 
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Scheme 5.1 Synthesis of N, S containing precursors. 
Synthesis of Fluorescent NSCD 
The N,S co-doped carbon dot  (NSCD-1, NSCD-2 and NSCD-3) with different 
amount of nitrogen content were prepared by hydrothermal treatment of single molecular 
precursor C-1, C-2 and C-3 respectively. In a typical experiment, N,S containing carbon 
precursor (2 mmol) was dissolved into 50 mL milipore water with few drops of ammonia 
solution (28%) and stirred to form a clear solution. The solution was then transferred into 
80 mL Teflon-lined stainless-steal autoclave and was heated at constant temperature of 
160 °C for 10 h with a heating rate of 1ºC/min. When cooled down to room temperature, 
an orange solution was obtained, which implied the formation of the CDs. Then, the 
obtained dispersion were filtered with a 0.22 µm filter membrane to remove the larger 
product, and then dialyzed against deionized water by a dialyzator with molecular weight 
cut off 1000 Da for 24 h. Finally, an orange coloured aqueous solution containing NSCD 
was obtained. The NSCD was recovered by lyophilizing the solution. 
Fluorescence Sensing of Hg
2+
 
The detection of Hg
2+
 ion was performed in milipore water, tap water and 
phosphate buffer solution. In a typical assay, NSCD (10 mL, 7 µg/mL) dispersion was 
added into water sample (400 mL), followed by the addition of different concentrations 
of Hg
2+
 ion. The PL spectra were recorded after the reaction for 30 min. The selectivity 
for Hg
2+
 was confirmed by adding other metal ion stock solutions instead of Hg
2+
 in a 
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similar way at a concentration of 60 µM. All experiments were performed at room 
temperature. 
In vitro Cytotoxicity and Live Cell Imaging 
HaCaT were harvested and the cell concentration was adjusted to 1×10
4
 cells/mL, 
cells were plated in a 96 well flat bottom culture plates (180 µL/well) and incubated with 
various concentrations (0.78, 3.185, 12.5, 25.0, 50.0, 100.0, and 200.0 µg/mL) of NSCD 
(in 20 µL). All cultures were incubated for 72 h at 37 °C and 5% CO2 in a humidified 
incubator. Viable cell concentration was checked by MTT (3-(4,5-Dimethyl-2-
2thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay. For detecting living cells 
through fluorescence imaging, the cells are incubated with NSCD (200 µg/mL) for 24 h 
at 37 °C. After being washed with fresh PBS three times the cells were imaged through 
fluorescence microscope. Then  Hg
2+
 (20 µM) was added and incubated for 2 h. the cells 
were imaged again after washing the culture medium three times with PBS. 
Calculation of detection limit 
All fluorescence emission spectra of the fluorophore were integrated vs. 
wavenumber, and calibration curves were generated, with the analyte concentration on 
the X-axis (in nM) and F0/F on the Y-axis, where F = the integrated fluorophore emission 
at a particular Hg
2+
 concentration and F0 = the integrated fluorophore emission in the 
absence of Hg
2+
. The lower mercury concentrations yielded a linear relationship, and the 
equation for the line was determined. The limit of the blank was taken to be the average 
of the blank (NSCD emission without Hg
2+
)+30 times the standard deviation of the blank. 
This value was entered into the equation determined in (for the Y value), and the 
corresponding X value was determined. This value provided the Limit of detection in 
nM. 
Measurement of fluorescence quantum yield (PLQY) and fluorescence life time 
The PLQY of the sample was calculated using quinine sulfate as reference 
following the procedure described in chapter-2. Time resolved fluorescence decay traces 
were deconvoluted from the signal and fitted using the FluoFit 4.4 package (Picoquant).  
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The experimental decay traces were fitted to triexponential functions via a Levenberg–
Marquardt algorithm based on nonlinear least-squares error minimization deconvolution 
method. Three different exponential terms were used to fit the experimental decay traces. 
The quality of the fits was judged by the reduced chi-squared method, χ2, the weighted 
residuals and the correlation functions. The latter two were checked for random 
distributions.  To compare the photoluminescence lifetime of the free NSCD and in 
presence of Hg
2+
 at different concentrations, it was necessary to determine their  average  
lifetime using eqn:  
τavg = ∑αiτi
2
 / ∑αiτi 
Where αi are the pre-exponential factors and τi are the lifetimes obtained in the 
triexponential fitting of the decay curves of carbon dot emission. 
 
5.3. Characterization 
The synthesized materials were all characterized by standard technique as 
described in Chapter-2. Fluorescence lifetime experiments were performed   with   a   
time-correlated single-photon counting (TCSPC) system under right-angle sample 
geometry. Live-cell imaging was done using Axiovert 40 carl zeiss india fluorescence 
microscope at excitation wavelength of 405 and 488 nm.  
 
5.4. Results and discussion 
Microstructure, HD size and stability 
 All three samples prepared with variable nitrogen content named as NSCD-1, 
NSCD-2 and NSCD-3 are well dispersed in water with hydrodynamic sizes of 19, 13 and 
25 nm respectively without any precipitation for months (Figure 5.1a). The alteration of 
zeta potential from positive to negative with increase in pH (Figure 5.1b) demonstrates 
the presence of acidic functional groups like -COOH, -COSH on the surface of NSCD. 
The FESEM image of NSCD-2 (Figure 5.1c) clearly reveals that the synthesized particles 
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are spherical, monodisperse and have a narrow size distribution between 5-10 nm. High 
resolution TEM image in Figure 5.1d indicates that particles are nearly spherical in 
morphology with uniform size of 3-5 nm. The size of the synthesized material is within 
the quantum range exhibiting excellent luminescent properties. The well-deﬁned crystal 
lattice (0.36 nm) of the NSCD-2 as shown in Figure 5.1e is in agreement with the basal 
spacing of graphite.  
 
Figure 5.1 (a) Hydrodynamic sizes and (b) zeta potential measurement of NSCDs, (c) 
FESEM image, (d) TEM image and (e) Lattice imaging of NSCD-2. 
XRD and Raman study 
The phase and purity of the synthesized NSCD were analyzed by XRD (Figure 
5.2a). The XRD pattern of the synthesized NSCDs show intense peak at 2θ = 22.4° and a 
weak peak at 2θ=42.1° which are assigned to (002) and (101) diﬀraction patterns of 
graphitic carbon respectively. The XRD result of the NSCD is similar to those of reported 
carbon dots.
45
 The (002) peak corresponding to interlayer spacing in graphite (0.34 nm) 
becomes slightly longer in NSCD-1 (0.36 nm), showing good crystallization 
characteristics which shifts to further larger end in NSCD-2 (0.39 nm). The increase in d 
value indicates increase in amorphous nature attributed to the introduction of more defect 
site through increasing N-doping in the crystal lattice. Based on the XRD results, it can 
be seen that samples having higher nitrogen composition exhibited lower diffraction 
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intensity and broader peak (002), compared with the NSCD-1 having comparatively less 
N content.  
 
Figure 5.2 (a) XRD patterns and (b) Raman spectra of NSCD. 
In the Raman spectrum of NSCD (Figure 5.2b), the peak at 1582 cm
-1
 assigned as 
G-band corresponds to the E2g mode of the graphite and is related to the vibration of sp
2
-
bonded carbon atoms in a two-dimensional (2D) hexagonal lattice. The D-band at around 
1352 cm
-1
 is associated with the vibrations of carbon atoms with dangling bonds in the 
plane terminations of disordered carbon structure. The intensity ratio (ID/IG), which is 
often used to correlate the structural purity to the graphite (measurement of the disorder 
extent, as well as the ratio of sp
3
/sp
2 
carbons), also indicates that the NSCDs are 
composed of mainly nanocrystalline graphite.
46
 The ID/IG ratio slightly increases from 0.6 
(NSCD-1) to 0.65 (NSCD-2) which can be attributed to origin of more structure defects 
in the sp
2
 carbon site due to increased amount of nitrogen dopant. The size of the 
nanocrystalline graphite obtained from the relation La = 44(ID /IG)
-1
 yields the value of 
about 7 nm which is close to the size observed in TEM images 
Surface composition  
 The SEM-EDAX and XPS results indicate that NSCDs are mainly composed of 
carbon, nitrogen, oxygen and sulphur. The peaks in the survey spectrum (Figure5.3 a) at 
165, 284-292, 398-406 and 528-540 eV correspond to binding energy of S2p, C1s, N1s 
and O1s with their atomic percentage 3.4, 64.9, 8.7 and 23 respectively. The high 
resolution scan of the C1s region (Figure 5.3b) shows carbons present in four different 
chemical environments, corresponding to sp
2
 (C=C) at 286.4 eV, Sp
3
 (C-C and C-H) at 
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285.3 eV, C-N/C-S/C-O at 287.6 eV and C=O/COOH/COSH at 289.6 eV. The C1s 
spectra corresponding to reference shows a shift of 1.8 eV to higher binding energy and 
hence taking the reference shift into consideration all other binding energies are to be 
evaluated. The high resolution spectra of N1s (Figure 5.3c) indicates the presence of both 
pyridinic type (401.3 eV) and pyrrolic (402.9 eV) N atoms. The high resolution scans of 
S2p region (Figure 5.3d) can be fitted into three peaks at 164.9, 166.2 and 169.5 eV, 
which represents S2p3/2 of COSH
47 
and S2p1/2 of -C-S- covalent bond of 
thiophene/thiazine and oxidized sulphur S=O bonding respectively. The N1s and S2p 
clearly show that almost all of N was doped into the carbon as pyridine/pyrrole-like N, 
whereas most of the S remain as surface functional group (-COSH and S=O). Only 27% 
of total S was doped as thiophene/thiazine-like S into the core of carbon dots. 
Incorporation of sulphur into aromatic system compared to N requires harsh condition, 
which results lower percentage of S doping. Furthermore, high resolution O1s 
photoemissions (Figure 5.3e) were also obtained corresponding to S-O (530.3 eV) bond, 
C=O (532.9 eV) bond and C-OH/C-O-C (534.8 eV) bond. The presence of oxygen 
enhanced the solubility of NSCD in water. 
 
Figure 5.3 (a) XPS survey and high resolution scan of (b) C1s, (b) N1s, (c) S2p, (d) O1s of 
NSCD-2, and (e) FTIR spectra of NSCDs. 
 The evidence for C–N, N–H, C=S, S-H, C=C, C=O and C=N was also conﬁrmed 
by FTIR spectra (Figure 5.3f). The broad absorption bands at 3000-3700 cm
-1
 in the FTIR 
spectrum are assigned to stretching vibrations of O-H and N-H, which indicates the 
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presence of lots of hydroxyl groups on the surface of NSCDs. The peaks corresponding 
to C=C stretch of aromatic hydrocarbons and the absorption from C=O (of COOH, 
COSH, CHO and CONH) is reflected in the wide range of 1750-1580 cm
-1
. The C=N and 
C=S stretch were observed at 1350 cm
-1
 and 1043 cm
-1
,  thereby  showing the  formation  
of  NSCDs. Weak S-H stretching at 2534 cm
-1
 and C=S stretching (1043 cm
-1
) give the 
evidence for existence of -COSH, -CSOH and -SH functional group on the surface of 
NSCD. As evidenced from FTIR the presence of various functional groups like hydroxyl, 
carboxy, amide, amine, carboxylic group, thioacids, epoxy, thiol imparts excellent water 
solubility to synthesized NSCD. 
Luminescent Properties 
 NSCD samples exhibit multiple excitonic bands different from commonly 
observed single exitonic band. This can be attributed to the formation of different types 
of excitation energy trap on the surface of NSCD by insertion of N and S atom to the 
hexagonal carbon lattice. The excitation spectra of NSCDs (Figure 5.4a) shows two 
major peaks at 275-280 nm and 355-370 nm ascribed to the π-π* transition of aromatic 
domains and trapping of excited state energy by surface states. In addition to this with 
increasing N content, shifting of the emission center towards higher wavelength (Figure 
5.4b) was observed which suggests that new emission centers were produced with 
increasing N content. Qain et al. reported that the pyridinic and pyrolic nitrogen atom can 
break the large conjugated carbon structure and induces the defect on which enhance the 
fluorescence properties of N-CD.
48
 We anticipate that in this case the introduced sulphur 
atom would enhance the effect of N atoms by creating more defects through thiophenic, 
thiol or thioacid sulphur atom along with pyridinic and pyrrolic nitrogen atom. In all 
cases excitation dependent emission (Figure 5.4c-e) was observed because of existence of 
a number of surface emissive traps as well like different size and morphology of the 
material. Nitrogen and sulphur bonding to carbon in CD improve the emission and thus 
NSCD shows higher PLQY than undoped carbon dot.  However, the PLQY of the 
NSCDs (Figure 5.4f) obtained from different precursor do not correlate with their 
nitrogen content. With increase in N content the PLQY of NSCD-2 (69%) is found to be 
more than NSCD-1 (62%), but NSCD-3 with highest N content has lower PLQY (38%). 
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This may be due to the incomplete carbonization of the long chain polymer precursor for 
NSCD-3. The low PLQY of NSCD-3 is in good agreement with smaller fluorescence 
lifetime compared to NSCD-2 (Table 5.1). The calculated PLQY of NSCD-2 (λex 360 
nm) is found to be higher than NSCD reported earlier.
21,25
 The measurement of 
fluorescence intensity on the exposure time of 2 h under fluorescence lamp indicates that 
the NSCD are highly photostable (Figure 5.4g). Fluorescence intensity (Figure 5.4h) 
remains constant with different concentrations of NaCl indicating the emission behavior 
is independent of ionic strength of the medium. Similar to CDs the PL intensity for 
NSCD-2 (Figure 5.4i) remains unchanged with in the pH range 3-8, suitable for 
biological sensing and live cell imaging application. 
 
Figure 5.4 (a) Excitation and (b) emission spectra of NSCDs, Excitation dependent 
emission spectra of (c) NSCD-1, (d) NSCD-2 and (e) NSCD-3, (f) fluorescence and 
absorbance of the NSCDs and Quinine Sulfate (g) Change in fluorescence intensity w.r.t. 
time, (b) Effect of ionic strengths on the fluorescence intensity of NSCDs (ionic strengths 
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were controlled by various concentrations of NaCl), (c) Effect of pH on the fluorescence 
intensity of NSCDs. 
Table 5.1 The Fluorescence parameters of all synthesized NSCDs. 
N,S co-doped CD λem (nm) φf (%) τ (ns) 
NSCD-1 405 62 4.3 
NSCD-2 422 69 5.8 
NSCD-3 434 38 2.7 
 
Fluorescence detection of Hg
2+
 
We explored the PL behavior of NSCD in designing highly selective and sensitive 
ON-OFF fluorescent Hg
2+
 sensor in aqueous solution. To our expectation, there was 65% 
decrease in fluorescence intensity (Figure 5.5a) at 435 nm as soon as 80 µM Hg
2+
 was 
gradually added; indicating that addition of Hg
2+
 can effectively quench the fluorescence 
of NSCD. The fluorescence quenching is owing to the nonradiative electron transfer from 
the excited state to the d-orbital of Hg
2+
. To evaluate the sensitivity of the system, 
different concentrations of Hg
2+
 within 80 µM were studied and found that the 
fluorescence intensity of the NSCD is sensitive to Hg
2+ 
and decreases with the increase of 
Hg
2+
. In the range of 0 to 0.1µM the relative fluorescence intensity (F0/F) shows good 
linear response with Hg
2+
 concentration which indicates that the fluorescence quenching 
process is dynamic in the above range. The dynamic quenching mechanism results from 
diffusive collision between the fluorophore and quencher during the life time of the 
excited state. The dynamic fluorescence quenching is described by the Stern-Volmer 
equation. 
𝐹0
𝐹
= 1 + 𝐾𝑆𝑉[𝑄] 
Where F0 and F are the fluorescence intensities of fluorophore in the absence and 
presence of the quencher (Q). KSV is the Stern-Volmer quenching constant and [Q] is the 
concentration of the quencher. The graph (Figure 5.5b) representing fluorescence 
intensity (F0/F) versus concentration of Hg
2+
 ions could be perfectly described by the 
Stern-Volmer plot with a linear behaviour, 
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𝐹0
𝐹
= 1.002 + 1.992[𝐻𝑔2+] 
in the range of 0 to 0.1×10
-6
 M, having R
2
=0.996, indicating that the quenching 
mechanism follows dynamic quenching. At higher concentration of Hg
2+
, there is 
deviation from linearity (Figure 5.5c), probably due to presence of both static and 
dynamic mechanism as observed by other researchers.
49
 The Stern-Volmer quenching 
constant was found as 1.99×10
6
 mol
-1
dm
3
. The limit of detection (LOD) was estimated as 
0.05 nM, which is lower than previously reported carbon dot based nanosensors.
41,50,51
 
The complexity of the intracellular system reasons a great challenge to the metal ions 
importantly in selectivity. To evaluate the selectivity of the NSCD towards Hg
2+
, 
fluorescence screening experiment was carried out. Nearly no fluorescence intensity 
(Figure 5.5d) changes was observed in emission spectra of NSCD with various metal ions 
like Co
2+
, Cu
2+
, Mn
2+
, Ni
2+
, Fe
2+
, Sn
2+
, Zn
2+
, Ca
2+
. However under identical conditions 
fluorescence intensity was significantly quenched for Hg
2+
. The selectivity coefficient 
(Table 5.2) for F0/F for Hg
2+
 is much higher than for other metals indicating that NSCD 
possessed high selectivity for Hg
2+
.  
 
Figure 5.5 (a) Fluorescence spectra of NSCD probe upon exposure to different amounts 
of Hg2+, (b) Linear dependence of fluorescence quenching of NSCD-2 with mercury 
concentration, Fluorescence quenching of NSCD with (c) Hg2+ concentration, (d) in the 
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presence of different cation, (e) mixture of cations, (f) Fluorescence response of NSCD-2 
after adding EDTA to NSCD-Hg2+. 
Table 5.2 Selectivity coefficients of Hg2+ over other metal ions. 
Metal ions Selectivity coefficients Metal ions Selectivity coefficients 
Co2+ 15 Fe2+ 10 
Cu2+ -14 Sn2+ 71 
Mn2+ 21 Zn2+ 29 
Ni2+ 33 Ca2+ 38 
 
The strong quenching effect may originate from soft-soft acid base interaction of 
sulphur part of NSCD and Hg
2+
.  In another control experiment, Hg
2+
 alone and the 
mixtures of Hg
2+
 and above-mentioned metal ions were added into the NSCD aqueous 
solution respectively then the quenching effects of Hg
2+
 and the mixtures of Hg
2+
 on the 
fluorescence of NSCD were examined (Figure 5.5e). In comparison with efficient 
quenching effect of the Hg
2+
 the influence from the other coexisting metal ions is 
negligible. These observations indicate that the NSCD sensor is insensitive to other metal 
ions but selective to Hg
2+
 in the mixtures. Unlike reported carbon dot, in our case the 
quenched photoluminescence of NSCD was not recovered by adding a strong metal ion 
chelator such as EDTA (Figure 5.5f) implying that the Hg
2+
 interacts with NSCD through 
sulphur. 
Investigation of the Sensing Mechanism 
The proposed fluorescence quenching mechanism for our NSCD-Hg
2+
 system is 
depicted in Figure 5.6. We anticipate that fluorescence quenching is due to nonradiative 
electron transfer from excited state to the metal through soft-soft interaction between 
sulphur of NSCD and the metal center. Fluorescence lifetime measurements were 
conducted to gain further insight into the mechanism of fluorescence quenching of the 
NSCD by Hg
2+
. The fluorescence lifetime of the NSCD is 5.8 ns, while the life time 
decays to 4.3 ns after Hg
2+ 
addition. It indicates that the fluorescence quenching is 
dynamic and involves nonradiative electron transfer process.  Though the thioacids (-
COSH/CSOH) and thiol (-SH) functionalities at the edges of NSCDs could be the 
possible binding sites for Hg
2+
, the absence of any significant  changes in FTIR spectra of 
Part-I                                                                                                             Chapter-5 
 
90 
 
NSCD-Hg
2+ 
in comparison to NSCD rules out the possibility of complex formation in 
ground state. The nature of Stern-Volmer plot also eliminates the possibility of static 
quenching (complex formation).  
 
Figure 5.6 Plausible mechanism for fluorescence quenching of NSCD by Hg2+. 
Efficient Hg
2+
 detection in water samples and PBS 
The excellent specificity combined with high sensitivity and selectivity of NSCD 
to Hg
2+
 ions suggests that the present chemosensor may be directly applied for detecting 
Hg
2+
 in practical fields. Thus we tested Hg
2+
 from natural water (tap water) and PBS. 
Prior to use all the samples were filtered through a 0.22 µm membrane to remove any 
suspended particles.  
 
Figure 5.7 Fluorescence spectra of NSCD probe upon exposure to different amounts of 
Hg2+ in (a) Tap water and (b) PBS. 
Figure 5.7 shows the fluorescence response of NSCD in presence of tap water and PBS 
containing different concentrations of Hg
2+
. It was observed that in all the cases the 
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fluorescence intensity decreased with increasing concentration of Hg
2+
. It clearly shows 
that although some organic/inorganic impurities and minerals exist in the tap water, the 
fluorosensor can still sensitively respond to 10 µM Hg
2+
, satisfying the practical Hg
2+
 ion 
detection in real samples. Also due to sensitive fluorescence quenching with Hg
2+
 in PBS 
this NSCD may be suitable for Hg
2+ 
detection in biological system through fluorescence 
imaging. 
Effect of pH on fluorescence quenching 
  The influence of pH on NSCD and subsequently on the quenching phenomenon 
was investigated. In case of both NSCD and NSCD-Hg system the emission band is 
slightly shifted, which indicates that protons can regulate the emission. It was observed 
that at lower pH values the intensity of fluorescence was higher and at higher pH values 
the intensity is less (Figure 5.8a). However with in pH range 4-8 much change was not 
observed. Such a pH-dependent fluorescence is ascribed to the extent of proton 
acceptance by pyridine nitrogen/thiophenic sulphur atoms followed by possible proton 
transfer from protonated nitrogen to the conjugated carbon structure. The excellent 
specificity combined with high sensitive and selectivity of NSCD to Hg
2+
 ions suggests 
that the NSCD can be utilized to monitor Hg
2+
 in the living cell. 
 
Figure 5.8 (a) Fluorescence quenching of NSCD w.r.t pH and (b) Cell viability by MTT 
assay. 
Cytotoxicity and Intracellular bioimaging and biosensing of Hg
2+
 
In order to detect Hg
2+
 in living cells, HaCaT cells were used to evaluate the 
cytocompatibility of NSCD. As expected, the viability of the HaCaT cells declined only 
by <15% upon addition of the NSCD at up to 200 µg/mL for an incubation period of 72 h 
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(Figure 5.8a). Thus the as prepared NSCD probe can be considered to be low toxic and 
biocompatible which is consistent with previously reported carbon dots. Taking the 
advantage of small size, high selectivity and biocompatibility, we explored the 
bioimaging application of NSCD in monitoring Hg
2+
 in living cell. We performed in vitro 
cellular uptake experiment with HaCaT cells.  The cells were first incubated with the 
probe (NSCD) for 12 h at 37 ºC, After the uptake, the particles were monitored by 
fluorescence microscopy and found to reside mainly in the cell membrane and the 
cytoplasmic area leaving the clear zones of the nuclei implying a good permeability to the 
cells. Then the intracellular Hg
2+
 imaging ability of the NSCD was tested. When the cells 
were supplemented with Hg
2+
 in the growth medium for 2 h the fluorescence intensity 
significantly decreased (Figure 5.9). The green signal from NSCD became dimmer with 
increasing concentration of Hg
2+
 signifying the ability of NSCD to display fluorescence 
turn-off behaviour in the living cells. 
 
Figure 5.9 The fluorescence image of HaCaT cells stained with NSCD (a), (c) Bright-ﬁeld 
transmission image of HaCaT cells (b) ﬂuorescence image of cells visualized by green 
emission of NSCD, (d) ﬂuorescence image of cells post-incubated in 20 μM Hg2+ solution. 
 
5.5. Conclusions 
 In summary, a simple, sensitive and selective N, S co-doped carbon dot based 
fluorescent sensor for Hg
2+
 detection has been demonstrated. 
  The present sensor was prepared from hydrothermal treatment of single 
molecular precursor, exhibiting high fluorescence quantum yield (69%) in 
contrast to previous report.  
 The soft-soft acid base interaction of sulphur part of NSCD and Hg2+ makes 
fluorescence probe more specific and selective towards Hg
2+
 contrast to other 
metal ions. 
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 The detection method is highly sensitive and the limit of detection of mercury ion 
is found to be 0.05 nM.  
 The detection method exhibits excellent selectivity in tap water and also in the 
presence of complex metal ions in intracellular environment. 
 Due to high photostability, low toxicity and low detection limit, these carbon dots 
are demonstrated as excellent probes for the detection of Hg
2+
 in the living cell. 
. 
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6.1. Preface 
Recently, incredible effort has been devoted for the development of nanostructured 
materials owing to their potential applicability in biological field
1-4 
including, disease 
diagnostics and therapy,
5-7
 biosensing,
8,9
 biocatalysis,
10,11
 drug delivery,
12-14
 protein/DNA 
bioseperation
15,16 
and bioimaging.
17,18
 The usefulness of the nanostructured material is 
mainly due to small size, large surface area, and the possibility to functionalize with 
targeting ligands, as well as imaging and therapeutic moieties. Nanosized materials 
provide a robust framework in which two or more components can be incorporated to 
give multi-functional capabilities. These nanostructured materials have several 
advantages in disease diagnostics and therapy over traditional methods, which are 
justified as follows: 
 Nanoparticles can easily integrate more  than  one  kind  of  imaging  or  
therapeutic  agents,  which makes  them  potential  multifunctional  nanoplatforms  
for  both diagnosis and therapy. 
 Large surface area and interior cargo volume of the nanoparticle ensure facile 
adsorption as well as high loading of various therapeutic agents.  
 Nanoparticles can be readily conjugated with molecular moieties capable of 
recognizing various complementary biomolecules including DNA strands and 
antigens with high sensitivity and selectivity, which is advantageous in targeted 
imaging, diagnosis, and delivery. Moreover presence of large number of targeting 
molecule on single nanoparticle can greatly enhance target-binding and speciﬁcity 
compared to single molecules due to so-called multivalent eﬀects.19 
 Appropriate size and surface modiﬁcation of nanoparticle minimizes the 
possibility of macrophagic clearance in the blood stream. 
These features provide nanomaterials with great potential as innovative diagnostic 
and therapeutic systems for the clinical applications. The major applications of 
nanomaterials in the biomedical ﬁeld can be mainly divided into imaging and therapy. 
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Multimodal Imaging 
In the medical diagnostics, the widely used techniques include optical imaging,   
magnetic   resonance   imaging (MRI), computed tomography (CT), ultrasound (US) and 
positron emission tomography (PET) or single photon emission computed tomography 
(SPECT). Each imaging modality has its own unique advantages along with intrinsic 
limitations, such as insuﬃcient sensitivity or spatial resolution, which make it diﬃcult to 
obtain accurate and reliable information at the disease site. However the combination of 
imaging modalities could improve medical imaging for diagnosis. Multimodal imaging is 
a powerful method that can provide more reliable and accurate detection of disease sites. 
Till now various combinations of imaging modalities were developed for both in vitro 
and in vivo imaging. Among them, the most popular nanostructured multimodal imaging 
probes are combinations of MRI and optical imaging modalities. MR imaging can 
accumulate simultaneous physiological and anatomical information with high spatial 
resolution, whereas optical imaging is associated with rapid screening of the information.  
Magnetic Resonance Imaging: MRI is one of the most powerful and non-invasive 
diagnostic technique for living organisms that produces excellent signal contrast for soft 
tissue by detecting the nuclear spin of hydrogen atoms, which predominantly come from 
water and fat in human body. MRI contrast agents can provide bright or dark contrast by 
accelerating either T1 or T2 relaxation of water protons, respectively.  
Superparamagnetic iron oxide nanoparticles (SPIONs) are being increasingly used 
as MRI contrast agents to improve the diagnosis and therapy. 
3,20-21 
These SPIOs are 
designed as T2 contrast agents. In T2 -weighted MRI, the tissue containing SPIOs exhibits 
reduced signal intensity. These iron oxide nanoparticles have the ability to dramatically 
shorten T2 relaxation times in the liver, spleen, and bone marrow by selective uptake and 
accumulation in the cells of the reticuloendotherial system (RES).
22,23 
 Organ tumors’ 
(liver, spleen tumor) those lack phagocytic activity can thus be detected by the darkening 
of surrounding normal tissue.
24 
SPIONs can also accumulate in the tumor by enhanced 
permeability and retention (EPR) effects, which facilitates tumor detection in tissues or 
organs that normally do not sequester SPIONs from blood circulation. Among the 
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commercially available SPIONs such as Feridex IV, Combidex, CLIO-tat, Resovist etc., 
Feridex IV and Resovist have been approved by FDA for clinical application.  
Most recently, these iron oxide based nanomaterials have been explored for in 
vivo molecular imaging of disease markers and physiological processes. Surface 
functionalized SPIONs associated with appropriate targeting agents could enable the 
ultrasensitive detection of diseases like atherosclerotic plaques, tumors, and apoptotic 
tissues etc.
25-29
 Kessinger et al. succeeded in quantitative measurement of the binding 
kinetics of superparamagnetic micelles to αvβ3-integrin expressed tumor endothelium 
through T2∗-weighted time-resolved MRI technique.
30
 Furthermore Labeling of 
progenitor cells,
31,32
 pancreatic islet cells
33
  etc. without affecting cell viability or function 
demonstrates the extensive applicability of SPIONs for in vivo cell tracking. 
Optical Imaging: Optical imaging is a non-invasive imaging technique based on the 
behavior of visible, ultraviolet and infrared light. It has excellent spatial resolution and 
detection sensitivity and low cost in cellular imaging. However, the auto fluorescence of 
tissue and light attenuation hindered its in vivo application.  Optical imaging using Near-
infrared (NIR) light has extensively used for in vivo imaging because tissues scatter and 
absorb less light at longer wavelengths, resulting in deeper penetration in biological 
tissues than visible light. 
Over the past several years, different kinds of nanostructures, including 
semiconductor quantum dots (QDs),
34,35 
lanthanide based luminescent nanoparticles,
36-38
 
gold nanoparticles,
39
 and nanoparticles containing organic dyes 
40
 have been developed 
for optical bioimaging. Semiconductor QDs possess novel electronic, optical and 
structural properties which can be utilized as contrast agents for deep tissue imaging. 
Multifunctional nanoparticles based on semiconductor QDs have been designed for 
imaging and cancer treatment.
41,42
 However inherent toxicity and chemical instability of 
quantum dots limit their clinical application. Most recently, lanthanide doped inorganic 
nanomaterials served as a suitable alternative due to their excellent up-conversion and 
down-conversion luminescence properties, including large Stokes shifts, narrow line-
width emission bands, high quantum yields, long lifetimes and superior photostability. 
Tm
3+
 and Yb
3+
 doped NaYF4 nanoparticles with size range 20-30 nm have been 
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successfully employed for NIR imaging of both in vitro and in vivo.
43
 Later in vivo 
whole-body imaging of small animals has been successfully realized based on lanthanide 
nanoparticle. 
44
  
Recently carbon based QDs (carbon dots and graphene quantum dots) are pursued 
as nontoxic alternatives in the development of fluorescence imaging agents for various 
biomedical purposes because they not only exhibit several favorable attributes of 
traditional   semiconductor based   QDs, but also show chemical inertness, low toxicity, 
high water solubility and biocompatibility.
45,46
 Carbon dot has been successfully 
employed as fluorescence probe for optical imaging of cells and tissues, from straight 
forward cell imaging to specific tissue targeting.
47-53
 The imaging efficacy of various 
carbon dots has also been extended for in vivo imaging.
54-57
 Most recently, Kim et al. 
synthesized near-infrared-fluorescence (NIR)-emitting carbon dots from tire soot and 
applied for both in vitro and in vivo imaging of glioma.
58
 Although the application of 
carbon dot in NIR imaging is at a very early stage, NIR properties of the carbon dots will 
no doubt lead to more research in the field of in vivo molecular imaging and biomedical 
studies for the diagnosis and therapy of diseases.  
Targeted drug delivery 
Targeted drug delivery is a method of delivering medication at the desired target 
in therapeutic concentration at the same time restricting its access to normal cellular 
lining. Insuﬃcient target selectivity of drugs can cause unwanted side eﬀects and reduce 
therapeutic eﬃcacy. Thus the targeted or site-specific delivery of drugs is very attractive 
goal because this provides one of the most potential ways to improve the therapeutic 
index of the drugs with minimal peripheral toxicity.  Passive targeting through the well-
studied enhanced permeability and retention (EPR) eﬀect is not universal for all types of 
tumor cells, and a lack of cell speciﬁc interactions might decrease therapeutic eﬃcacy 
and induce multiple drug resistance.
59-62
  
In contrast, active targeting through covalent attachment of targeting molecules 
such as folic acid,
63 
hyaluronic acid,
64
 aptamer,
65
 antibody,
66
 peptide,
67
 or endoglin
68
 to 
the nanoparticle surface could promote the site-specific delivery of therapeutics. The 
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specific binding of these targeting ligands with the overexpressed receptors on tumor cell 
surfaces facilitates the selective cellular uptake. Specifically the small molecule folic acid 
(FA) has been widely investigated as targeting ligand and has shown a notable 
enhancement in uptake eﬃciency of numerous type of drug delivery system.69-72  
Magnetic targeting has long been considered as a viable approach for site-specific 
delivery of therapeutics. Through proper design of the externally applied magnetic ﬁeld, 
therapeutic agents attached to magnetic nanoparticles can be concentrated and retained at 
the preferred site under magnetic guidance which enables the targeted delivery of 
therapeutics to the desired spot. The idea of using magnetic microspheres as vehicles for 
drug delivery in cancer therapy was first introduced by Widder et al.
73
 Later magnetic 
nanoparticles were introduced for magnetically guided drug delivery which may offer 
better biocompatibility, optimal biodistribution, and deeper tumor penetration compared 
to microparticles. Yang et al. explored the possibility of utilizing iron oxide nanoparticles 
as a drug delivery vehicle for minimally invasive magnetic targeting of brain tumors.
74
 
Many other types of magnetic nanostructures/assembles, including liposomes-, micelles-, 
and mesoporous silica-coated superparamagnetic iron oxide nanoparticles, have been 
successfully employed for magnetic targeting of chemotherapeutic drugs.
75,76
  
 
6.2. Multifunctional Nanoparticle 
Enormous amount of evidence have shown that nanostructured materials are 
capable of improving the efﬁciency of therapeutic intervention. However, only relying on 
the self-functioning of nano-systems is not sufﬁcient to match the changeable and 
complicated disease microenvironment. Considering those disadvantages, researchers 
would like to design and fabricate nanostructured materials with multiple functionalities 
to improve the therapy. For example imaging, as a visualization technique, was 
introduced to the development of nanocarriers which could improve the therapy by 
efficient monitoring of therapeutic response. In this regard multifunctional nanomaterials 
have been designed to carry out diverse functions in contrast to the conventional methods 
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of conferring individual functionality, such as delivery of a single type of pharmaceutical 
compound.
77-82  
 
Judicious combinations of different kinds of entities in a single particle will 
enable the development of multifunctional nanotheranostics that could target, detect and 
treat the diseased site. 
79,83
 The term “theranostics” signifies the development of more 
specific therapies for various diseases with simultaneous diagnostic capabilities. For 
example, the combination of MRI contrast agent and anticancer drug can allow the 
detection of disease through non-invasive MRI and targeted chemotherapy. There are   
many   possible   combinations   of   the   various   imaging and therapeutic modalities. 
Multifunctional nanoparticle simultaneously achieves co-delivery of multiple therapeutic 
agents, and provides targeted delivery by appropriate surface modiﬁcation of the carriers' 
surface. In this regard, numerous multifunctional nanostructure materials have been 
developed and their utility for various biomedical applications has been explored. 
Contrast to organic-based nanomaterials (polymeric nanoparticles, micelles, and 
liposomes), inorganic nanomaterials such as mesoporous silica, magnetic nanoparticles, 
up-conversion nanoparticle, gold nanoparticles, quantum dots etc. have shown 
tremendous promise in biomedical applications owing to their robustness and longevity 
as core materials, aboudant availability and low cost.
84,85
 Although there has been 
explosive research activity in the  development  of  multifunctional nanoparticles for 
theranostic applications, there remain major challenges that need to be overcome in order 
to achieve real clinical applications.  
In this prospective, our present investigation involves the development of 
advanced multifunctional mesostructured silica nanocomposite for diagnosis and therapy. 
Here a brief overview on fabrication of mesoporous silica based multifunctional 
nanocomposites and their subsequent biomedical application is presented as it is relevant 
to our work. 
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6.3. Multifunctional mesoporous silica nanocomposite (MSN) 
Among various nanostructured inorganic materials studied for biomedical 
applications, mesostructured silica nanoparticle have gained tremendous attention for the 
development of multifunctionality due to their advantageous structural properties, such as 
high internal surface area and pore volume, tunable pore sizes, colloidal stability, and the 
possibility to speciﬁcally functionalize the inner pore system and/or the external particle 
surface.
86-88
 The  highly  porous materials  can  be  utilized  in  the  storage and delivery 
of small molecules such as ﬂuorescent  dyes  and  drugs  as  well  as larger molecules 
such as nucleotides and proteins. Furthermore, they are able to act as molecular machines 
for controlled release of guest molecules from the pores in response to certain stimuli. 
These highly attractive features make multifunctional mesoporous silica nanoparticles a 
promising and widely applicable platform for diverse biomedical applications including 
bioimaging for diagnostics,
84,87
 biosensing,
89,90
 biocatalysis,
91,92
 bone repair,
93 
and  drug  
delivery.
14,94
  
Multifunctional mesoporous silica nanomaterials can be obtained by simply 
conjugating two different components at separate regions (interior pore walls and 
external surface of the particle). For imparting multifunctionality to mesoporous silica 
nanoparticle following two steps are followed.  
(i) Encapsulation of nanocomponents such as QDs, metallic nanoparticle, imaging 
agent or different therapeutic agents with in the silica matrix  
(ii) Molecular functionalization which involves attaching antibodies, proteins, dyes, 
marker molecules and drug molecules to the silica surface  
As these functionalized particles can exhibit several features synergistically and deliver 
more than one function simultaneously they could have unique advantages in biomedical 
applications.  
Encapsulation approach 
Encapsulation approach has a number of advantages over organic coating.
95
 This 
robust strategy is highly stable and provides scope for introducing organic functionalities 
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for conjugation of active molecules like fluorophore, target molecule, therapeutics. Also 
encapsulation of inorganic nanomaterials or therapeutics with silica matrix ensures the 
preservation of unique properties of the encapsulated entity.
96
 
Hyeon et al. developed a simple and general method for encapsulation of 
hydrophobic inorganic nanoparticles in mesoporous silica shell by transferring 
presynthesized oleic acid stabilized iron oxide nanoparticles to aqueous media by capping 
with CTAB which on subsequent silica sol-gel reaction followed by the removal of 
surfactants resulted in the production of mesoporous silica spheres embedded with iron 
oxide nanoparticles.
97
 Along with Fe3O4 nanoparticles other hydrophobic nanostructured 
materials such as one-dimensional α-FeOOH nanotubes, spherical MnO nanoparticle 
were coated with mesoporous silica.
98
 Subsequently various strategies have been 
developed by several researchers for coating of metal nanoparticle, metal oxide, up-
conversion nanoparticle and QDs to develop the various mesoporous silica coated 
nanostructured materials.
99-103
 Moreover, different kinds of entity, such as metallic or 
oxide nanoparticles, quantum dots, organic fluorescence dyes, and drug molecule alone 
or in combination could be readily immobilized in silica matrix or mesopores, rendering 
them useful as multifunctional biomedical applicant. Furthermore the silica coating 
provided a robust barrier against oxidation of the QD core and reduced nonspecific 
adsorption on the nanoparticle. In 2008, Hyeon group extended their protocol for 
fabrication of mesoporous silica coated Fe3O4 core-shell nanoparticle applied for 
simultaneous in vivo multimodal imaging and drug delivery.
98
 The superparamagnetic 
iron oxide nanoparticle core serves as magnetic resonance (MR) imaging contrast agent 
where as mesoporous silica shell is utilized for drug delivery application. Furthermore, 
organic fluorescence dyes such as fluorescein isothiocyanate (FITC) and rhodamine B 
isothiocyanate (RITC) were immobilized in mesopores silica for in vivo fluorescence 
imaging.  
Surface functionalization  
The silica precursor (alkoxysilanes) used for synthesis of mesoporous silica 
nanoparticle allows for direct or indirect incorporation of functional groups like –OH, -
NH2, -COOH, -SH on to the surface. Alternatively these functional groups can be 
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introduced in a separate post-synthesis step including attachment of additional surface 
layers. These functional groups play an important role for bioconjugation of various 
therapeutic agents, target molecules. Selective modification of the internal pore and the 
external particle surface with organic and inorganic moieties is often an essential 
requirement for development of multifunctional drug carriers with desired features. 
External surface functionalization provides superior colloidal and chemical stability to 
the system and improves the biocompatibility and therapeutic profile of the system 
through attachment of speciﬁc cell targeting molecules, imaging agents,104-106 whereas the 
internal organic moieties provides boosted interaction and covalent binding of cargo 
molecules, such as drugs or proteins, which allows for  control  over  diﬀusional  
transport,  delivery  kinetics,  and stability of the therapeutic molecules. 
107,108
  
The surface functionalization of mesoporous silica is mainly through 
postsynthetic grafting and via co-condensation using silane coupling agents. It can be 
done by covalent coupling of desired molecule through amine, thiol or epoxide 
terminated silica surface. Another method involves the modification of the silica surface 
by molecules that already have a silane group integrated within the molecule. The surface 
of the nanoparticle can be modified to obtain -COOH, -NH2, -SH and reactive -OCN 
groups by using a carboxylated silane, aminosilane, mercaptosilane, cyanogen bromide 
reagents respectively. Biomolecules, such as proteins and antibodies, containing free 
amine functional groups are then attached covalently to the carboxyl functionalized silica, 
using carbodiimide-coupling chemistry.
109
 Cancer targeting ligands such as folates are 
attached chemically to aminated silica surface using carbodiimide chemistry.
110
 In a 
similar fashion sulfohydryl-modified silica surface are conjugated to disulfide-linked 
oligonucleotides (e.g. DNA) through disulfide-bond formation.
111
 The surface hydroxyl 
groups of silica can also be activated by the cyanogens bromide to produce reactive -
OCN derivative which reacts readily with proteins through amine groups, forming a 
‘zero-length’ bioconjugate.112   
The advancements in co-condensation and post-synthetic methods have also made 
it possible to introduce a numerous of organic molecules to the silanol groups on the 
exterior surface of mesoporous silica nanoparticles through covalent or electrostatic 
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interactions. In one example, polyethyleneimine (PEI) polymers were attached to the 
surfaces of MSNP to improve nucleic acid delivery.
113 
Bein and co-workers established a 
site-selective delayed co-condensation approach to produce bifunctional MSNs with a 
selective functionalization of the interior.
114,115 
Dual functional mesostructured 
nanotheranostics was developed by Lin et al. for simultaneous ﬂuorescence imaging and 
gene transfection.
116 
A multifunctional mesoporous silica system was developed by 
functionalization in with  fluorescent  contrast  agent  AT-TO647N,  drug  photosensitizer  
Pd-porphyrin  payload  for therapeutic intervention (photodynamic therapy), and bio-
molecular ligands  cRGDyK  peptides  on  the  outermost surface  for  targeting  the  αvβ3 
integrins of  cancer  cells.
117 
These surface modifications of MSNs minimize nanoparticle 
aggregation and reduce nanoparticle non-specific binding. 
 
6.4. Recent developments of mesoporous silica based multifunctional nanostructures 
Following the above mentioned steps, numerous multifunctional mesoporous 
silica nanoparticles congregated with diagnostics and therapeutics agents simultaneously 
have been designed. Imaging modalities have the potential  to  play  an  important  
theranostic  role  in  medicine since they permit the monitoring of drug delivery 
eﬃciency as well  as  the  visualization  of  aﬀected  areas.  One such multifunctional 
hollow mesoporous silica hybrid nanoparticle has developed by Qian et al. for efficient 
ultrasound based imaging and controlled hydrophobic drug (paclitaxel) delivery.
118 
Drug 
loaded hollow spherical nanostructure combined with ultrasound irradiation showed fast 
ultrasound responsiveness for controlled drug release and higher in vitro and in vivo 
tumor inhibition rates compared with free paclitaxel and paclitaxel-loaded particles. Up-
conversion based multifunctional mesoporous silica nanoparticle shows interesting NIR 
excitation bioimaging for better therapeutic purose.
119 
A multifunctional up-conversion 
based mesoporous silica nanocomposite (β-NaYF4:Yb
3+
,Er
3+@β-NaGdF4:Yb
3+
) was 
reported for simultaneous drug delivery (doxorubicin) and dual imaging (up-conversion  
luminescence  and  MRI).
120 
The nanocomposites exhibited low systematic toxicity and 
high in vivo antitumor therapy efﬁcacy. Recently Fan et al. designed a novel up-
conversion based mesoporous silica nanotheranostic for tri-modal synergetic therapy and 
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multimodal imaging.
121 
The hollow cavity of rattle type core shell nanotheranostics was 
loaded with radiosensitizer/chemodrug docetaxel (Dtxl) whereas the pores of silica serve 
as the carrier for radio-/photo-sensitizer hematoporphyrin (HP). Upon NIR excitation and 
X-ray irradiation, synergetic chemo-/radio-/photodynamic therapy can be achieved by the 
co-delivery of radio-/photo-sensitizer HP and radiosensitizer/chemodrug Dtxl which 
produces remarkably enhanced therapeutic effects both in vitro and in vivo. The therapy 
was boosted with simultaneous magnetic/up-conversion luminescent (MR/UCL) bimodal 
imaging. In other MSNs studies, fluorescence resonance energy transfer (FRET) was 
used to monitor the therapy.
122 
 Li et al. developed a tumor marker (surviving mRNA) 
mediated “on-demand” drug release system using multifunctional mesoporous silica 
nanoparticle. The relevant change in donor and acceptor fluorescence signal was used to 
monitor the unlocking and release event in real-time.
123 
Mesoporous silica nanoparticle 
based numerous multimodal imaging probes have also developed for diagnostic 
purposes.
124,125 
 
Another function of multifunctional mesoporous silica nanoparticle is that of 
being a gatekeeper in stimuli-responsive delivery systems.  For example, MSNs can act 
as smart drug delivery system by capping nanochannel entrances with external stimuli 
(e.g., pH, osmolarity, photo-activated) responsive entities to prevent the premature 
release of conveyed cargo.
126,127 
Zhao et al. developed multifunctional iron 
oxide/mesoporous silica core/shell (Fe3O4@mSiO2) nanoparticle, end-capped with pH-
stimuli-responsive hydroxyapatite (HAp) nanovalves for pH-responsive drug release. The 
dissolution of hydroxyapatite in an acidic environment triggers the release of the loaded 
drugs.
128 
MSNs have also been utilized for co-delivery of various therapeutic agents. Ma 
and his group developed a hollow mesoporous silica nanoparticle (HMSNP) based pH-
responsive drug/siRNA co-delivery vehicles capable of simultaneously delivering 
doxorubicin and siRNA against the Bcl-2 protein into targeted cancer cells.
129
 The hollow 
nature of the HMSNPs not only improves the anticancer drug loading capability, but also 
enhances the siRNA binding ability towards certain cancer cells. In other mesoporous 
silica based multifunctional studies, mesoporous silica coated  gold  nanorods  were  used  
as a light-mediated multifunctional theranostic carrier for cancer treatment.
101
 The inner 
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AuNR core functioned both as TPI imaging agent and hyperthermia agent, whereas the 
outer mesoporous SiO2 shell served as effective drug carrier. 
Moreover, mesoporous silica based multifunctional platform has also been used to 
encapsulate cancer drugs, superparamagnetic iron oxide nanocrystals, fluorescent tags, as 
well as targeting groups on the surface. Drug delivery, magnetic resonance and 
fluorescence imaging, magnetic manipulation, and cell targeting are simultaneously 
possible using these multifunctional mesoporous silica nanoparticle.
130 
Liong et al.  
highlighted the development of various mesostructured multifunctional nanoparticles for 
simultaneous imaging and delivery of molecules in biological applications. Very recently, 
Mohapatra et al. developed multifunctional mesoporous hollow silica nanocapsules for 
targeted co-delivery of cisplatin-pemetrexed and MR imaging.
131 
The exterior surface of 
the hollow mesoporous silica nanosphere was selectively acid functionalized and utilized 
to conjugate the anticancer drug cisplatin, the marker molecule folic acid (FA) for 
targeted delivery, and rhodamine isothiocyanate (RITC), whereas the interior space was 
utilized to encapsulate superparamagnetic CoFe2O4 nanoparticles (for MR imaging) as 
well as the hydrophobic anticancer drug pemetrexed. Such a dual drug loaded 
nanocapsule showed enhanced cytotoxicity than individual drugs due to the simultaneous 
action of both the drugs cisplatin and pemetrexed, and targeted delivery of the drug 
capsule through folate receptor mediated endocytosis. 
The unique structural feature of mesoporous silica allows decoration of 
nanoparticles onto its surface, which enables assembly of numerous nanoparticles and 
sequential addition of different functional nanoparticles. Using these facile assembly 
processes, a wide variety of theranostic nanoplatform has been achieved. For “on-
demand” controlled release of encapsulated drugs, various inorganic nanoparticles (Au, 
CdSe, Fe3O4 etc.), were assembled on the surface of mesoporous silica via stimuli-
responsive tethers.
132-135 
These assembled nanoparticles could function as gatekeepers 
and could be removed by either intracellular or external triggers such as pH change, 
reduction process, enzyme reaction, or irradiation of light. Hyeon’s group demonstrated a 
simple method for assembly of hydrophobic iron oxide nanoparticles on silica particles 
through covalent attachment Br terminated iron oxide nanocrystals with amine 
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functionalized surface.
136 
The same group developed a multifunctional dye doped MSNs 
decorated with iron oxide nanoparticles for drug delivery as well as MR imaging.
137 
This 
developed system signiﬁcantly displayed the biomedical potential of MSNs for 
simultaneous ﬂuorescence imaging with the RITC dye, MR imaging with the iron oxide 
nanoparticles, and drug delivery with doxorubicin through in vivo studies with tumor-
bearing mouse models. The better T2 MR contrast effect is due to presence of iron oxide 
nanocrystals on the silica surface and clustering of magnetic nanoparticle. In combination 
with the targeting moieties or gate-keeper concepts, these multifunctional MSNs hold 
promise as target-speciﬁc multimodal imaging or theragnosis. Recently Gd2O3:Yb/Er 
assembled mesoporous MCM-41 nanocomposites was reported for NIR light triggered 
doxorubicin release.
138 
  Gold nanocrystals were integrated with the amino group 
functionalized nanocomposites in order to induce a wavelength-dependent enhancement 
of the up-conversion intensities. Particularly, under 980 nm NIR laser irradiation, the 
green up-conversion emission overlaps the surface plasmon resonance (SPR) band of 
gold nanocrystals, which causes a photothermal eﬀect of gold nanocrystals and induces a 
rapid DOX release from the Au hybrid materials.  
The above discussion demonstrated the mesoporous silica based multifunctional 
nanoparticles have significant advantages in biomedical application over traditional small 
molecule imaging or therapeutic agents. The exciting findings demonstrated not only 
their drug delivery capacity, but also effective cell-specific targeting, enhanced contrast 
imaging, and stimuli-controlled drug release behavior.   
 
6.5. Objective of the present work 
Despite the significant efforts in developing mesoporous silica based 
nanotheranostics, there still remains considerable challenge for their successful clinical 
implication. For instance, the preservation of individual functional properties like 
magnetic and fluorescent of each integrated moiety during the development of 
multifunctional nanoparticle is an important factor which influences the efficiency of 
these multifunctional nanoparticles in diagnostic applications. Apart from this, one of the 
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major challenges involves the administration of sparingly soluble or hydrophobic drugs. 
To overcome the solubility issue, many hydrophilic drug conjugates and carrier 
molecules are introduced. However the lack of potent activity and stability in the 
hydrophobic form limit their applications. Another challenge involves. Addressing the 
existing lacunas associated with the development of mesoporous multifunctional 
nanoparticle, the current research effort involves the development of new water 
dispersible multifunctional mesoporous silica based luminescent magnetic material  
through an easy method involving cheap and easily available starting materials for 
multimodal cancer-specific imaging and therapy. The objectives of the present work are 
as follows:  
 Development of simple inexpensive chemical route for the synthesis of 
mesoporous silica based magnetic luminescent hybrid nanoparticles with 
optimum luminescent and magnetic property. 
 Incorporation of highly luminescent biocompatible carbon quantum dot 
alternative to more toxic metal-based semiconductor quantum dots (QDs) for 
optical imaging. 
 Modification of the synthesized multifunctional nanoparticle surface with various 
ligands to achieve high colloidal stability in physiological environment. 
 To regulate the loading and stimuli responsive control release of the drug while 
keeping the therapeutic activity intact. 
 Evaluation of developed drug loaded multifunctional nanoparticles for cancer-
cell specific multimodal imaging and drug delivery. 
In line with this approach in the present thesis, mesoporous silica coated 
magnetite core-shell nanoparticles with incorporated luminescent nanoagent have been 
synthesized. To circumvent the drawbacks associated with dyes and/or semiconductor 
QDs, new age luminescent inorganic materials such as rare-earth and carbon quantum dot 
(CD) have been used for luminescence functionalization. In order to facilitate cancer-
specific therapy the nanocomposites have been decorated with folic acid targeting ligand. 
The hydrophobic chemotherapeutic drugs have been loaded using suitable strategy. The 
developed fluorescent magnetic nanotheranostics have  been  extensively  characterized  
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using  modern spectroscopic  techniques  and  their  diagnostic  as  well  as  therapeutic  
potential (fluorescence imaging, MR Imaging and drug delivery)  has  been evaluated  in  
vitro. The full details of our research effort have been described in subsequent chapters.  
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7.1. Introduction 
Recently, rare earth-doped nanoparticles have attracted great attention for use as 
luminescent biolabels owing to their excellent luminescence properties, including large 
Stokes shifts, narrow line-width emission bands, high quantum yields, long lifetimes and 
superior photostability.
1-4 
Their luminescence properties in most cases are due to 
forbidden f-f electron configuration transitions (except for Ce
3+
and Eu
2+
 involving d-
electrons). As these low-lying energy levels are well isolated from the environment, their 
optical properties are rarely affected by surface modification, nature of host material and 
the nanoparticle size. The unique luminescence properties of rare earth based 
nanoparticles provide tremendous advantages over conventional fluorophores for 
biomedical applications. These  advantages includes (1) enhanced penetration depth into 
biological samples,
5 
(2) very low auto-ﬂuorescence from surrounding tissues,6 (3) 
decreased photo-damage to the biological specimens,
7 
(4) non-photobleaching, non-
photoblinking and high spatial resolution during bioimaging 
8,9 
and (5) low cytotoxic to a 
broad range of cell lines.
10,11 
Moreover, the high magnetic moment of certain ions, like 
Gd
3+
, under magnetic ﬁeld renders them potent contrast agents for magnetic resonance 
imaging (MRI).
12 
Therefore the rare earth doped nanoparticle have attracted reviving 
interest for their biomedical applications in areas as diverse as biodetection,
13 
bioimaging,
14 
drug delivery,
15 
photodynamic therapy (PDT),
16 
photothermal  therapy  
(PTT),
17 
and  disease  theranostics.
18 
Till date much progress have been accomplished in 
the structure/morphology control, functionalization design, and optical performance 
optimization of these rare earth based nanomaterials for versatile biomedical applications, 
as summarized in many recent reviews and book chapters.
19-22 
 
 
Figure 7.1 Application of rare earth doped nanoparticle 
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Being a potential luminophore, rare earth doped nanoparticle has been integrated 
with magnetic nanoparticles to prepare multifunctional magnetic/luminescent composites 
including γ-Fe2O3/NaYF4:Y,Er nanoparticles,
23 
Co:Nd:Fe2O3/Gd2O3:Eu core-shell 
particles,
24 
Tb-doped γ-Fe2O3 nanocrystals,
25 
Fe3O4@Y2O3:Eu nanocomposites,
26 
LaPO4:Ce
3+
,Tb
3+
coated Fe3O4 koosh nanoballs,
27
 Fe3O4@YPO4:Tb,Eu hybrid sphere.
28 
However, the fluorescence quenching effect of magnetite limits the potential applications 
of these integrated structures in several areas. In order to overcome, an inert silica layer 
was introduced that can effectively separate lanthanide based luminescent component 
from the magnetite. Till date, there are few reports on the synthesis of rare earth based 
luminescent magnetic with inert silica layer. Li et al. reported the synthesis of 
bifunctional magnetic-luminescent Fe3O4@SiO2/Y2O3:Tb nanocomposite by assembling 
Y2O3:Tb nanorods onto the surface of Fe3O4@SiO2 core-shell nanostructures.
29 
Lin and 
his co-worker have prepared a magnetic luminescent and mesoporous core shell 
structured nanocomposite (Fe3O4@nSiO2@mSiO2@YVO4:Eu
3+
) as carrier for ibuprofen 
(IBU).
30
 Some other reported examples include Fe3O4/SiO2/YVO4:Eu
3+
 
magnetic/luminescent nanocomposites,
31 
Fe3O4@LaF3:Ce
3+
,Tb
3+
 bifunctional 
nanocomposites.
32 
While few scenarios can also be envisaged for applications of such 
novel and complex integrated materials in life sciences, their practical applications are 
still in their infancy.  
On the other hand, 5-Fluorouracil (5-FU) is a widely used chemotherapy drug for 
treatment of a broad variety of solid tumors including pancreas, ovary, liver, brain, breast 
and gastrointestinal cancers, alone or in combination with chemotherapy regimens.
33-36 
The mode of action of 5-FU has been ascribed to the misincorporation of 
fluoronucleotides into RNA and DNA and to the inhibition of the nucleotide synthetic 
enzyme thymidylate synthase (TS).
37 
5-FU when locally injected is rapidly absorbed 
through the blood capillaries into systemic circulation. This results in relatively low 
levels of drug near the site of action with the subsequent loss of efficacy and increased 
risk of systemic toxicity.
38,39 
Additionally, the limited aqueous solubility restricts the use 
of 5-FU.
40 
Selective delivery of chemotherapeutic agents to the disease site represents a 
major challenge for improving current chemotherapy outcome.
41
 Targeted delivery of the 
drug is an emerging therapy strategy gifted with disease-targeting functions and carrying 
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cytotoxic components by enabling the specific delivery of chemotherapeutic agents to 
aberrant tissues, thereby increasing their local efficacy while limiting their peripheral 
toxicity. 
In this chapter, we have addressed these issues with the development of 
fluorescent magnetic nanoparticles based nanoformulation for the site specific delivery of 
5-FU. The versatile scope of biofunctionalisation, established biocompatibility of 
phosphate moiety and utility of yttrium or phosphorous element for radiotherapy of 
cancers inspired us to fabricate yttrium phosphate based magnetic ﬂuorescent 
nanocomposites. For this purpose we have prepared luminescent Fe3O4@mesoporous 
silica-YPO4:Tb nanoparticles with Fe3O4 as the core and Tb
3+
-doped yttrium phosphate 
incorporated mesoporous silica as the shell. These fluorescent magnetic nanoparticles 
have been decorated with folate and β-cyclodextrin using glutathione as a linker in order 
to facilitate hydrophobic anti-cancer drug 5-FU storage as well as delivery. The 
synthesized material has been characterized by X-ray diffraction, FTIR, DLS, TEM, 
SEM, BET, fluorescence spectrophotometry, vibration sample magnetometry. The 
cytotoxicity of the drug carrier as well as drug release profile has also been investigated. 
 
7.2. Experimental 
 Chemicals 
Thionyl chloride, β-cyclodextrin, (NH4)2HPO4, triethyl amine, ethanol, ethyl 
acetate, acetone and chloroform were obtained from Merck, India. Benzyl ether, 
Cetyltrimethylammonium bromide (CTAB), 5-Fluorouracil (5-FU), Fe(acac)3, 
Glutathione (GSH),  3-glycidoxypropyltrimethoxysilane (GTPS), oleic acid, oleylamine, 
tetraethyl orthosilicate (TEOS), Tb(NO3)3.5H2O, Y(NO3)3.6H2O, 2,2’-(ethylenedioxy)-
bis-(ethylamine)    (EDBE), 2-carboxyethyl phosphonic acid (CEPA), folic acid (FA), di-
tert-butyldicarbonate (BoC2O), dicyclohexyl carbodiimide (DCC) and N-hydroxy 
succinimide (NHS) were purchased from Sigma Aldrich, USA. Commercially available 
dioxane and toluene were purified by distillation over sodium metal with benzophenone. 
Prior to use, dimethylsulfoxide (DMSO) was vacuum distilled. Pyridine was puriﬁed by 
distillation over KOH. 
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Preparation of monodisperse hydrophobic Fe3O4 nanoparticle 
Hydrophobic Fe3O4 nanoparticles were synthesized by a high-temperature 
solution-phase reactions of iron acetylacetonate with 1,2-hexadecanediol in the presence 
of oleic acid and oleylamine.
42 
In a typical procedure the mixture of Fe(acac)3 (706 mg, 2 
mmol), 1,2-dodecanediol (2.023 g, 10 mmol), oleic acid (1.9 mL, 6 mmol), oleylamine  
(1.97 mL, 6 mmol)  and  benzyl  ether  were heated to reflux (300 °C)  under nitrogen 
atmosphere for 1 h. Then as-synthesized mixture was allowed to cool to room 
temperature and Fe3O4 nanoparticles were precipitated by adding ethanol. The precipitate 
was collected by centrifugation at a speed of 10000 rpm for 10 minutes. 
Synthesis of mesoporous silica coated magnetite nanoparticle Fe3O4@m-SiO2 
Mesoporous silica coating on Fe3O4 nanoparticle was carried out by modified 
Stӧber’s method using CTAB as a template, where CTAB serves as the stabilizing 
surfactant for the transfer of hydrophobic Fe3O4 nanocrystals to the aqueous phase.
43
 In a 
typical procedure, 350 mg of oleic acid stabilized monodisperse magnetite nanoparticles 
dispersed in 30 mL of chloroform was added to a 100 mL of aqueous CTAB (2 g) 
solution and the resulting solution was stirred vigorously for 30 min. The formation of an 
oil-in-water microemulsion resulted in a turbid brown solution. Heating the brown 
solution at 60 °C for 20 min induced evaporation of the chloroform, this generated 
aqueous dispersion of nanoparticles. The resulting mixture solution was added to a 
mixture of 200 mL of water and 5 mL of 2M NaOH solution and heated upto 70 °C. Then 
TEOS (3 mL) and ethyl acetate (10 mL, 0.1 M) were successively added to the diluted 
aqueous solution containing the magnetite nanoparticles. The resulting mixture was 
stirred for 3 h and the precipitate was magnetically separated (DynaMag2, Invitrogen), 
and thoroughly washed with ethanol to remove unreacted species and surfactant, then 
dried at 60
 
°C in an oven for overnight.   
Synthesis of Fe3O4@m-SiO2@YPO4:Tb
3+
 composite nanoparticle 
To deposit YPO4:Tb on the mesoporous silica surface of Fe3O4@m-SiO2 core-
shell nanostructures, aqueous solution of Y(NO3)3.6H2O (0.383 g, 1 mmol) and 
Tb(NO3)3.5H2O (0.087 g, 0.2 mM) were added to 50 mL of dispersed  Fe3O4@m-SiO2 
(0.4 g) nanoparticles and stirred for 2 h. To the above mixture solution (NH4)2HPO4 was 
added under vigorous stirring and continued stirring for another 3 h. Finally particles 
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were separated, thoroughly washed and oven dried on air at 60 °C for overnight. The 
doping concentration of Tb
3+
 was 20 mol% of Y
3+
 in YPO4. 
Synthesis of epoxide functionalized Fe3O4@m-SiO2@YPO4:Tb
3+
 nanoparticle 
To modify the surface with epoxide, about 0.3 g of Fe3O4@m-SiO2@YPO4:Tb
3+
 
particles were added to 30 mL of dry toluene with 0.1 mL (0.44 mmol) of 3-
glycidoxypropyltrimethoxysilane (GPTS) under N2 atmosphere and refluxed for 24 h. 
After the reaction, the functionalized particles were magnetically separated, washed 
extensively with acetone, and dried in vaccum. 
Synthesis of glutathione (GSH) conjugated β-cyclodextrin (GSH-cyclodextrin) 
To the stirred solution of GSH (200 mg, 0.65 mmol) in dioxane (10 mL), thionyl 
chloride (0.48 mL, 6.5 mmol) was added dropwise at room temperature. Then it was 
allowed to reflux for 24 h under nitrogen atmosphere followed by complete removal of 
the solvent under vacuum below 60 °C. Then to it, β-cyclodextrin (740 mg, 0.65 mmol) 
in dioxane (10 mL) and triethyl amine (0.4 mL) was added, and allowed to reflux for 
another 24 h under nitrogen atmosphere. After the reaction, dioxane was evaporated and 
the product (GSH-cyclodextrin, 465 mg, yield 51%) was extracted with ethanol. 
Synthesis of cyclodextrin-modified folate decorated nanocarrier 
To load 5-FU, the particles were conjugated with GSH-cyclodextrin by ring 
opening of epoxide ended nanoparticles. Typically, aqueous ethanolic solution of GSH-
cyclodextrin (709 mg, 0.5 mmol) was added to epoxide functionalized Fe3O4@m-
SiO2@YPO4:Tb
3+
 and the mixture were allowed to stir overnight at 60 °C. Then the 
particles were magnetically separated and washed with water. In order to facilitate 
receptor mediated endocytosis, the nanocarrier was further functionalized with folic acid.  
Prior to synthesis of folate decorated fluorescent magnetic nanoparticles, amine 
functionalized folic acid was prepared following the procedure reported by Mohapatra et 
al..
44 
For conjugation, amine functionalized folic acid (FA-NH2) (285 mg, 0.5 mmol) 
dissolved in dimethyl sulfoxide was stirred overnight at 60 °C with aqueous dispersion of 
Fe3O4@m-SiO2@YPO4:Tb
3+
@GSH-cyclodextrin. Finally folate decorated luminescent 
particles were magnetically separated and washed with water.  
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Loading and release of 5-FU 
5-FU loading has been achieved by simple inclusion of hydrophobic drug onto the 
cyclodextrin-modified nanoparticle. Briefly, 40 mg nanoparticles was stirred with 
saturated solution of 5-FU (5mg/30 mL) at 60 °C for 72 h. Then the particles were 
recovered using magnetic separator, washed thoroughly with water and suspended in 
phosphate buffer. The release of 5-FU from the nanoparticles was investigated in the 
citrate phosphate buffer (at pH 7.0, 6.2, 5.2 and 3.2) at 37 °C. At speciﬁed time intervals, 
accumulated amount of drug released into the solution was quantified using a UV-vis 
spectrophotometer (λmax(5-FU)=266 nm). The release proﬁles were plotted as the relative 
release percentages of 5-FU against time.  
Calculation of drug loading capacity 
The drug loading capacity was calculated as per the following method. First 5-FU 
was loaded onto the nanocarrier (β-cyclodextrin and FA-NH2 decorated nanoparticle) as 
described above and then separated from the aqueous suspension medium using magnetic 
separator. The obtained drug-loaded nanocomposites were incubated at 60 °C in vacuum 
overnight and were weighted. Drug concentration in supernatant was analyzed by the 
ultraviolet absorption (λmax(5-FU) = 266 nm), with reference to a calibration curve on a 
UV-Vis spectrophotometer. The measurements were performed in triplicate. Drug-
loading content and encapsulation efficiency were obtained by equations 1 and 2, 
respectively.
45 
 
Drug-loading content (%) =    
Weight of the drug in nanoparticles 
weight of the nanoparticles
 x 100..…..(1) 
                                           =  
4.58
40
 x 100 
                                 
                                     = 11.45%              
 
Encapsulation efficiency (%) =
Weight of the drug in nanoparticles 
Weight of the feeding drug
 x 100…….    (2) 
                                                 
                                        = 
4.58
5.0
x 100 = 91.6% 
Cytotoxicity of the nanocarrier 
The cytotoxicity of the nanocarrier was evaluated on Human cervical carcinoma 
(HeLa) and mouse fibroblasts (L929) cells. These cells were obtained from the National 
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Centre for Cell Sciences (Pune, India), cultivated in minimal essential medium (MEM) 
and Dulbecco’s modified eagle medium (DMEM) respectively supplemented with 10% 
fetal calf serum, 100 units/mL penicillin, and 100 μg/mL streptomycin, 4 mM L-
glutamine under 5% CO2 and 95% humidified atmosphere at 37 °C. From 10
4 
cells/mL 
cell suspension, 180 μL cell suspension was seeded into each well of 96 wells tissue 
culture plates and incubated for 18 h followed by addition of Fe3O4@m-
SiO2@YPO4:Tb
3+
@GSH-cyclodextrin@FA nanoparticles at concentrations 25, 50, 100 
and 200 µg/mL. Following the incubation for 72 h at 37 °C in a humidified incubator 
(HERA cell) maintained with 5% CO2. Thereafter, MTT (10 μL; 5 mg/mL) was added to 
each well and the plate was incubated for an additional 4 h at 37 °C under 5% CO2. After 
the addition of 10% sodium dodecyl sulfate (SDS, 100 μL/well), the assay plate was 
allowed to stand at room temperature for 12 h. For each well, the optical density (OD) at 
570 nm with back ground subtraction at 690 nm was recorded by means of microtiter 
plate reader. The following formula was used to calculate the inhibition of cell growth: 
Cell viability (%) = (mean of OD value of treatment group/mean OD value of 
control)×100.
46 
All Experiments were performed in triplicates for each sample and 
control per assay. 
 
7.3. Characterizations 
The phase formation of crystallographic state of synthesized particles was 
performed by an X’pert Pro Phillips X-ray diffractometer using CuKα source. The 
morphology and microstructure were analyzed by Scanning electron microscope 
(HITACHI COM-S-4200) and High resolution transmission electron microscopy (JEOL 
3010, Japan) operated at 300 kV. The images were analyzed using image-J software. 
Hydrodynamic size of the drug carrier at various stages of synthesis was measured at 
25.0±0.5 °C, by laser light scattering using a particle size analyzer (Nano ZS 90, 
Malvern). Measurements were performed at 90° angle in 0.01 M phosphate buffer 
varying pH 4 to 8. The stability of the formulations was evaluated by measuring the size 
of the particles after one week of storage at 4.0±0.5 °C in water. The surface functional 
group and conjugation of the different moiety to the nanoparticle were invistegated by 
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FTIR spectroscopy (Thermo Nicolet Nexus FTIR model 870 spectrometer). Surface 
composition of folate decorated particles was obtained byanalyzing XPS data using AlKα 
excitation source in ESCA-2000Multilab apparatus (VG microtech). Nitrogen 
adsorption/desorption analysis was measured at a liquid nitrogen temperature (77 K) 
using a Micromeritics ASAP 2010M instrument. The speciﬁc surface areas and total pore 
volume were calculated by the Brunauer–Emmett–Teller (BET) and BJH methods 
respectively. The fluorescence emission spectra were performed on a Horiba Fluoromax 
4 spectrophotometer at excitation energy of 340 nm. The magnetic properties of 
Fe3O4@m-SiO2 and composite nanoparticles were determined using vibrating sample 
magnetometer (VSM), Lakeshore 7410 at 25.0±0.5 °C. UV absorption measurements, at 
the maximum absorbance wavelength (266 nm) in Shimadzu 220V (E) UV-vis 
spectrophotometer were carried out to measure the 5-FU concentration in all the systems 
investigated, using quartz cells of 1 cm path length.  
 
7.4. Results and Discussion 
Synthesis 
The synthetic strategy of the magnetic luminescent nanocarrier is illustrated 
schematically in scheme 7.1. The ordered  mesoporous  silica-coated  magnetite 
nanoparticles was synthesized using modified Stӧber’s method, which were further 
functionalized by precipitating luminescent material (YPO4:Tb) on silica matrix. The 
superparamagnetic feature of the synthesized particles facilitates their easy and 
quantitative separation using external magnet. In the second step, the surface of the 
nanoparticles was modiﬁed with GTPS in order to produce epoxy group ended particles. 
To load with the drug, the particles were further functionalized with cyclodextrin using 
glutathione (GSH) as a coupling agent in the third step. Glutathione is a small sized 
natural tripeptide (γ-Glu-Cys-Gly) that contains a -SH group and two carboxylic groups. 
Moreover it is the most abundant thiol species in the cytoplasm and the major reducing 
agent in biochemical process.
47
 For conjugation of β-cyclodextrin, first the glutathione-
cyclodextrin ester has been prepared followed by epoxide-opening by the GSH-
cyclodextrin ester through -SH group. Finally, the hydrophobic drug 5-FU was loaded on 
cyclodextrin-functionalized nanoparticles via formation of 5-FU/cyclodextrin inclusion 
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complex. In addition to this, to facilitate receptor mediated endocytosis, the nanocarrier 
was decorated with folates through epoxide opening by FA-NH2.  
 
Scheme 7.1 Schematic representation for synthesis of 5-FU loaded fluorescent magnetic 
Fe3O4@mSiO2@YPO4:Tb hybrid nanocomposite. 
 
XRD Study 
 The crystal structures and the phase purity of the Fe3O4@mSiO2@YPO4:Tb were 
determined by XRD. In Figure 7.1, all the reflection  peaks  of  the  products  can  be  
easily  indexed  to  a crystalline cubic spinel structure of Fe3O4 with a lattice constant 
a=8.410 A
o
 (JCPDS No. 82-1533). For Fe3O4@m-SiO2, the broad band at 2θ=22° can be 
assigned to the amorphous silica shell (JCPDS No. 29-0085). Besides the corresponding 
peaks of Fe3O4, the diffraction peaks of YPO4 (JCPDS No. 74-2429) can be detected for 
Fe3O4@m-SiO2@YPO4:Tb sample. The weak reflection peak intensity of Fe3O4 in the 
hybrid was probably due to low content of magnetic materials or low level of 
crystallization. 
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Figure 7.1 XRD patterns of (a) Fe3O4, (b) Fe3O4@m-SiO2, (c) Fe3O4@m-SiO2@YPO4:Tb 
after heating at 300 °C for 4h. 
 
Microstructure 
The morphologies of the as-prepared products were characterized by scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). The SEM 
image of Fe3O4@m-SiO2 particles (Figure 7.2a) shows that the nanoparticles are 
spherical in nature with a smooth surface and are almost monodisperse. After deposition 
of YPO4 the surface of silica becomes relatively rough. The morphological features such 
as the spherical shape, non-aggregation, and narrow size are found to be retained in case 
of Fe3O4@mSiO2@YPO4:Tb (Figure 7.2b), similar to Fe3O4@mSiO2. Furthermore, no 
irregular particles related with the introduced phosphors are detected. The results suggest 
that the deposition has little influence on the spherical morphology and the phosphor 
layer is uniformly deposited on the silica surface. TEM was employed to further examine 
the detail structure and morphology of Fe3O4 and Fe3O4@mSiO2@YPO4:Tb 
nanoparticles. The TEM image of Fe3O4 nanoparticles (Figure 7.2c) clearly indicates the 
formation of uniform, monodisperse particle with narrow size distribution of 5-7 nm. The 
high crystallinity of the sample is confirmed by the obvious lattice fringe (inset, Figure 
7.2c). The three components in the Fe3O4@mSiO2@YPO4:Tb particles can be well 
distinguished by variation in contrast in different layers (inset, Figure 7.2d) due to 
difference in electron penetrability. It is well indicated that the inner magnetic core is 
surrounded by a silica shell with a diameter of 30 nm on which a very thin layer of 
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YPO4:Tb of thickness 2.5 to 3 nm is deposited. However, aggregation/coalescence of 
individual Fe3O4@mSiO2@YPO4:Tb was found, and the aggregation might occur during 
TEM sample preparation and drying effect as observed in other cases.
26
 The EDS 
spectrum (Figure 7.2e) confirms the presence of, Fe, Si, Y, Tb, and P on 
Fe3O4@mSiO2@YPO4:Tb particles. 
 
Figure 7.2 SEM images of (a) Fe3O4@m-SiO2, (b)Fe3O4@m-SiO2@YPO4:Tb nanoparticles, 
and  TEM images of (c) Fe3O4 with lattice imaging (inset), and (d) Fe3O4@m-
SiO2@YPO4:Tb nanoparticles, inset is the image at high magnification showing the core 
shell structure, (e) EDX spectrum of Fe3O4@m-SiO2@YPO4:Tb nanoparticles. 
 
Hydrodynamic size and stability  
The hydrodynamic (HD) size of drug conjugated fluorescent magnetic 
nanoparticles at various stages of synthesis (Figure 7.3a) indicates the formation of stable 
non-aggregated particles. The drug loaded particle showed a mean HD size of 71 nm, 
which is not significantly affected with change of pH (3-8) (Figure 7.3b). Measurement 
of HD size against time shows that there is no change of hydrodynamic size after several 
days (Figure 7.3c). Such a stable HD size minimizes the possibility of macrophagic 
clearance of drug conjugates in the blood stream. Measurement of zeta potential against 
pH shows that at low pH zeta potential is 24.3 mV which shifts to -39 mV at higher pH 
which indicates the presence of -COOH groups on the surface (Figure 7.3d).  
Part-II                                                                                                            Chapter-7 
 
129 
 
 
Figure 7.3 (a) Change in hydrodynamic size of the drug carrier at various stages of 
synthesis, Variation of the HD size of drug conjugate (b) with pH, (c) with time, and (d) 
Measurement of zeta potential of the drug loaded nanoparticle against pH. 
 
FTIR Study 
.   Figure 7.4 shows FTIR spectra at various stages of synthesis. Fe3O4@m-
SiO2@YPO4:Tb particles show strong absorption at 500-600 cm
-1 
corresponding to 
characteristic vibration of Fe-O in the magnetite lattice. The bands at 1000-1100 cm
-1
 
(intense splitted band) and 642 cm
-1
 were attributed to the stretching and bending 
vibration of phosphate. Broadening of the band due to phosphate is overlapping of Si-O-
Si (ʋasym, 1091 cm
-1
) and Si-OH (ʋsym, 1005 cm
-1
) bands of silica. The presence of intense 
band at 3450 and 1644 cm
-1
 suggest the presence of large number of H2O and -OH 
groups on the surface which play the major role not only in high aqueous stability but 
also provides enough scope for further surface modification with GPTS. A broad intense 
peak at 1270 cm
-1
, due to the symmetrical stretching or ring breathing frequency of 
epoxide ring confirms the surface modification of Fe3O4@m-SiO2@YPO4:Tb 
nanoparticles by GTPS. In the spectrum of Fe3O4@m-SiO2@YPO4:Tb@GSH-
cyclodextrin, the intensification of methylene peak at 2935 cm
-1
 (characteristics of β-
cyclodextrin) along with disappearance of ring breathing frequency of epoxide indicates 
that GSH-cyclodextrin has been conjugated by epoxide ring opening. Furthermore, the 
epoxide ring opening takes place by more nucleophilic –SH group in GSH-cyclodextrin 
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as indicated by the disappearance of -S-Hstr (at  2550 cm
-1
) in  Figure 3(d). The most 
characteristic amide bands of folic acid at 1686 and 1510 cm
-1
 have become prominent 
suggesting the successful attachment of folic acid onto the nanoparticle.  
 
Figure 7.4 FTIR spectra of (a) Fe3O4@m-SiO2@YPO4:Tb, (b) Fe3O4@m-
SiO2@YPO4:Tb@GPTS, (c)Fe3O4@m-SiO2@YPO4:Tb@cyclodextrin-GSH, (d) Fe3O4@m-
SiO2@YPO4:Tb@cyclodextrin-GSH@FA-NH2.  
 
X-ray photoelectron spectroscopy   
X-ray photoelectron spectra were further used to establish the successful 
conjugation of GSH-cyclodextrin and FA on luminescent magnetic nanoparticle. In a 
typical survey spectrum of the functionalized nanoparticles (Figure 7.5a), the peaks at 
binding energies 100, 131, 150, 158, 280-290, 402.3, 530-538, 683-692, 705-730 eV are 
ascribed to binding energy in Si2p, P2p, Tb4d, Y3d, C1s, N1s, O1s, F1s and Fe2p regions 
respectively. High resolution scan for C1s shows that the curve is well fitted into five 
peaks centered at 284.1, 284.6, 285.9, 288.1, 289.2 eV corresponding to the C=C, C-C/C-
H, C-N/C=N/C-O, C=O/ NHCO and COOH carbon (Figure 7.5b). The broad peak for 
N1s binding energy can be fitted into three peaks at 397.7, 399.6 and 400.7 eV 
corresponding to C=N, NH2, -NHCO groups (Figure 7.5c). O1s binding energy at 531.4 
eV can be fitted into three peaks corresponding to oxygen being present in three different 
environments. Peaks appearing at 529.2, 531.4 and 533.2 eV correspond to M-O, C-O, 
COOH and -NHCO- respectively (Figure 7.5d). Fe2p3/2 and Fe2p1/2 electrons show 
binding energy at 709.1 and 723.7 eV which is consistent with the Fe2p binding energy 
of magnetite nanoparticles (Figure 7.5e). Binding energy for S2p is at 161.9 eV 
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corresponds to C-S-C group.
48 
Y3d photoelectron line position is at 157.8 and 159.7 eV 
due to Y3d5/2 and Y3d3/2 states respectively (Figure 7.5g). P2p peak with binding 
energy 134 eV is attributed to pentavalent tetra coordinated phosphorus (PO4 tetrahedra) 
(Figure 7.5h).
 49 
Presence of F1s peak at 687.8 eV confirms the loading of 5-FU on the 
cyclodextrin conjugated nanoparticles (Figure 7.5i).
50  
 
Figure 7.5 XPS survey spectrum (a), and High resolution scan corresponding to (b) C1s, 
(c) N1s, (d) O1s, (e) Fe2p, (f) Y3d, Tb4d and S2p, (g) Y3d and S2p, (h) P2p, (i) F1s. 
 
BET surface area 
The N2 adsorption-desorption isotherms of Fe3O4@m-SiO2 and Fe3O4@m-
SiO2@YPO4:Tb nanoparticles have been shown in Figure 7.6a. The average pore 
diameter calculated using the Barrett-Joiner-Halenda (BJH) method was 5.1 nm and 4 nm 
for Fe3O4@m-SiO2 and Fe3O4@m-SiO2@YPO4:Tb nanoparticle respectively which in 
good agreement with mesoporous size (Figure 7.6b). Both the samples show typical type 
IV isotherm with H3 hysterisis, which does not exhibit a limiting uptake over a range of 
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high p/p0. It indicates the formation of aggregates of plate like particles giving rise to slit 
shaped pores. The result reveals that deposition of phosphor layer on the surface of silica 
hasn’t changed the basic pore structure of the Fe3O4@mSiO2 sample. The BET surface 
area of Fe3O4@m-SiO2 and Fe3O4@m-SiO2@YPO4:Tb was found to be 530 and 270 
m
2
/g with respective pore volumes of 0.38 cm
3
/g and 0.26 cm
3
/g. The decrease in surface 
area in Fe3O4@m-SiO2@YPO4:Tb particles is due to uniform deposition of YPO4: Tb 
particles in the porous slit of Fe3O4@m-SiO2. The BET results indicate that 
Fe3O4@mSiO2 nanoparticles are highly porous and have large surface area, which 
enables rapid growth of luminescent material (YPO4:Tb) on the silica matrix and also 
ensures high drug encapsulation capacity of our drug delivery system. 
 
Figure 7.6 (a) Nitrogen adsorption-desorption isotherm and (b) the corresponding pore 
size distribution of (A) Fe3O4 @mSiO2, (B) Fe3O4 @mSiO2@ YPO4:Tb 
 
Photoluminescence properties 
The fluorescence emission spectra of Fe3O4@m-SiO2@YPO4:Tb (Figure 7.7) 
under 340 nm excitation displays four strong and narrow emission bands between 450 
and 650 nm, which are assigned to 4f →4f transitions related to Tb3+ ions. The most 
intense peak at 543 nm corresponds to the 
5
D4 → 
7
F5 transition, while the peaks at 489, 
585, and 622 nm are assigned to the transitions from 
5
D4 →
7
FJ (J=6, 4, 3) respectively, 
which are characteristic emissions of Tb
3+
. The strongest emission at 545 nm is 
responsible for green emission of Tb
3+
. The peaks at 489 nm and 545 nm correspond to 
the electric dipole allowed transition and magnetic dipole allowed transition, respectively. 
These results are similar to the emission peaks of pure YPO4:Tb nanoparticles. Therefore, 
the existence of Fe3O4 may not affect the fluorescence property of the resulted hybrid 
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nanoparticles. In other words, the inner silica shell successfully blocks the energy transfer 
between lanthanide ions and metal ions which reduces the probability of fluorescence 
quenching by magnetic core.
5 
The inset in Figure 7.7 shows the fluorescent image of drug 
loaded particles Fe3O4@mSiO2@YPO4:Tb under excitation of 488 nm. Particularly, no 
significant change in the characteristic emission peaks for 5-FU loaded Fe3O4 
@mSiO2@YPO4:Tb reveals that the system can be easily tracked or monitored in the 
biological system. Furthermore, it is importantly noted that the PL intensity of 5-FU 
loaded Fe3O4@mSiO2@YPO4:Tb is less than that of Fe3O4@mSiO2@YPO4:Tb (Figure 
7.7c). However after releasing of 5-FU there was slight enhancement of PL intensity 
(Figure 7.7b). It is well known that the emission of rare earth ions will be quenched to 
some extent in the environments that have a high phonon frequency. Thus this decrease 
in PL intensity with conjugation of cyclodextrin-5-FU inclusion complex can be related 
to the quenching effect of Tb
3+
 emission caused by organic groups of high vibration 
frequency (1000-3500 cm
-1
).
30,51 
When 5-FU was released the quenching effect is relaxed 
to some extent hence there is slight enhancement in PL intensity. For such correlation 
between PL intensity and drug release, the developed system can be used as a probe for 
monitoring the disease therapy.  
 
Figure 7.7 PL emission spectra of (a) Fe3O4@m-SiO2@YPO4:Tb, (b) Fe3O4@m-
SiO2@YPO4:Tb@cyclodextrin-GSH@FA and (c) Fe3O4@m-SiO2@YPO4:Tb@cyclodextrin-
GSH@FA-5-FU, the inset is the fluorescent image of Fe3O4@m-
SiO2@YPO4:Tb@cyclodextrin-GSH@FA-5-FU at λex 488 nm. 
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Magnetic properties  
The magnetic properties of 5-FU-Fe3O4@m-SiO2@YPO4:Tb particles were 
characterized using a vibrating sample magnetometer (VSM) with the magnetic ﬁeld 
cycle between -20,000 and +20,000 Oe at 300 K. The saturation magnetization (Ms) of 5-
FU-Fe3O4@m-SiO2@YPO4:Tb was 23 emu/g, which is lower than the as prepared Fe3O4 
is 70 e.m.u/g.
42 
This significant reduction in the magnetization value of the hybrid 
material is due to the lower proportion of magnetic Fe3O4 in the nanocomposites and a 
larger amount of non-magnetic conjugates on the surface of the nanoparticles, which also 
suppresses the exchange coupling and dipolar interactions among coated nanoparticles. 
The sample exhibits superparamagnetic behavior with a negligible coercivity or 
remanence (Figure 7.8a), hence demonstrating the suitability of our multifunctional 
nanoprobe as a contrast enhancing agent in MRI.
52
 Moreover, the homogenous dispersion 
of drug carrier shows fast response to the external magnetic ﬁeld with no residual 
magnetism (Figure 7.8b).  The result reveals that the particles exhibit excellent magnetic 
responsivity and re-dispersible properties, which suggests a potential application for 
magnetic targeting and separation.  
 
Figure 7.8 Field dependent magnetization curve (a) and magnetic separation (b) of 5-FU 
loaded Fe3O4@m-SiO2@YPO4:Tb nanoparticles. 
 
In vitro cytotoxicity of the nanocarrier 
The evaluation of cell viability of Fe3O4@mSiO2@YPO4:Tb@cyclodextrin-
GSH@FA nanoparticles through MTT assay is presented in Figure 7.9a. Our nanocarrier 
did not impose any cytotoxicity in both L929 and HeLa cells. The nanoparticles are 
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tolerable up to high dose (200 μg) and long incubation time (72 h), which indicates that 
Fe3O4@mSiO2@YPO4:Tb@cyclodextrin-GSH@FA nanoparticles are biocompatible. 
Loading and release of 5-FU 
 The drug storage and release properties of the designed system as a candidate of 
hydrophobic anticancer drug carriers were tested by selecting 5-FU as a model drug. The 
drug was loaded into the Fe3O4@mSiO2@YPO4:Tb@cyclodextrin-GSH@FA 
nanoparticles through the surface-conjugated cyclodextrin by forming an inclusion 
complex. The adsorption profile of 5-FU shows that maximum inclusion of the drug 
occurred after 70 h. Typically the percentage of 5-FU adsorbed on to the fluorescent 
magnetic carrier with respect to the initial drug solution is 91.6%. Hence the 
encapsulation efficiency of the carrier reached 91.6%. Simultaneously, this corresponds 
to 114. 5 mg drug per g of nanoparticles. The high drug loading loading capacity may 
result from high surface area of mesoporous silica facilitating conjugation of large 
amount of cyclodextrin on its surface.  
 
Figure 7.9 (a) In vitro cell viability of HeLa and L929 cells with the drug carrier 
Fe3O4@mSiO2@ YPO4:Tb@cyclodextrin-GSH@FA, and (b) Cumulative 5-FU releases from 
Fe3O4@m-SiO2@YPO4:Tb@cyclodextrin-GSH@FA-5-FU in PBS at different pH (7-3.2). 
 
The cumulative 5-FU release at pH 7, 6.2, 5.2 and 3.2 has been depicted in Figure 
7.9b. It was observed at pH 3.2, a burst release of 50% was observed after 10 h which 
slowly increased to 96%. This initial burst of 5FU release could be partly attributed to the 
weak bonds or the adsorption of drugs on the surface of nanoparticles.   When the pH is 
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slightly increased to 5.2, the release rate of 5-FU is decreased to 45% at 10 h. 
Furthermore, only 15% of 5-FU was observed after 10 h with increase in pH to 7. The 
overall release rates were higher in lower pH and less release was observed in 
physiological pH. This pH dependent release behavior may be ascribed to the stability of 
5-FU/cyclodextrin inclusion complex.
53 
At acidic pH the stability of 5-FU/cyclodextrin 
guest/host inclusion complex is less hence fast release of 5-FU occurs. Particularly, at 
tumor site the pH is less than that of normal tissues; hence the pH-sensitive drug release 
will be triggered when the drug loaded carrier will be concentrated at the tumor site using 
an external magnetic field.  In addition to this our system shows a sustained release 
pattern over a prolonged time. Hence it can be used for controlled release of 5-FU. 
 
7.5. Conclusion 
 In this chapter, mesoporous fluorescent magnetic Fe3O4@m-SiO2@YPO4:Tb 
particles with a size of 52 nm have been prepared. 
 The mesoporous silica makes the hydrophobic iron oxide water soluble and 
reduces the probability of fluorescence quenching. 
 The synthesised nanocomposite possesses high surface area, bright luminescence 
and appreciably high saturation magnetization at room temperature. 
 These hybrid nanospheres were functionalized with β-cyclodextrin and folic acid 
using glutathione as a robust coupling agent. 
 These β-cyclodextrin functionalized particles shows high loading capacity and pH 
sensitive sustained release behavior for anticancer drug 5-fluorouracil. 
 The overall size of the drug conjugate is 71 nm and the particles are highly stable 
in aqueous medium without any detoriation of HD size. 
 The good biocompatibility, high surface area, and intrinsic property of the 
nanocomposite suggest that this new nanomaterial can act as a potentially useful 
intracellular nanovehicle for magnetically guided cancer targeted delivery of 5-
FU. 
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Chapter 8 
Luminescent carbon dot decorated magnetic hollow mesoporous silica 
nanotheranostics: A novel multifunctional platform for simultaneous 
camptothecin delivery and multimodal imaging 
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8.1. Introduction 
Hollow structured  nanospheres   with controlled pore volume and shell thickness have 
gained considerable interest due to stable mesoporous structure, low density, large 
surface area, tunable pore size, easily modified surface and high guest-loading capacity, 
which would be beneficial for applications including diagnostics, drug delivery, tissue 
engineering, biosensors and bioseparation systems.
1-4 
Furthermore the hollow cavity 
allows the incorporation of other species for designing of diverse multifunctional 
materials. In past few years extensive effort has been devoted to the design of 
multifunctional materials incorporating magnetic and luminescent functionalities into 
single mesoporous silica host for a wide range of biological applications. While magnetic 
nanoparticles can be used as contrast agents in magnetic resonance imaging (MRI) and 
facilitate magnetic responsive separation, detection, targeting, and hyperthermia, 
luminescent nanoparticle enable optical bioimaging and photothermal therapy.
5-8
  
Luminescent carbon dots (CD) a new class of carbon-based nanomaterials have 
attracted much attention because their excellent luminescence properties, including large 
two-photon excitation cross-sections, lack of blinking, high water solubility, low 
cytotoxicity, and excellent biocompatibility.
9-11 
These superior properties make these 
materials promising alternatives to common toxic metal-based quantum dots for 
numerous exciting applications such as biosensing,
12 
biological labelling,
13
 photo-
catalysis
14 
and optical-electronic devices.
15 
The exploration of CD towards the theranostic 
application where its fluorescent property can hand out the real time monitoring of the 
drug release efficacy is at very early stage. Chou et al. reported a facile method for the 
gram scale production of CD/mSiO2-PEG which was used in controlled release of 
doxorubicin in HeLa cells.
16 
Subsequently CD was explored for pH-sensitive
17,18
 and 
photosensitive
19 
release of doxorubicin coupled with efficient monitoring through 
bioimaging. Recently CD functionalized gold nanorod is utilized for multifunctional 
application such as drug delivery, photothermal therapy and biological imaging.
20 
The 
integration of luminescent properties of CDs to magnetic properties can further offers a 
new potential, where the former serves as a fluorescent probe for visualising biological 
process in vitro and in vivo, later for magnetic tracking and drug delivery. However very 
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few reports are availables on fabrication of CD based magnetic luminescent 
nanocomposits.
21-23
 Gajbhiye et al. synthesized a magnetic nanoparticle doped 
carbogenic nanocomposite for magnetic resonance and fluorescence multimodal imaging 
and demonstrated its efficiency both in vitro and in vivo fluorescence as well as magnetic 
resonance imaging.
24 
Most recently hybrid luminescent magnetic CD nanoparticle was 
demonstrated for dual-modal imaging, near-infrared light-responsive drug carrier and 
photothermal therapy.
25
  
Camptothecin (CPT), isolated from camptotheca acuminate is a plant alkoliod 
exhibits significant antitumor activity on a broad spectrum of tumors. CPT can 
effectively inhibit the relaxation process of DNA related to replication and transcription 
by the stable combination with topoisomerase I and DNA.
26 
However the severe systemic 
toxicities, extreme aqueous insolubility, low stability of the lactone form at physiological 
pH limit its clinical application.
27,28 
As a consequence, a variety of nanomedicines 
including polymer drug conjugates,
29,30
 micelles,
31 
nanoparticles (NPs),
32,33  
and vesicles
34
 
were developed for CPT delivery to decrease potent toxicities and improve its properties. 
However most of these carriers cannot congregate formulation requirements like 
controlled size with low dispersity, high loading efficiency, controlled drug release 
kinetics, sufficient aqueous stability, capability of staying nonaggregated in biological 
media and easy production from gram to kilogram scale, which are very much decisive 
for their clinical translation.
35 
One important strategy to improve CPT delivery is specific 
targeting and appropriate conjugation of the drug through flexible surface chemistry. A 
galactose-appended camptothecin prodrug was developed to target the hepatoma cell line 
where the drug release (by disulﬁde-bond cleavage via reaction with glutathione) was 
visualized through ﬂuorescence imaging. However it failed to show significant anticancer 
activity due to lysosomal hydrolysis of CPT lactone ring.
36 
A novel luminescent magnetic 
CdTe/ iron oxide nanoparticles with folate-conjugated tetrapeptide composites has 
developed by Zhang et al. for tumor-targeted CPT delivery.
37 
Although the developed 
novel multifunctional nanoparticles possess reasonably good biocompatibility and growth 
inhibition properties, the possibility for long term slow release of Cd leading to 
cytotoxicity
38 
and the low drug loading efficiency owing to the lack of robust drug 
conjugation chemistry limit their practical medical application. Therefore, stable 
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biocompatible fluorescent magnetic carrier with better drug loading capability as well as 
active targeting of camptothecin are highly desired for improving cancer therapeutic 
eﬀect.  
In this chapter, hollow mesoporous silica based luminescent magnetic hybrid 
nanoparticles by incorporating iron oxide nanoparticles as magnetic and carbon dot as the 
luminescent component have been developed. The nanomaterial is characterized by a 
series of physical characterization technique such as XRD, magnetic measurements, 
Raman, and TEM. In order to conjugate drug molecule, water soluble CPT conjugate has 
been synthesized and coupled to the nanohybrid surface through robust chemistry using 
silane coupling agent. Furthermore, folic acid has also been conjugated to ensure the 
targeted specific delivery of the drug. The conjugation of the drug has been established 
through FTIR and XPS studies. The DLS and zeta potential studies over time ensure 
excellent stability of the nanoparticles in physiological medium. The in vitro cytotoxicity 
of the drug carrier as well as intracellular uptake and cell apoptosis were evaluated in 
HeLa cells through fluorescence microscopy. The possible application of the developed 
multifunctional particles was also evaluated through MR imaging.  
 
8.2. Experimental 
Chemicals 
  Benzyl ether, Cetyltrimethylammonium bromide (CTAB), camptothecin(CPT), 
Fe(acac)3, 3-glycidoxypropyl trimethoxy silane (GTPS), oleic acid, oleylamine, tetraethyl 
orthosilicate (TEOS), diglycolic anhydride, diisopropylcarbodimide and 2,2’-
(ethylenedioxy)-bis-(ethylamine) (EDBE) were purchased from Sigma Aldrich, USA. 
Acetone, chloroform, diethyl ether, dichloromethane, ethanol, ethyl acetate, and triethyl 
amine were procured from Rankem, India. Dimethylaminopyridine (DMAP) and 
t
butanol 
were bought from Spectrochem Private Limited. Commercially available 
dichloromethane and toluene were purified by distillation over phosphorous pentoxide 
and sodium metal with benzophenol respectively. Prior to use, dimethylsulfoxide 
(DMSO) was vacuum distilled.  
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Synthesis of γ-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl} conjugated camptothecin (EDBE-
CPT)  
Synthesis of mono-t-butylester of diglycolic acid (1): A solution of diglycolic anhydride 
(1 g, 9 mmol) and DMAP (1.05 g, 9 mmol) in dry t-butanol (8 mL) was stirred at reﬂux 
temperature for 18 h.
40
 The solvent was removed under reduced pressure and the residue 
was dissolved in water. The aqueous solution was acidiﬁed to pH 2.5-3.0 with 1 N HCl 
and extracted with diethyl ether, dried over anhydrous Na2SO4 and concentrated under 
reduced pressure to give 1 (1.3 g, yield 79%). 
 IR (KBr): 3468, 2986, 2922, 2846, 1739, 1636, 1398, 1370, 1303, 1246, 1140, 1054 cm
-
1
. 
1
HNMR (400 MHz, CDCl3): δ 8.74 (s, br, 1H), 4.26 (s, 2H), 4.13 (s, 2H), 1.49 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ 173.1, 169.9, 83.0, 69.3, 68.9, 28.0. MS (ESI): m/z 
(relative intensity) 213.1 ([M+Na], 100). 
Synthesis of camptothecin-20-monoester of mono-t-butylester of diglycolic acid (2): A 
mixture  of  1  (42 mg,  0.2 mmol),  camptothecin  (40 mg, 0.1 mmol),  DMAP  (27 mg,  
0.2 mmol),  and  DIPC  (0.03ml, 0.2 mmol) in anhydrous dichloromethane (6 mL) was 
stirred for 24 h at room temperature.
40 
The reaction mixture was washed with water,  then  
saturated sodium bicarbonate, 0.1 N HCl and again with water. The organic layer was 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure, 
recrystallization of the resultant solid from dichloromethane/ether gave 2 (53 mg, yield 
66 %).  
IR (KBr): 3395, 2923, 2846, 1742, 1717, 1653, 1619, 1558, 1502, 1460, 1432, 1418, 
1399, 1368, 1275, 1253, 1194, 1139, 1057 cm
-1
.
1
HNMR (400 MHz, DMSO-d6): δ 8.70 
(s, br, 1H), 8.18-8.12 (m, 2H), 7.87(t, 1H), 7.72 (t, 1H), 7.13 (s, 1H), 5.52 (s, 2H), 5.31 (s, 
1H), 4.60-4.55 (d, 2H), 4.43-4.39 (d, 2H), 2.17-2.13 (m, 2H), 1.40 (s, 9H), 0.94 (t, 
3H).
13
CNMR (100 MHz, DMSO-d6): δ 169.3, 168.9, 167.5, 157.2, 152.8, 148.3, 146.5, 
145.6, 130.8, 129.3, 130.2, 129.0, 128.4, 128.2, 119.2, 95.3, 81.5, 76.8, 68.2, 67.4, 66.7, 
50.7, 30.6, 28.1, 7.9. MS (ESI): m/z (relative intensity) 551 ([M+CH3OH], 100). 
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Synthesis of camptothecin-20-monoester of diglycolic acid (3): A solution of compound 
2 (80 mg, 0.15 mmol) in dichloromethane (4 mL) and TFA (0.4 mL) was stirred at room 
temperature for 30 min. The solvent was removed under reduced pressure, and the 
resulting solid was recrystallized from dichloromethane/ether to yield 3 (51 mg, 81%).  
IR (KBr): 3337, 2970, 2913, 1740, 1678, 1650, 1618, 1575, 1522, 1457, 1432, 1395, 
1360, 1323, 1256, 1197, 1170, 1138, 1060 cm
-1
. 
1
HNMR (400 MHz, DMSO-d6): δ 13.4 
(s, 1H), 8.70 (s, 1H), 8.23-8.12 (m, 2H), 7.87(t, 1H), 7.72 (t, 1H), 7.14 (s, 1H), 5.52 (s, 
2H), 5.30 (s, 1H), 4.62-4.58 (d, 2H), 4.44-4.40 (d, 2H), 2.17-2.14 (m, 2H), 0.99 (t, 3H). 
13
CNMR (100 MHz, DMSO-d6): δ 171.3, 169.4, 167.5, 157.0, 152.8, 148.3, 146.5, 145.6, 
130.3, 130.8, 129.4, 129.0, 128.4, 128.2, 119.2, 95.4, 76.8, 67.7, 67.5, 66.7, 50.7, 30.6, 
7.9. MS (ESI): m/z (relative intensity) 487 ([M+Na], 71) 
Synthesis of γ-N-{2-[2-(2-aminoethoxy)ethoxy] ethyl} conjugated camptothecin-20-
monoester of diglycolic acid (CPT-EDBE) (5): Tert-butyl N-{2-[2-(2-
aminoethoxy)ethoxy]ethyl}-carbamate was prepared by following the method as reported 
by Mohapatra et al..
39
A mixture of the carbamate (74 mg, 0.3 mmol), 3 (82 mg, 0.2 
mmol), DMAP (54 mg, 0.4 mmol), and DIPC (0.06 mL, 0.4 mmol) in anhydrous 
dichloromethane (10 mL) was stirred for 24 h at room temperature. The reaction mixture 
was washed with water, then saturated sodium bicarbonate, 0.1 N HCl and again with 
water.  The organic layer was dried over anhydrous Na2SO4 and the solvent was removed 
under reduced pressure, recrystallization of the resultant solid from 
dichloromethane/ether gave 4 (65 mg, 51%).  
IR (KBr): 3423, 3335, 3266, 3115, 2974, 2908, 1748, 1647, 1600, 1575, 1440, 1399, 
1368, 1343, 1323, 1253, 1197, 1156, 1113, 1068, 1001 cm
-1
. 
1
HNMR (400 MHz, DMSO-
d6): δ 8.69 (s, 1H), 8.18-8.11 (m, 2H), 7.85(t, 1H), 7.71 (t, 1H), 7.35 (s, 1H), 6.77 (br s, 
1H), 6.12 (br s, 1H), 5.43 (s, 2H), 5.28 (s, 1H), 4.6-4.57 (d, 2H), 4.44-4.39 (d, 2H), 3.49-
3.44 (m, 8H), 3.49-3.43 (m, 2H), 3.06-3.04 (m, 2H), 1.90-1.85 (m, 2H), 1.33 (s, 9H), 0.99 
(t, 3H). 
13
CNMR (100 MHz, DMSO-d6): δ 172.9, 157.3, 156.0, 154.4, 153.0, 150.5, 
149.7, 148.4, 145.9, 130.9, 130.3, 129.5, 128.9, 128.4, 128.1, 119.5, 97.2, 78.1, 72.8, 
70.6, 70.0, 69.9, 69.6,  68.2, 65.7, 66.7, 50.7, 39.0, 30.7, 28.7, 8.2. MS (ESI): m/z 
(relative intensity) 717 ([M+Na], 100) 
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A solution of compound 4 (96 mg, 0.15 mmol) in dichloromethane (5 mL) and 
TFA (0.5 mL) was stirred at room temperature for 30 min. The solvent was removed 
under reduced pressure, and the resulting solid was recrystallized from 
dichloromethane/ether to yield 5 (63 mg, 78%). 
IR (KBr): 3426, 3273, 3109, 2963, 2913, 2851, 1743, 1675, 1650, 1597, 1580, 1502, 
1482, 1435, 1399, 1345, 1317, 1273, 1259, 1197, 1156, 1133, 1068, 1032, 1001 cm
-1
. 
1
HNMR (400 MHz, DMSO-d6): δ 8.69 (s, 1H), 8.18-8.11 (m, 2H), 7.85(t, 1H), 7.71 (t, 
1H), 7.35 (s, 1H), 6.77 (br s, 1H), 6.12 (br s, 1H), 5.43 (s, 2H), 5.28 (s, 1H), 4.61-4.57 (d, 
2H), 4.44-4.39 (d, 2H), 4.3-4.0 (br S), 3.59-3.54 (m, 2H), 3.4-3.35 (m. 2H), 1.89-1.85 (m. 
2H), 0.9-0.86 (t, 3H). 
13
CNMR (100 MHz, DMSO-d6): δ 172.9, 159.0, 158.62, 157.31, 
152.98, 150.47, 148.37, 145.94, 130.86, 130.26, 129.46, 128.95, 128.41, 128.12, 119.51, 
97.22, 72.84, 69.83, 67.08, 65.71, 65.36, 50.68, 41.16, 30.75, 23.69, 8.20. MS (ESI): m/z 
(relative intensity) 595 ([M+1], 100). 
Synthesis of CD decorated magnetic mesoporous hollow silica nanosphere 
Synthesis of monodisperse hydrophobic Fe3O4 nanoparticle: The magnetic particles 
were prepared by modified Sun et al. procedure using a solvothermal technique.
41
 Briefly 
Fe3O4 nanoparticles were synthesized through mixing of Fe(acac)3 (706 mg, 2 mmol), 
1,2-dodecanediol (2.023 g, 10 mmol) and benzyl ether (20 mL). Oleic acid (1.9 mL, 6 
mmol) and oleylamine (1.97 mL, 6 mmol) were sequentially added to it and transferred to 
a teflon-lined stainless-steel autoclave, followed by heating to 180 °C for 8 h (1 °C/min). 
Then as-synthesized mixture was allowed to cool to room temperature and Fe3O4 
nanoparticles were precipitated by adding ethanol. The precipitate was collected by   
centrifugation at a speed of 10000 rpm for 10 minutes. 
Synthesis of mesoporous silica coated Fe3O4 nanoparticle (Fe3O4@m-SiO2): Fe3O4 
nanoparticles were coated with mesoporous silica using CTAB as a template.
42 
In a 
typical procedure, 30 mg of oleic acid stabilized monodisperse magnetite nanoparticles 
dispersed in 2 mL of chloroform was added to a 20 mL of aqueous solution containing 
0.4 g of CTAB and the resulting solution was stirred vigorously for 30 min. The 
formation of an oil-in-water microemulsion resulted in a turbid brown solution.  Heating 
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the brown solution at 60 °C for 20 min induced evaporation of the chloroform, this 
generated aqueous dispersion of nanoparticles. Then 5 mL of the resulting mixture 
solution was diluted with 100 mL of water, and the mixture was heated up to 70 °C. Then 
3 mL of 2M NaOH solution, TEOS (3 mL) and ethyl acetate (10 mL, 0.1 M) were 
successively added to the diluted aqueous solution containing the magnetite 
nanoparticles. The resulting mixture was stirred for 3 h at 70 °C and the precipitate was 
magnetically separated. The surfactant was removed by extraction with acidic ethanol 
solution. 
Deposition of Luminescent Carbon dot on Fe3O4@m-SiO2: Deposition of luminescent 
carbon dot (CD) on the surface of mesoporous silica coated magnetic particle (Fe3O4@m-
SiO2) was achieved by hydrothermal carbonization of orange juice in the template free 
channels of the mesoporous silica. In a typical procedure, dispersed Fe3O4@m-SiO2 
nanoparticles (200 mg in 10 mL ethanol) were mixed with 25 mL of orange juice 
(absolutely pulp free) in 20 mL ethanol and then the mixture was transferred into an 80 
mL teflon-lined stainless-steel autoclave and was heated at constant temperature of 130 
°C for 150 min (1 °C/min). After the reaction, the autoclave was cooled down naturally. 
The resulted luminescent magnetic nanocomposite (Fe3O4@m-SiO2-CD) was 
magnetically separated and first washed thoroughly with dichloromethane followed by 
water to remove the water soluble adsorbed luminescent CDs.  
Synthesis of folate and camptothecin conjugated CD decorated magnetic mesoporous 
silica 
In order to conjugate folic acid and CPT, the hybrid Fe3O4@m-SiO2 nanoparticles 
were initially functionalized with epoxide. A mixture of 0.2 mL (0.88 mmol) 3-
glycidoxypropyltrimethoxysilane and Fe3O4@m-SiO2-CD particles (300 mg) in dry 
toluene (30 mL) was stirred and heated at reﬂux under dry nitrogen gas with 
triethylamine as a catalyst for 24 h. The functionalized particles were magnetically 
separated, washed extensively with acetone, and dried. Prior to synthesis of folate 
decorated Fe3O4@m-SiO2-CD, amine functionalized folic acid is prepared following the 
report developed by Mohapatra et al..
39
 For conjugation, amine functionalized folic acid 
(FA-NH2) (11 mg, 0.02 mmol) dissolved in DMSO was stirred overnight at 70 °C with 
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dispersed epoxide ended Fe3O4-mSiO2-CD (100 mg) in presence of ZnCl2 catalyst. 
Finally folate decorated luminescent particles were magnetically separated and washed 
with water (Fe3O4@m-SiO2-CD-FA). For conjugation of CPT, in a 50 mL two necked 
round bottom flask, EDBE-glycolic acid-CPT (5) (54 mg, 0.1 mmol) and catalytic 
amount of ZnCl2 were taken in 5 mL dry DMSO. To this solution 100 mg Fe3O4@m-
SiO2-CD-FA nanoparticle in 10 mL DMSO was added and allowed to stir at 70 °C for 20 
h in nitrogen atmosphere. Then the particles were recovered using magnetic separator, 
washed thoroughly with millipore water and suspended in phosphate buffer (pH 7.4) and 
used for in vitro studies (Fe3O4@m-SiO2-CD-FA-CPT). 
In vitro camptothecin (CPT) release 
The in vitro delivery of CPT was performed by suspending a suspension of 
Fe3O4@m-SiO2-CD-FA-CPT particles (5 mL, 1 mg/mL) in a solution containing 0.1 
mg/mL
 
cathepsin B and 10 mL of FBS. The solution pH was adjusted to 4, 5, 6 and 7.4 
using 0.1 M HCl and NaOH, and then the solution was shaken (100 rpm) at 37 °C. At 
speciﬁed time intervals, accumulated amount of drug released into the solution was 
quantified using a UV-vis spectrophotometer, λmax (CPT) = 340 nm. The release proﬁles 
were plotted as the relative release percentages of CPT against time. The drug loading 
capacity and encapsulation efficiency were determined as 17.5% and 87.5% respectively 
by following the method described in chapter-7. 
Cytotoxicity  
  Human cervical carcinoma (HeLa) cells were obtained from the National Centre 
for Cell Sciences (Pune, India), cultivated in minimal essential medium (MEM) and 
Dulbecco’s modified eagle medium (DMEM) respectively supplemented with 10% fetal 
calf serum, 100 units/mL penicillin, and 100 μg/mL streptomycin, 4mM L-glutamine 
under 5% CO2 and 95% humidified atmosphere at 37 °C. From 105 cells/mL cell- 
suspension, 180 μL cell-suspension was seeded in each well of 96 wells tissue culture 
plates and incubated for 18 h followed by addition of Fe3O4@m-SiO2-CD, Fe3O4@m-
SiO2-CD-CPT and Fe3O4@m-SiO2-CD-FA-CPT nanoparticle, at concentrations 10 
μgmL-1 to 50 μgmL-1. The cells were incubated for 72 h at 37 °C in a humidified 
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incubator (HERA cell) maintained with 5% CO2. The cell proliferation was estimated by 
MTT assay as described in chapter-7. 
Intracellular uptake 
  For investigation on cell uptake of Fe3O4@m-SiO2-CD-FA-CPT nanoparticle, the 
HeLa cells were treated with 5 µg mL
-1
 of nanoparticle for 0, 30, 60, 90 and 120 min. 
The cells were washed several times with PBS and subsequently treated for 5 min using 
DAPI (1 mgml
-1
) at 37 °C to stain the nuclei. The cells were washed with PBS to remove 
extra dye molecules and then ﬁxed with 4% paraformaldehyde for 15 min. Then cells 
were washed with PBS and examined under fluorescence microscopy.  
 DAPI staining for nuclear morphology 
To study the nuclear morphology of the HeLa cells, DAPI staining was performed 
following the reported procedure. HeLa cells treated with PBS, 1, 5, 10 μg/mL of drug 
conjugated particles for 24 h. The cells were fixed with 3.7% formaldehyde for 15 min, 
permeabilized with 0.1% Triton X-100 and stained with 1 mg/mL DAPI for 5 min. The 
cells were then washed with PBS and examined under fluorescence microscopy. 
Quantum Yield Calculations 
 
The quantum yield (Φ) of the Fe3O4@m-SiO2-CD was calculated using quinine 
sulfate as reference.
43
 For calculation of quantum yield, five concentrations of each 
compound were made, all of which had absorbance less than 0.1 nm at 340 nm. Quinine 
sulfate (literature Φ = 0.54) was dissolved in 0.1 M H2SO4 (refractive index (η) of 1.33) 
while the nanoparticle was taken in water (η = 1.33). Their fluorescence spectra were 
recorded at same excitation of 340 nm. Then by comparing the integrated 
photoluminescence intensities (excited at 340 nm) and the absorbance values (at 340 nm) 
of the sample with the references quinine sulfate quantum yield was determined.   The 
data was plotted (Figure 8.1) and the slopes of the sample and the standards were 
determined.  The data showed good linearity with intercepts of approximately zero.  
The quantum yield was calculated using the below equation    
Φx = ΦST  (mx / mST) (η
2
x /η
2
ST )   
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Where Φ is the quantum yield, m is slope, η is the refractive index of the solvent, ST is 
the standard and X is the sample. The quantum yield for Fe3O4@m-SiO2-CD is found to 
be 12.4%. 
 
Figure 8.1Fluorescence and Absorbance of the Fe3O4@m-SiO2-CD and Quinine Sulfate 
MR Imaging  
  The relaxation time (T2) and transverse relaxivity (r2) of the nanoparticle were 
measured with varying iron concentration (0.015-0.075 mM) using a clinical MRI 
scanner (MAGNETOM Symphony, SIEMENS) at a magnetic field of 1.5 T. T2-weighted 
images were obtained with a spin echo multisection pulse sequence having fixed 
repetition time (TR) of 4000 ms with various echo times (TE) ranging from 105 to 291 
(105, 116, 128, 139, 151, 163, 174, 186, 198, 291). The spatial resolution parameters 
were as follows: field of view (FOV) = 300×300 mm
2
, matrix = 358×358, slice thickness 
= 4.0 mm. The MRI signal intensity (SI) was measured using in-built software. T2 values 
were obtained by plotting the SI of each sample over a range of TE values. T2 relaxation 
times were then calculated by fitting a first-order exponential decay curve to the plot. The 
fitting equation can be expressed as: 
 𝑆𝐼 = 𝑆0𝑒
−𝑇𝐸
𝑇2
⁄ + 𝐵 
Where SI is the signal intensity, TE is the echo time, S0 is the amplitude, and B is the 
offset. The relaxivity value r2 is determined  from  the  slope  of  the  linear  plots  of  
relaxation  rate  R2  (1/T2 , s
−1
) against Fe concentrations (mM). 
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𝑅2 =  𝑅2
0 + 𝑟2 [𝐹𝑒] 
Calculation of number of Camptothecin, Folic acid and Fe3O4 per hollow sphere 
From TGA analysis the weight loss for surface organic modification is 4%  
Weight loss of 1 g sample is 0.04 g  
During the synthesis, the ratio of camptothecin (CPT) and folic acid (FA) conjugates has 
been maintained as 5:1 
 So, total organic content in 1g of drug and folic acid conjugated hybrid nanoparticle is 
5 × 𝑚𝑜𝑙 𝑤𝑡 𝑜𝑓 𝑐𝑎𝑚𝑝𝑡𝑜𝑡ℎ𝑒𝑐𝑖𝑛 𝑐𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑒 × 𝑥 + 1 × 𝑚𝑜𝑙 𝑤𝑡 𝑜𝑓 𝑓𝑜𝑙𝑖𝑐 𝑎𝑐𝑖𝑑 𝑐𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑒  
Using the above equation, we calculated that, 1 g sample contains 4.5 × 10−5 mole of 
CPT and 9.25 × 10−6 mole of FA 
BET surface area of the Fe3O4@m-SiO2-CD hollow sphere is found to be 135 m
2
/g 
From TEM, the surface area of single hollow sphere is calculated as 9.36 × 10−16 m2 
Total number of hollow sphere present in 1 g sample is 
135
9.36×10−16
=  1.4 × 1017  
Thus 9.36 × 10−16 hollow spheres are conjugated with 4.5 × 10−5 and 9.25 × 10−6 
mole of CPT and FA respectively.  
Each hollow sphere is conjugated with 199 (3.3 × 10−22mole) and 40 (6.6 × 10−23mole) 
numbers of CPT and FA respectively. 
From TEM, volume of single Fe3O4 nanoparticle is calculated to 4.188 × 10−19 m
3 
Mass of single Fe3O4 nanoparticle = volume×density = 2.165 × 10−15 mg (density of 
the magnetite nanoparticle is 5.17 g/cm
3
)  
From AAS analysis 1 g CPT and FA conjugated nanoparticle contains 348 mg iron  
Then number of Fe3O4 nanoparticle present in 1 g composite is  
348
2.165×10−15
=  16 × 1016 
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Thus number of Fe3O4 nanoparticle per each hollow sphere is found to be 
16×1016
1.4×1017
= 1.14 
≈ 1 
 
8.3. Characterization 
 The synthesized materials were characterized by modern spectroscopic technique 
as described in characterization section of chapter-7. In addition, low angle powder X-ray 
diffraction (XRD) analysis was carried out with a Philips PW3040/00 diffractometer 
(operating at 40 kV and 30 mA), using a Cu Kα radiation. The Raman spectrum of as-
prepared samples was recorded at ambient temperature on Renishaw in Via Raman 
microscope (UK make).  
 
8.4. Results and Discussion 
Synthesis 
Scheme-8.1 illustrates the synthetic strategy of the CPT conjugated fluorescent 
magnetic hollow nanosphere. The mesoporous silica coated Fe3O4 nanoparticles were 
synthesized through sol-gel method using CTAB as surfactant where it acts as a 
stabilizing surfactant for the transfer of hydrophobic Fe3O4 nanocrystals to the aqueous 
phase as well as the organic template for the formation of the mesoporous silica spheres. 
The mesoporous silica coated magnetite nanoparticles were luminescent functionalized 
by the deposition of CD through hydrothermal treatment of orange juice. It was well 
established in our previous work that the major constituents orange juice such as sucrose, 
ascorbic acid and citric acid can act as efficient precursor for carbon dots.
43
 The hydrogen 
bonding interaction between the surface silanol groups and constituents of orange juice 
facilitates the adsorption of precursors in the mesoporous channels which are converted 
to carbon dot upon hydrothermal treatment. Thus growth of carbon nanoparticles takes 
place within the porous frame work of mesoporous silica rather than outside. In order to 
conjugate CPT and target molecule folic acid, the Fe3O4@m-SiO2-CD hybrid particles 
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were functionalized with 3-glycidoxy-propyltrimethoxysilane to form epoxy ended 
Fe3O4@m-SiO2-CD nanoparticles. 
 
Scheme 8.1 Synthesis of fluorescent magnetic nanoparticles conjugated with CPT and 
folic acid. 
Prior to CPT conjugation on Fe3O4@m-SiO2-CD nanosphere, water soluble CPT 
conjugate was synthesized (scheme-8.2). It has been reported that the solubility, tumor 
accumulation and circulatory retention of potent hydrophobic anticancer drug 
camptothecin dramatically increases by conjugating it with polyethylene glycol (PEG) 
dicarboxylic acid with the hindered tertiary alcohol at position 20 of ring E through a 
scissile ester bond.
44
 We deemed to synthesize the water soluble form of CPT by 
coupling a small highly hydrophilic spacer (2,2’-(ethylenedioxy)-bis-(ethylamine) 
(EDBE) through a linker diglycolic acid (scheme 2).  For this purpose diglycolic 
anhydride was first opened with tertiary butyl alcohol to give the protected ester acid 1, 
followed by condensation with camptothecin in presence of DIPC and subsequent ester 
cleavage to give slightly water soluble derivative 3. To this tert-butyl N-{2-[2-(2-
aminoethoxy)ethoxy]ethyl}-carbamate (EDBE-Boc) has been coupled using 
carbodiimide to give 4 which after deprotection of Boc gives water soluble CPT 
derivative 5. 
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Scheme 8.2 Synthesis of camptothecin conjugated with EDBE. 
 In ordered to impart target specific delivery of the multifunctional particle 
(Fe3O4@m-SiO2-CD), the particles were coupled with FA-NH2 through epoxide ring 
opening in presence of catalytic amount of ZnCl2. In a similar fashion, the water soluble 
CPT conjugate 5 has also been coupled (Scheme-8.1).  
This synthetic strategy would have several advantages like  
 It will overcome the difficulties of functionalization with high molecular 
weight (> 1000Da) PEG
44
  
 It can ensure a particle of controllable size which is not possible with high 
molecular weight polymers,  
 The drug cannot be escaped during the circulation before reaching the target 
site as it is strongly bound through covalent bond, 
 It will release CPT in its active lactone form through a predictable hydrolysis 
of ester bond with in the tumor cell.  
Investigation of phase by XRD and Raman spectroscopy 
The formation of nanocomposite and possible phase change during hydrothermal 
carbonization of orange juice was examined by XRD. In the wide angle X-ray diffraction 
pattern of the Fe3O4@m-SiO2-CD (Figure 8.2a), the diffraction peaks could be indexed to 
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crystalline cubic spinel structure of Fe3O4. Apart from characteristic peaks of Fe3O4, the 
broad band at 18-22° can be assigned to amorphous silica shell (JCPDS No. 29-0085) and 
CD. In the low-angle XRD patterns (Figure 8.2b), two well-resolved diffraction peaks 
between 0.5 to 4.0° representing long range ordering of the mesoporous structure are 
observed. The peaks can be indexed to (100) and (110) reflections. These peaks have d-
spacing ratios 1:√3 associated with ordered 2D hexagonal mesostructure (p6mm). The 
higher intensity of (110) reflection peak and the broadening of the peak in the composite 
compared to reported mesoporous silica may be attributed to the non-uniform distribution 
of matter in the unit cell and less structural ordering respectively due to carbonization 
under hydrothermal condition.  
 
Figure 8.2 (a) Wide angle X-ray diffraction and (b) Low angle XRD pattern of Fe3O4@m-
SiO2-CD, (c) Raman spectra of Fe3O4@m-SiO2 and Fe3O4@m-SiO2-CD. 
In the wide angle XRD, the broad peak for carbon dot at 2θ=20-24° overlaps with 
amorphous mesoporous silica range, presence of CD cannot be distinguished from XRD 
pattern. However, appearance of two characteristic vibrations at 1363 and 1578 cm
-1
 for a 
defect band (D band) and a graphite band (G band) in the Raman spectrum (Figure 8.2c) 
confirms the deposition of CD on the silica coated magnetite. The G band is attributed to 
the vibration of sp
2
-bonded carbon atoms in a 2D hexagonal lattice, while the D band is 
associated with vibrations of carbon atoms with dangling bonds in plane terminations of 
the disordered graphite. The ID/IG ratio was found to be 1.6, which is almost higher than 
that reported for bare CD. The relative high D-band intensity may be due to small particle 
size and the presence of abundant oxygen containing groups on the surface.
43
 
Furthermore, the distinct peaks at 684, 530 and 320 cm
-1
 correspond to magnetite core of 
the Fe3O4@m-SiO2-CD nanoparticles.  
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Microstructure 
The shape and size of the as-prepared Fe3O4@m-SiO2-CD particles were 
characterized by TEM analysis. As shown in Figure 8.3a, typical TEM reveals the 
formation of clear and spherical hollow silica spheres with a size range of 100-150 nm 
which is appropriate for drug and gene delivery.
45,46
 Each silica sphere contains one or 
more magnetite nanocrystals embedded within its structure. The hollow structure arises 
because of trapping of ethyl acetate within the hydrophobic part of the mesophase during 
the sol-gel reaction
42
 and remains structurally stable during the hydrothermal treatment. 
The porous nature of the silica is clear in the image at higher magnification (Figure 8.3a 
inset). The high resolution TEM image shows dark spotted ruffled surface which clearly 
reveals that CDs were successfully grown and embedded in the mesoporous channels of 
the hollow silica sphere (Figure 8.3b).  
 
Figure 8.3 (a) TEM images of Fe3O4@m-SiO2-CD, inset TEM image at higher 
magnification (b) TEM image at higher magnification representing deposition of CDs in 
the mesopores. 
Hydrodynamic size and stability 
The hydrodynamic (HD) size of the nanoparticles after each step of the synthesis 
indicates the presence of stable non-aggregated particles which facilitates complete 
modification of the surface. In addition to this, HD size slightly increases after each 
modification indicating addition of one molecular layer after each step (Figure 8.4a). The 
CPT drug conjugated particle showed a mean HD size of 122 nm, which is not 
significantly affected with change of pH (3-9) (Figure 8.4b). These functional 
nanoparticles were highly stable in aqueous medium as their HD size remains almost 
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constant over a long time (Figure 8.4c). The zeta potential measurement of CPT-modified 
particles shows positive zeta potential of +12.5 mV owing to the presence of surface -
NH2 group from folic acid. With decrease in pH up to 2.8 the zeta potential increases to 
36.37 indicating the protonation of the free -NH2 groups. At the same time with increase 
in pH the zeta potential becomes negative due to opening of lactone ring of CPT giving 
rise to free acid (Figure 8.4d).  
 
Figure 8.4 (a) Change in hydrodynamic size of the drug carrier at various stages of 
synthesis, Variation of the HD size of drug conjugate (b) with pH, (c) with time, (d) 
Measurement of zeta potential of the drug loaded nanoparticle against pH. 
BET surface area 
The nitrogen adsorption-desorption measurement was used to investigate the 
porosity of the sample. The synthesised Fe3O4@m-SiO2 particles exhibit type IV 
isotherm with a hysteresis (Figure 8.5a), which is a characteristics of mesoporous 
materials. The BET surface area was found to be 595 m
2
/g. BJH pore size distribution 
determined from the desorption branch of the isotherm showed the formation of 
mesopores with maximum diameter centered at 5.6 nm and volume at 0.47 cc/g (Figure 
8.5b). However after carbonization the nature of the adsorption-desorption isotherm of 
Fe3O4@m-SiO2-CD changes to type III due to formation of slit like pores.  The BET 
surface area as well as pore diameter is decreased to 135m
2
/g and 4.72 nm respectively 
for Fe3O4@m-SiO2–CD particles. The substantial decrease in surface area and pore size 
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is due to deposition of carbon dots on the inner surface of mesoporous silica. Though 
there is decrease in pore size and pore volume due to shrinkage of mesoporous wall 
during hydrothermal treatment and deposition of carbon dots still the surface area is 
reasonable for drug delivery applications. 
 
Figure 8.5 (a) N2 adsorption-desorption isotherm and (b) pore size distribution of 
Fe3O4@m-SiO2 before and after CD deposition. 
FTIR study  
Figure 8.6 shows FTIR spectra at various stages of synthesis of Fe3O4@m-SiO2-
CD-FA-CPT which clearly establish the conjugation of the CPT and FA on the surface of 
the hybrid nanoparticles. Appearance of the broad bands centered at 3416 cm
-1
 in 
Fe3O4@m-SiO2-CD suggest that a large number of OH groups and H2O molecules exist  
on the surface, which not only play the major role in high aqueous stability but also 
provides enough scope for further functionalization of the particle. The broadness of the 
peak at 1620 cm
-1
 indicates the presence of functional groups like -COOH, -epoxy, 
carbonyl and hydroxyl groups on the surface as reported in case of hydrothermal 
synthesis of CD. The presence of these functional groups also increases its solubility in 
water. The appearance of methylene peak at 2917 and 2850 cm
-1
 along with ring 
breathing frequency of epoxide at 1195 cm
-1
 and 1709 cm
-1
 corresponding formation of 
O=C-O-Si
47
 in epoxy-functionalized particles indicates the surface modification with 
GTPS. The band at 3540, 3423 and 3315 cm
-1
 in the spectrum of folic acid corresponding 
to ring O-H, N-H groups cannot be distinguished in the Fe3O4@m-SiO2-CD-FA 
conjugate due to broadness of the peak. However, peaks corresponding to aromatic C=C 
stretching and N-H bending are prominent in Fe3O4@m-SiO2-CD-FA. The disappearance 
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of epoxide ring breathing peak in Fe3O4@m-SiO2-CD-FA-CPT shows the opening of the 
epoxide ring by the camptothecin conjugate 5 as presented in the scheme 8.1. Further, the 
appearance of C=O stretching at 1760 cm
-1 
correcsponding to lactones along with 
intensification of both methylene and aromatic C=C stretching band confirms the 
attachment of CPT on hybrid nanoparticles in its lactone form.  
 
Figure 8.6 FTIR spectra of Fe3O4@m-SiO2-CD-FA-CPT nanoparticles at various stages of 
synthesis. 
X-ray photoelectron spectroscopy   
X-ray photoelectron spectra were further used to validate the surface modification 
of nanoparticle with CPT and folic acid. In a typical survey spectrum of Fe3O4@m-SiO2-
CD-FA-CPT particles (Figure 8.7a), the peaks at binding energies 100, 280-290, 400.3, 
529-538, 705-730 eV correspond to binding energy of Si2p, C1s, N1s, O1s and Fe2p 
electrons with their atomic percentage 8.29, 59.37, 7.3 , 24.86, and 0.3 respectively. The 
high resolution scans of N1s region can be fitted into three peaks. The broad peak at 
398.4 corresponds to -NH2 in the folic acid, secondary amines in the linker and -NH2 
group of unreacted/physically adsorbed compound 5 and FA-NH2 (Figure 8.7b). The 
peak appearing at 399.1eV is attributed to nitrogen present in the aromatic ring while the 
amide nitrogen appears at slightly higher energy 400.1 eV due to electron pulling effect 
of oxygen. Multiple Si2p photoemissions were observed corresponding to Si atoms 
bonded to C (Si-C, 99.3 eV) and Si atoms bonded to O (Si-O, 101.7 eV) (Figure 8.7c). 
The Fe2p region shows two peaks at 710.6 and 724 eV which is consistent with the Fe2p 
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binding energy of Fe3O4 nanoparticle (Figure 8.7d). The distinct high binding energy at 
about 287.7 and 286.6 eV were characteristic of  the -COOH/-COOR and -C=O/NHCO  
group of CPT and folic acid which  indicated  their successful grafting onto the surface of 
nanoparticle (Figure 8.7e). In addition to this the high resolution C1s shows emissions 
centered at 284.3, 284.6 and 285.9 corresponding to the C-C/C-H, C=C, C-N/C=N/C-O 
carbon. Furthermore, high resolution O1s photoemissions were also obtained 
corresponding to C-C=O, -OH (530.4, 532 eV) bond and a C-O-C=O bond (532.7 eV) 
(Figure 8.7f), which also conﬁrmed the existence of folic acid and CPT.  
 
Figure 8.7 (a) XPS survey spectrum and High resolution scan of Fe3O4@m-SiO2-CD-FA-
CPT corresponding to (b) N1s, (c) Si2p, (d) Fe2P, (e) C1s, (f) O1s. 
Photoluminescence and magnetic properties 
The PL excitation spectrum recorded at λem of 400 nm shows three excitonic 
bands centered at 370, 350 and 338 nm. This behaviour indicates that there are at least 
three types of excitation energy trapped on the surface of the synthesized particle. When 
the sample is excited at 360 nm, there is a strong emission peak around 443 nm indicating 
a blue light emission (Figure 8.8a). Unlike other semiconductor nanoparticles the 
photoluminescence in case of carbon dots is a combined effect of quantum confinement 
and surface defects that originate energy levels in between valence and conduction band 
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that justifies light emission.
48 
These electronic level distributions allow radiative 
recombination of excitons.
49,50 
Compared to bare CD prepared from orange juice,
43
 the 
emission spectrum of the Fe3O4@m-SiO2-CD shows a narrower FWHM due to narrow 
size distribution upon growth of CD in a mesoporous template. The mesoporous silica not 
only confines the growth of CDs with narrow distribution in the pores of silica but also 
prevents the aggregation of the nanosized CDs. The excitation dependent emission 
(Figure 8.8b) of Fe3O4@m-SiO2-CD particles can be ascribed to surface states apart from 
reasons like free zig zag sites, aromatic conjugate structure, radiative recombinations as 
in case of carbon dots. Due to presence of several surface functional groups like C-OH, 
C-O-C, C=O, and C-H, a series of emissive traps between π and π* states C=C are 
originated. When a certain excitation wavelength illuminates the CD a surface energy 
trap will dominate the emission. As the excitation wavelength changes, another 
corresponding surface state emissive trap will become dominant. In case of the hybrid 
particle the position of emission peak varied only slightly by altering the excitation 
indicating more uniform size distribution and less availability of free surface functional 
groups. However this excitation dependent emission gives rise to several visible 
consequences in fluorescence imaging and makes the material suitable as a bioimaging 
probe. The synthesized hybrid nanoparticle showed excellent photostability as there was 
no significant change in fluorescence intensity even after continuous excitation at 360 nm 
for 3 h (Figure 8.8c). The fluorescence microscopy image of synthesized Fe3O4@m-SiO2-
CD shows strong green luminescence. Also the aqueous dispersion of the particles 
emitted green fluorescence on irradiation under UV lamp (Figure 8.8d). 
The field dependent magnetization for both hybrid nanoparticle and CPT 
conjugated nanoparticle did not show hysteresis (Figure 8.8e), which represented their 
superparamagnetic characteristics desirable for their application in drug delivery. Thus 
the surface modification had no detrimental effect on the intrinsic superparamagnetism of 
Fe3O4. However the saturation magnetisation (Ms) value of Fe3O4@m-SiO2-CD (2.2 emu 
g
-1
) was decreased to 0.9 emu g
-1
 on conjugation of folic acid and CPT. This decrease in 
saturation magnetization can be attributed to the combined effect of decrease in magnetic 
content as well as restriction in inter-particle magnetic coupling interaction due to surface 
modification by organic moiety. Furthermore, appreciably high deposition of CD on the 
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surface of Fe3O4@m-SiO2 is also responsible for this substantial reduction in magnetic 
saturation value. Fortunately, the saturation magnetisations value of the synthesized 
Fe3O4@m-SiO2-CD-FA-CPT nanoconjugate fulﬁl the requirements for drug delivery, 
separation and MRI application.
51
  
Figure 8.8 (a) Excitation-emission spectra, (b) wavelength dependent emission, (C) Effect 
of time on fluorescence intensity of Fe3O4@m-SiO2-CD-FA-CPT particle, (d) (1) Typical 
Fluorescence microscopy image and (2) digital photograph under daylight (left) and UV 
lamp (right) of Fe3O4@m-SiO2-CD, (e) Room temperature magnetization behaviors, (f) 
Interaction of Fe3O4@m-SiO2-CD-FA-CPT particles with external magnetic field. 
Camptothecin loading and release 
The hollow mesoporous fluorescent magnetic carrier can be used as a drug 
delivery and are able to carry a high payload of guest molecules (17.5%). Such high CPT 
loading is resulting from the high surface area of hollow mesoporous silica which 
facilitates more interior spaces and conjugation sites. It is noteworthy that such high drug 
loading capacity will allow small doses of Fe3O4@m-SiO2-CD-FA-CPT circumventing 
the toxicity arising due to high doses of mesoporous silica.
52 
The drug encapsulation 
efficiency of the carrier reached 87.5%.  The choice of cleavable ester bonds is perhaps 
the most promising strategy to release CPT at right place and right time through the 
enzymatic cleavage inside the lysosome. The imperative benefit of fluorescent magnetic 
CPT-conjugate is that it prevents premature release of CPT before reaching the target. In 
absence of cathepsin B less than 19% of the drug was released after 20 h incubation time 
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which gradually increased to 52% by the end of 100 h (Figure 8.9a). At the same time 
when the lysosomal condition was mimicked in presence of enzyme cathepsin B almost a 
burst release of 50% was observed in first 20 h which slowly increased to 92% with 100 
h incubation time at neutral pH. The drug release is higher at neutral pH and less acidic 
pH in accordance to other systems where drug is covalently attached to the carrier 
through ester linkage.
28
 At pH 5.3, a burst release of 25% was observed after 10 h, which 
gradually increased to 83% after 80 h. When the pH is decreased to 3.9, the release rate 
of CPT is decreased slightly to 22% at 10 h, which reached to 74% after 80 h. Although 
the cumulative release of CPT is less than the same at alkaline pH, but the release 
behavior of our system at pH 4-5 is comparable or even better than the delivery systems 
already reported for camptothecin.
28-33
 These results indicate that our Fe3O4@m-SiO2-
CD-FA-CPT nanoparticles can be used as a carrier for CPT without premature release of 
the drug in the blood vessel and also shows a sustained release pattern over a prolonged 
time inside the lysosomal compartment.  
 
Figure 8.9 (a) Cumulative CPT releases from Fe3O4@m-SiO2-CD-FA-CPT, (b) In vitro cell 
viability of HeLa with as prepared Fe3O4@m-SiO2-CD, Fe3O4@m-SiO2-CD-CPT and 
Fe3O4@m-SiO2-CD-FA-CPT nanoparticles. 
Cytotoxicity 
To test the efficacy of CPT cleavage inside the target cells, HeLa cells were 
cultured with Fe3O4@m-SiO2-CD, Fe3O4@m-SiO2-CD-CPT and Fe3O4@m-SiO2-CD-
FA-CPT in a folate deficient medium. Nanoparticles deprived of CPT were found to be 
extremely noncytotoxic indicating the biocompatibility of the synthesized nanocarrier 
(Figure 8.9b). As expected, the delivery of the CPT loaded particles to HeLa cells leads 
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to cell growth inhibition and finally to cell death through formation of CPT stabilized 
topoisomerase I-DNA covalent complex. The observed reduced cellular viability in case 
of drug loaded particle (Fe3O4@m-SiO2-CD-CPT) established the ability of the cells to 
induce enzymatic cleavage of CPT. However, the proliferation of HeLa cells reduced 
drastically in a dose dependent manner when incubated with Fe3O4@m-SiO2-CD-FA-
CPT. This is attributed to the active uptake of nanoparticles in a folate receptor mediated 
endocytosis in the folate receptor over expressed HeLa cell that interfered with the cell 
proliferation. The IC50 value (the concentration at which cell growth is uninhibited by 
50%) of our nanomedicine is found to be 2.1 μg/mL.  
In vitro Intracellular uptake and cell apoptosis 
Figure 8.10 illustrated fluorescence images of HeLa cells incubated with 
Fe3O4@m-SiO2-CD-FA-CPT nanoparticles in a time dependent manner and DAPI was 
used as a nuclear contrast dye to appreciate localisation. Green fluorescence was detected 
in the cytoplasm of cells after 30 min demonstrating their cellular internalization through 
folate receptor mediated endocytosis. The green emission comes from carbon dots and it 
was progressively increased in the cytoplasm with longer incubation time.  
 
Figure 8.10 Representative fluorescence images of HeLa cells incubated with Fe3O4@m-
SiO2-CD-FA-CPT in different time intervals. 
To verify whether Fe3O4@m-SiO2-CD-FA-CPT could induce cell death through 
initiation of apoptosis, HeLa cells were exposed to the drug loaded nanoparticle (1-10 
µgmL
-1
) for 24 h, washed to remove the noninternalized nanoparticles and subsequently 
visualized using fluorescence microscopy. The cells showed nuclear fragmentation which 
is a trademark of apoptosis. With a dose dependent manner an increase in the formation 
of fragmented nuclei containing condensed nuclear material was observed in fluorescence 
microscopy after nuclear staining with DAPI (Figure 8.11).  
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Figure 8.11 DAPI fluorescence (200X) images of HeLa cells incubated with (A)PBS, (B) 1, 
(C) 5, and (D) 10 μg/mL Fe3O4@m-SiO2-CD-FA-CPT for 24 h. The arrows represent 
apoptotic features such as nuclear condensation, fragmentation etc. 
In vitro MRI 
As an initial investigation towards potential imaging functionality during 
chemotherapy, the visibility of nanocapsules was tested in water and HeLa cells by MRI. 
As shown in Figure 8.12, with increasing concentration of Fe3O4@m-SiO2-CD-FA-CPT 
in the phantom solution, the signal intensity decreased indicating that the magnetic 
hollow spheres have generated magnetic resonance contrast on transverse (T2) proton 
relaxations times weighted sequence due to the dipolar interaction of magnetic moments 
between the nanoparticles and proton in the water.
53 
The T2 relaxation time was inversely 
proportional to the particle concentration as expected. The transverse relaxivity (r2) of the 
drug conjugate is found to be 150.03 mM
-1
S
-1
 resulting in better negative contrast effect 
than commercially available dextran coated iron oxide such as feridex (r2 = 120 mM
-1
S
-1
), 
combidex (65 mM
-1
S
-1
), CLIO-tat (62 mM
-1
S
-1
).
54
  
To confirm the association of these nanoparticles with FR-overexpressing HeLa 
cells, MR phantom imaging was carried out. MR phantom samples were prepared by 
incubating HeLa cells with the magnetic nanocapsules in agarose. The T2-weighted 
phantom images of cells incubated with Fe3O4@m-SiO2-CD-FA-CPT showed a 
significant negative contrast enhancement with increase in dose. In addition to this, 
maximizing the intake of nanoparticles with time through folate receptor mediated 
edocytosis in a folate-receptor overexpressed cancer cell would further enhance the 
contrast in MRI.
55 
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Figure 8.12 (a) MR phantom images of Fe3O4@m-SiO2-CD-FA–CPT particles in water and 
HeLa cells (b) Relaxivity (r2) measurement of Fe3O4@m-SiO2-CD-FA–CPT. 
 
8.5. Conclusion 
 The hollow mesoporous silica-based luminescent magnetic hybrid nanoparticles 
have been synthesized by incorporating iron oxide nanoparticle as magnetic 
component and carbon dot as the luminescent component. 
 The particles show MR contrast behaviour by affecting the proton relaxation with 
transverse relaxivity (r2) 150.03 mM
-1
S
-1
. 
 Water soluble conjugate of CPT has been synthesied through a scissile ester bond 
by coupling a small highly hydrophilic spacer (2,2’-(ethylenedioxy)-bis-
(ethylamine) (EDBE) through a linker diglycolic acid. This surface engineering 
design promotes a reliable strategy for the administration of water insoluble drug 
camptothecin. 
 The synthesized fluorescent magnetic nanoparticles have been conjugated with 
hydrophobic drug camptothecin and a molecular marker folic acid using 
appropriate surface chemistry. 
 These multifunctional nanoparticles are not only extremely stable in aqueous 
buffer but also possess appreciably good cytotoxicity through induction of 
apoptosis. 
 The dual optical and magnetic properties of the developed multifunctional hollow 
nanosphere may be utilized in advanced imaging technologies to track the 
curative responses.  
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Future Scope  
Considering the observed excellent theragnostic potential of the developed 
nanostructures in vitro, they can be experimented for in vivo applications.  As proper 
surface functionalization is the most important factor to enhance and fine-tune the 
pharmacological properties of nanomaterials, the synthesized carbon quantum dots (CD) 
can be biofunctionalized for biosensing application. Furthermore the doping not only 
enhances the fluorescence quantum yield of the carbon quantum, it also tunes its 
electronic properties. In this regard, our prepared nitrogen, sulphur co-doped carbon 
quantum dot (NSCD) can be explored for photacatalytic degradation of various organic 
pollutants and pesticides which will be more beneficial to regulate the environmental 
pollution. There is also a substantial scope to prepare NSCD based heterogeneous 
nanostructures for development improved photocatalyst. 
CDs with bright fluorescence having relatively low-energy excitation sources 
have more effective tissue penetration with reduced interference from background 
fluorescence. In line with these advantages, there is wide scope for the fabrication of CD 
with excitation in red/near-IR spectral region using simple inexpensive chemical routes. 
Furthermore exploiting the surface functionalization technique, these high quality CDs 
can be coupled with bioactive species to enable specific targeting in cellular and in vivo 
imaging and related biomedical applications.  
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